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INTRODUCTION 
The Eukaryotic cell cycle. 
The classical eukaryotic cell cycle is divided into four phases (Fig. 1a). This is illustrated 
graphically in Fig. 1a using a typical Drosophila imaginal disc cell cycle as an example. 
To permit cell division to occur the entire chromosomal content of DNA is replicated 
once during a period of DNA synthesis (S phase). Replicated DNA is segregated into 
two daughter cells during mitosis (M phase) in such a way that both cells receive an 
equal complement of DNA. Cytokinesis follows chromosomal segregation during M 
phase, creating two distinct daughter cells with a pre-S phase complement of DNA. Two 
 
 
Figure 1.1: A Drosophila imaginal disc cell cycle. 
A typical cell cycle is divided into four phases; a period of chromosomal DNA segregation (mitosis or M 
phase), a period of DNA replication (S phase) and two intervening gap phase (G1 and G2) (a). In 
Drosophila mitosis is triggered by the catalytic activity of Cdk1, complexed to its cyclin partners A and B. 
S phase is induced by Cdk2/CycE and Cdk1/CycA. Mitosis is subdivided into four distinct phases (b). 
During interphase DNA is in a relaxed decondensed form. In prophase DNA starts to condense. Nuclear 
envelope integrity is disrupted at the prophase/metaphase transition. Condensed DNA aligns on the 
metaphase plate in a compact form during metaphase. Cohesive forces between sister chromatids and 
pushing forces generated by mitotic spindles emanating from the spindle poles align DNA on the 
metaphase plate. Cohesion is disrupted at the metaphase/anaphase transition by proteolysis of 
cohesins. Sister chromatids are pulled to opposing poles in anaphase by the mitotic spindle. In 
telophase DNA decondenses and cytokinesis establishes two sister cells. 
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Gap phases, G1 and G2 separate mitosis and S phase. S phase and the accompanying 
gap phases are often collectively referred to as interphase. Mitosis is further divided into 
four phases, defined by DNA morphology (Fig. 1b). As cells exit interphase DNA 
condenses in a period known as prophase. During metaphase highly condensed sister 
chromatids align on the metaphase plate. Metaphase is maintained by pushing forces 
from the spindle poles and cohesive forces between sister chromatids. The cohesive 
force is established by a conserved family of proteins, known as cohesins (Guacci et al., 
1997; Michaelis et al., 1997). Cohesin activity has been studied in greatest detail for S. 
cerevisiae. In the budding yeast the cohesin complex consists of the four proteins Smc1, 
Smc3, Scc1 and Scc3, where Smc1 and Smc3 are responsible for DNA contact. 
Cohesins associate with DNA at many regions along the chromosome arms and at 
centromeric regions. At the metaphase/anaphase transition cohesion between sister 
chromatids is disrupted by cohesin proteolysis. 
This proteolysis is catalyzed by separins (Nasmyth et al., 2000). Separins have been 
characterized in a number of organisms and are highly divergent, with the exception of a 
conserved C-terminal separin domain. The budding yeast separin, Esp1p cleaves Scc1 
at two places, disrupting cohesion (Uhlmann et al., 1999). Separins are maintained in an 
inactive state until the metaphase/anaphase transition by associated proteins known as 
securins (Ciosk et al., 1998). Securins have been characterized in budding and fission 
yeast; Pds1p and Cut2p respectively. In budding yeast cohesion Pds1p is destroyed 
during metaphase, releasing Esp1p and allowing cohesin proteolysis (Uhlmann et al., 
1999). In higher eukaryotes cohesion is lost during prophase for most of the chromatid, 
excluding the kinetochore (Losada et al., 1998). Kinetochore cohesion is disrupted at the 
metaphase to anaphase transition. In higher eukaryotes it is still not clear which activities 
function as securins and separins. In Drosophila the genes pimples (pim) and three rows 
(thr) are obviously involved in this process as mutations in either gene fail to disrupt 
kinetochore cohesion at the metaphase to anaphase transition (D'Andrea et al., 1993).  
Cdk regulation 
The eukaryotic cell cycle is driven by the activities of a conserved family of proline-
directed serine/threonine kinases; the Cyclin Dependent Kinases (CDKs) (Nurse, 1990). 
CDKs are relatively inert kinases that are fully active after association with positive 
regulatory subunits, the cyclins (Fisher, 1997) and after CDK phosphorylation on a 
conserved threonine residue (T161) (Fig. 2). T161 is in a structural element, the T-loop, 
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which blocks substrate access to the active site of CDKs (Morgan, 1995). 
Phosphorylation of T161 opens the active site allowing access of substrates to CDKs. 
T161 phosphorylation is catalyzed by a CDK Activating Kinase (CAK) (Solomon et al., 
1992). The budding yeast CAK, CIV1 is a monomeric kinase of approx. 40kDa molecular 
weight (Kaldis et al., 1996; Thuret et al., 1996). The true nature of CAK in higher 
eukaryotes has not been fully resolved. A heterotrimeric complex of Cdk7/CycH/Mat1p 
has CAK activity in vitro and cdk7 temperature sensitive mutants in Drosophila are lethal 
with several cell cycle defects (Devault et al., 1995; Fisher and Morgan, 1994; Larochelle 
et al., 1998). However, this complex also phosphorylates the C-terminal domain of RNA 
polymerase II and is believed to play a role in transcription (Roy et al., 1994; Serizawa et 
al., 1995). It is not clear whether the ability of Cdk7 to activate other CDKs is an in vitro 
artifact, or whether it reflects an in vivo property of Cdk7. As well as activation by CAK, 
CDKs are inactivated by inhibitory phosphorylation on conserved threonine 14 and 
tyrosine 15 residues by wee and myt kinases (Morgan, 1995). Inactivation of CDK by 
wee or myt is reversed by dephosphorylation mediated by the Cdc25 phosphatase 
(Russell and Nurse, 1986). Two Cdc25 homologues exist in Drosophila; string (stg) and 
the germline homologue twine (twe). 
 Lower eukaryotes such as budding and fission yeast have only one CDK (CDC28 and 
cdc2, respectively), while several CDK homologues exist in higher eukaryotes. CDK 
homologues adapted cell cycle stage specificity as they evolved. It has been proposed 
that the committing step to cell cycle initiation in metazoans is catalyzed by complexes of 
Cdk4 or Cdk6 with Cyclin D (CycD) (Kato et al., 1993). CDK/CycD complexes are 
proposed to respond to external signals such as mitogen stimulation by initiating cell 
division. CDK/CycD complexes phosphorylate pocket proteins such as Rb, thereby 
relieving Rb-mediated inhibition of the transcription factor E2F (Matsushime et al., 1994). 
Rb inhibits E2F in a simple stoichiometric way as well as by recruiting histone 
deacetylase activity to E2F-responsive genes (Dyson, 1998). Deacetylation leads to 
localized DNA condensation, making genes inaccessible to transcription factors. E2F is 
required for the transcription of numerous genes involved in the transition from G1 to S 
phase such as ribonucleotide reductase and CycE (Dyson, 1998). Cdk2/CycE also 
phosphorylates Rb, enhancing E2F activation. Drosophila has only one Cdk4/6 
homologue, Cdk4 and cdk4 mutants have been described recently (Meyer et al., 2000). 
Drosophila Cdk4 has Rb-phosphorylating activity and associates with CycD, suggesting 
that Cdk4 function has been conserved during evolution. Interestingly, Cdk4/CycD 
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activity is neither specific to G1, nor necessary for the cell cycle in Drosophila (Datar et 
al., 2000; Meyer et al., 2000). Cdk4 null mutants are not lethal and the entire cell cycle, 
not just G1 is prolonged in mutants. Similarly, overexpression of Cdk4/cycD accelerates 
the entire cell cycle, not just G1. It appears instead that CycD may play a role in growth 
regulation in Drosophila. In concurrence with these phenotypes, knock-out mice where 
individual CycD genes have been deleted also have hypotrophic phenotypes (Fantl et 
al., 1995).Thus, the exact in vivo functions of CycD and its associated CDKs remain to 
be clarified. 
 
Fig. 1.2: CDK regulation. 
Numerous activities regulate CDK in positive and negative manners. CDKs are fully active after 
association with cyclin partners and phosphorylation of a conserved threonine residue (T161). 
Association with cyclins puts bound ATP in the correct orientation and phosphorylation of the T loop 
leads to a CDK conformational rearrangement. The negatively charge phosphate group on T161 is 
attracted to a basic cluster away from the active site, exposing the active site to CDK substrates. CDKs 
are downregulated by phosphorylation of conserved threonine (T14) and tyrosine residues (Y15) 
situated close to the active site. Inhibitory phosphates are removed by the conserved CDC25 
phosphatase in a step that is limiting for entry into mitosis. A critical means of CDK inactivation at 
specific times is ubiquitin-mediated proteolysis of cyclin proteins. A third form of CDK regulation is non-
covalent inhibition by CDK Inhibitor (CKI) proteins. Arrows indicate upregulation of CDK/cyclin activity 
and bars indicate down regulation. 
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In higher eukaryotes S phase is triggered by Cdk2, while entry into mitosis relies on 
Cdk1 activity. Cdk1 associates with Cyclin A (CycA) and B-type cyclins, while Cdk2 
associates with Cyclin E (CycE). Mammalian Cdk2 also associates with CycA and 
Cdk2/CycA has S phase functions in mammals (Pagano et al., 1992). The contribution of 
individual CDKs and cyclins to S phase and M phase in Drosophila has been studied in 
detail. Mitosis relies on Cdk1, which associates with CycA, Cyclin B (CycB) and Cyclin 
B3 (CycB3), while Cdk2 associates with Cyclin E (Knoblich et al., 1994). CycA is the 
only essential mitotic cyclin. Homozygous cycA mutants die during G of the 16th cycle 
(Lehner and O'Farrell, 1989). Cdk1/CycA also contributes to S phase, but is not 
essential for this aspect of the cell cycle (Sprenger et al., 1997). Homozygous cycB and 
cycB3 mutants are viable (Jacobs et al., 1998), indicating that their functions are 
essential for cell cycle progression, although cycB3 mutant females are sterile. The 
mitotic cyclins have dynamic patterns of subcellular localization. CycA and CycB are 
cytoplasmic during interphase and accumulate in the nucleus in prophase (Jacobs et al., 
1998; Lehner and O'Farrell, 1989). Nuclear envelope breakdown occurs during the 
prophase/metaphase transition, after which all cyclins are uniformly distributed 
throughout the cytoplasm. As mitosis progresses the cyclins are destroyed in a 
stereotypical temporal order. CycA is destroyed at the metaphase to anaphase 
transition, CycB is destroyed during the anaphase to telophase transition and CycB3 
during late telophase (Sigrist et al., 1995). 
Sequential cyclin inactivation by proteolysis is a characteristic of all higher eukaryotic 
mitotic programs. (Hunt et al., 1992). Cyclins are destroyed by the proteasome in a 
ubiquitin dependent manner (Koepp et al., 1999). In the case of CycB destruction 
depends on a conserved motif, the destruction box (RXXLXXXXN) at the N-terminus of 
the protein (Glotzer et al., 1991). Removing the destruction box from CycB confers 
stability to the protein and attaching the CycB destruction box to heterologous proteins 
can induce their destruction (Glotzer et al., 1991). Destruction boxes have been 
observed in other proteins that are turned over during mitosis, suggesting that this signal 
motif may be a general mediator of protein destruction during mitosis (Cohen-Fix et al., 
1996; Leismann et al., 2000). It has not been demonstrated which motif determines 
CycA destruction. Cdk1 inactivation by cyclin destruction is necessary for progression 
through mitosis. An N-terminal truncated CycA (CycA∆170) is stable in Drosophila. 
Drosophila embryos expressing CycA∆170 arrest in metaphase (Sigrist et al., 1995). 
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Indestructible CycB expression leads to an anaphase arrest and indestructible CycB3 
expression leads to a telophase arrest.  
Multi-ubiquitin chains attached to lysine residues serve as a tag directing cyclins to the 
proteasome for destruction (Hochstrasser, 1996). Ubiquitins are transferred to 
substrates in a three-step reaction. A ubiquitin-activating enzyme, E1 hydrolyzes ATP 
and forms a high-energy thioester between a cysteine of its active site and the C 
terminus of ubiquitin. Activated ubiquitin is transferred to ubiquitin-conjugating enzymes, 
E2s, which form thioester-linked complexes with ubiquitin. Finally, ubiquitin is covalently 
attached to the substrate protein either directly by the E2s, or by ubiquitin-protein 
ligases, E3s. Recently a novel ubiquitination factor, E4, was identified that drives 
multiubiquitin chain assembly, yielding long chains (Koegl et al., 1999). The Anaphase 
Promoting Complex/Cyclosome (APC/C) is an E3 ligase that targets mitotic cyclins for 
destruction in a large number of organisms (Zachariae and Nasmyth, 1999). The APC/C 
targets mitotic cyclins for destruction during M phase and G1. In budding yeast the two 
proteins Cdc20p and Hct1p confer specificity on the APC/C in a poorly understood 
manner (Fang et al., 1998; Kramer et al., 1998; Schwab et al., 1997; Visintin et al., 
1998). Homologues of both proteins have been identified in many organisms. The 
Drosophila homologues Fizzy (Fzy) and Fizzy-related (Fzr) are required for APC/C 
function during mitosis and G1 respectively (Dawson et al., 1993; Dawson et al., 1995; 
Sigrist and Lehner, 1997). A second multiprotein E3 complex, the SCF (Skp1-Cullin-F-
box protein) triggers the degradation of many cell cycle proteins in G1. (Bai et al., 1996). 
Substrates are recognized by specific F-box proteins in SCF complexes and then 
ubiquitinated. Recognition by F-boxes often depends on substrate phosphorylation 
(Feldman et al., 1997; Skowyra et al., 1997; Skowyra et al., 1999). 
Cyclin Dependent Kinase Inhibitors (CKIs). 
A further conserved mechanism of down-regulating CDK activity is mediated by CDK 
Inhibitor (CKI) proteins (Peter and Herskowitz, 1994; Sherr and Roberts, 1999; Sherr 
and Roberts, 1995). CKIs have been identified in a large number of organisms, and 
function by associating with CDKs, cyclins or both. CKIs inhibit CDK activity and prevent 
CDK activation without covalent modification of CDKs. Mammalian CKIs fall into two 
distinct families. The INK4 family of inhibitors specifically inhibits CycD in complex with 
Cdk4 and Cdk6 (Guan et al., 1994; Serrano et al., 1993). A second family of CKIs, the 
KIP/CIP family functions downstream of CycD/CDK complexes (Toyoshima and Hunter, 
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1994). This family consists of the three proteins p21, p27 and p57. All three function by 
inhibiting the S phase cyclins, CycA and CycE. The KIP/CIP family of CKIs has an 
additional, unexpected function. They are required for the formation of active CDK/CycD 
complexes (Cheng et al., 1999). The sequestration of KIP/CIP inhibitors by CDK/CycD 
has a secondary consequence of releasing active Cdk2/CycA and Cdk2/CycE 
complexes, which are free to induce S phase. Interestingly, no CKI has been 
characterized in mammals that specifically inhibits mitotic cyclins, although both budding 
and fission yeast have such a CKI; SIC1 and rum1 respectively (Correa-Bordes and 
Nurse, 1995; Mendenhall, 1993). A search of the recently completed Drosophila genome 
did not reveal any CKIs of the INK4 family. Drosophila has a single gene that belongs to 
the p21/p27 class of CKIs, dacapo (de Nooij et al., 1996; Lane et al., 1996). Dacapo is 
required for the establishment of the first G1 state of embryonic development during 
cycle 17. It binds CycE/Cdk2 and inhibits kinase activity in vivo and in vitro (Lane et al., 
1996). Dacapo is also required at later stages, such as during eye development, for the 
establishment and maintenance of G1. 
CKIs function as inducible cell cycle repressors or as intrinsic elements of the cell cycle. 
A classical inducible CKI is the budding yeast protein Far1p (Chang and Herskowitz, 
1990). FAR1 is induced in response to mating factor or nutrient deprivation and enforces 
a G1 arrest by down-regulating the activities of the yeast G1 cyclins; Cln1p, Cln2p and 
(Peter et al., 1993; Valtz et al., 1995). In higher eukaryotes p21 can be induced by the 
p53 transcription factor in response to DNA damage. This elicits a G1 arrest by inhibiting 
the activities of CycA and CycE.  
The yeast protein Sic1p is one of the best studies CKIs which function as an integral 
element of the cell cycle apparatus (Mendenhall, 1993). Sic1p is required to maintain a 
G1 state by inhibiting the B-type cyclins, Clb5p and Clb6p (Schwob et al., 1994). 
CDC28/CLB5 and CDC28/CLB6 are essential for execution of S phase in yeast. Sic1p 
inhibits Clb5p and Clb6p in G1, preventing premature S phases. CLN levels rise as cells 
pass START, the point of commitment to execution of a cell cycle. Single and double 
CLN mutants are viable, but yeast mutants lacking all three CLNs are lethal (Richardson 
et al., 1989). Mutants arrest in G1 with high levels of Sic1p. Removing SIC1 from this 
mutant background restores viability, indicating that the only essential function 
performed by the CLNs is to downregulate Sic1p (Dirick et al., 1995). CDC28/Cln 
complexes phosphorylate SIC1 at the end of G1. Phosphorylated Sic1p is recognizes by 
Cdc4p an F-box component of an SCF complex (Feldman et al., 1997). Sic1p is then 
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ubiquitinated and turned over by the proteasome. Sic1p proteolysis is essential for cell 
cycle progression, as expression of SIC1 isoforms lacking CDC28 phosphorylation sites 
leads to a G1 arrest (Nishizawa et al., 1998). Sic1p proteolysis allows Cdc28p/Clb5p and 
Cdc28p/Clb6p complexes to initiate S phase.  
As well as contributing to regulation of the G1-S transition recent data has emerged 
supporting a role for Sic1p in exit from mitosis (Donovan et al., 1994). In late interphase 
and early mitosis cellular levels of Sic1p are relatively low due to high Cdc28p kinase 
activity. Cdc28p phosphorylates the Sic1p transcription factor Swi5p, resulting in a 
cytoplasmic accumulation of Swi5p (Moll et al., 1991). cdc28p also directly 
phosphorylates Sic1, thereby targeting it for degradation (Feldman et al., 1997). This 
depression of Sic1p proteins levels is reversed at the metaphase to anaphase transition 
due to the release of the Cdc14p phosphatase from the nucleolus. The Cdc14p 
phosphatase is retained in the nucleolus by Net1p during interphase (Shou et al., 1999; 
Visintin et al., 1999). At the metaphase to anaphase transition Net1p is inactivated by 
proteins of the Mitotic Exit Network (MEN) signaling cassette (Jaspersen et al., 1998; 
Shou et al., 1999). Cdc14p dephosphorylates several key proteins, including Sic1p, 
Swi5p and Hct1p. Hct1p is the budding yeast homologue of Fzr. In its unphosphorylated 
form Hct1p is inactive and targets mitotic cyclins for destruction (Zachariae et al., 1998). 
Swi5p accumulates in the nucleus In its unphosphorylated form and activates the 
transcription of Sic1p (Toyn et al., 1997). Unphosphorylated Sic1p is no longer a target 
for the proteasome, allowing the protein to accumulate. The consequence of Hct1p and 
Sic1p activation is a precipitous drop in Cdc28p activity, forcing an exit from mitosis and 
entry into G1. 
The Drosophila cell cycle. 
Many deviations from the standard cell cycle described above have been reported in 
Drosophila (Edgar et al., 1994). The first thirteen divisions are extremely rapid. They are 
nuclear cycles as opposed to cell cycles and occur synchronously in a common 
syncitium. Each division occurs in approx. 10min and consists entirely of S and M 
phases with no intervening gap phases (Edgar and Lehner, 1996). The first thirteen 
divisions occur entirely under the control of maternally provided products. These 
products are exhausted after the 13th division at the mid-blastula transition (MBT). A 
prolonged interphase is introduced and all subsequent divisions depend on the correct 
transcription of zygotic genes. The first G2 is introduced in the 14th cycle by the inhibitory 
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phosphorylation of Cdk1 on T14 and Y15 . Entry into mitosis depends on transcription of 
the cdc25stg phosphatase, which relieves Cdk1 inhibition (Edgar and O'Farrell, 1990). 
cdc25stg is transcribed in a complex pattern of 25 domains with bilateral symmetry along 
the anterior/posterior axis and mitosis 14 occurs in an almost identical pattern of 
domains (Foe, 1989). Cycle 15 and 16 also have extended interphases which are 
established in G2 (Edgar and O'Farrell, 1990). None of cycles 14, 15 or 16 have a G1. S 
phase follows the preceding mitosis immediately. After completion of the 16th division a 
prolonged G1 is introduced to most cycles, with the exception of cells of the nervous 
system. Several internal cells such as the salivary glands undergo repeated rounds of 
DNA replication (endocycles) without intervening divisions. Proliferative cycles 
recommence only after completion of embryogenesis. Most external structures are laid 
aside as columnar epithelia, known as imaginal discs. Imaginal disc proliferation starts in 
the first instar stage and proceeds into the third instar stage where patterning occurs. 
Roughex (Rux). 
Rux inhibits CycA during male meiosis and eye development. After completion of WT male meiosis haploid 
nuclei (transparent) are visible paired up with dense mitochondrial nebenkern (dark circles) (a). In rux 
mutant two nuclei (arrows) are visible with every nebenkern (arrowhead). The extra nucleus is the result of 
an aberrant 3rd meiotic division in rux mutants (b). Eye patterning is also disturbed in rux mutants. The 
mature adult eye consists of a regular lattice array of approx. 800 individual ommatidia (c). During eye disc 
development a G1 is established in the morphogenetic furrow (e, arrowhead). A wave of S phase cells lies 
posterior to the morphogenetic furrow. In rux mutants eye patterning is grossly disturbed (d). This is a result 
of precocious S phases occurring in the morphogenetic furrow (f). (c) and (d) are scanning electron 
micrographs and (e) and (f) are antibody staining of third instar larval discs with anterior to the right. S 
phases are visualized in (e) and (f) by staining with an anti-BrdU antibody. (a) and (b) are take from (Gonczy 
et al., 1994) and (c-f) are taken from (Thomas et al., 1994). 
 
Fig. 1.3: Rux is a negative regulator of Cdk1/CycA in Drosophila. 
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Several activities contribute to establishment of G1 at the correct stages of Drosophila 
development. After completion of mitosis Cdk1 is inactivated by inhibitory 
phosphorylation on T14 and Y15. Cyclin levels are maintained low by APC/C dependent 
destruction. Dacapo also contributes to establishment of the first G1, as mutants fail to 
arrest in G1 of cycle 17 and perform an additional division. An additional gene product, 
Roughex (Rux), contributes to the establishment and maintenance of G1 at different 
stages of development (Sprenger et al., 1997; Thomas et al., 1994; Thomas et al., 
1997). Rux was originally identified in a screen looking for genes involved in eye 
development (Thomas et al., 1994). Mutants have rough and reduced eyes and the gene 
was mapped to the X chromosome, giving rise to the name. Mutant males are also 
sterile. Antibody staining or in situ hybridization with RNA probes does not reveal the 
endogenous pattern of Rux expression, presumably due to low level expression. Several 
mutant alleles exist and two mutant alleles, rux8 and rux4 have been sequenced 
(Thomas et al., 1994). The wild type gene codes for a 335 amino acid protein with a 
predicted molecular weight of 38kDa and antibody staining demonstrate that it is a 
nuclear protein. A database search does not reveal any homologues, indicating that Rux 
is a novel protein. 
One of the most obvious aspects of mutations at the rux locus are rough eyes in adult 
flies. Patterning of the eye imaginal disc commences in the third instar (Ready et al., 
1976). Patterning is often viewed as two mitotic waves sweeping from the posterior to 
the anterior of the disc. The two waves are separated by an indentation along the dorso-
ventral axis of the disc, the morphogenetic furrow (MF). Whereas, cells anterior to the 
MF are asynchronous and all cell cycle stages are distinguishable cells are synchronized 
within the MF. G2 cells immediately anterior to the MF are driven into mitosis and G1 
cells are retained in G1 (Thomas et al., 1994). The consequence is that all cells are 
synchronized in G1 within the MF. Some of the cells posterior to the MF enter a second 
synchronous round of division before differentiation, while others differentiate 
immediately. The resulting adult eye is characterized by a reiterative array of cell shaped 
ommatidia. In rux mutants the regular shape of the adult eye is completely abolished 
(Thomas et al., 1994). This arises from a disturbance of the stereotyped cell cycle 
pattern in the eye disc. A G1 is not established in the MF in rux mutants. Instead the MF 
is characterized by a band of precocious S phases. Removing a single copy of cycA or 
cdc25stg restores a G1 to the MF and rescues the eye phenotype of rux mutants, 
indicating that CycA activity is elevated in the developing eye of rux mutants. 
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The sterile phenotype of rux mutant males is also caused by disturbances in cell cycle 
progression (Gonczy et al., 1994). During spermatogenesis males normally undergo two 
separate meiotic divisions, generating haploid sperm. rux males perform an additional 
meiotic division which resembles meiosis II. The result is aneuploid nuclei and male 
sterility. Fertility is restored to mutant males by removing a single copy of cycA or 
cdc25twe, the germline homologue of cdc25stg, indicating that the molecular basis of this 
phenotype is also an increase of CycA activity in rux mutants. As both the rough eyes 
and male fertility of rux mutants are rescued by lowering cycA levels it is likely that Rux 
downregulates CycA activity during development. Male flies containing an extra copy of 
the WT rux gene are sterile due to an arrest of the cell cycle in meiosis I, indicating that 
Rux is a dose-dependent regulator of meiosis. Rux performs additional functions besides 
downregulating CycA in the eye and during male meiosis, as mutants display a 
considerably reduced viability (Thomas et al., 1994). 
Overexpression of Rux at different stages of development also has several cell cycle 
consequences. Rux overexpression in embryos arrests cells in G2 (Foley et al., 1999; 
Thomas et al., 1997). Rux overexpression in various imaginal discs also prevents 
execution of mitosis. Instead endocycles are often observed (Thomas et al., 1997). An 
additional consequence of Rux overexpression is an alteration in the subcellular 
localization of CycA and CycB. CycA and B are normally cytoplasmic in interphase cells. 
Rux overexpressing cells in the embryo and the eye disc show a large accumulation of 
both cyclins in the nucleus (Foley et al., 1999; Sprenger et al., 1997; Thomas et al., 
1997). Rux overexpression also inhibits S phase functions of CycA. Overexpression of 
CycA or CycA∆170 leads to ectopic S phases in the embryonic epidermis. A co-
expression of Rux inhibits these ectopic S phases (Sprenger et al., 1997). As Rux 
prevents S phases performed by CycA∆170 inhibition does not rely solely on cyclin 
destruction. 
Previous attempts to describe in vitro interactions between Rux and CycA were not 
successful (Thomas et al., 1997). Rux interacts with CycE in a two-hybrid assay, 
however it could not be determined if Rux also interacts with CycA, as full-length CycA is 
toxic to yeast. A GST-Rux fusion protein does not inhibit the in vitro kinase activity of 
Cdk2/CycE or Cdk1/CycA, however it should be noted that the GST tag is extremely 
bulky and has almost the same molecular weight as Rux. Rux has four potential CDK 
phosphorylation sites and Cdk1/CycA and Cdk2/CycE precipitated from embryonic 
extracts phosphorylate Rux. Overexpression of Rux does not inhibit CycE-dependent S 
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phases, but CycE does downregulate Rux protein levels. Rux protein levels were 
detected by anti-lacZ staining of discs expressing a Rux-lacZ fusion under the control of 
the rux promoter. Rux protein is detected in cells anterior to the MF and is 
downregulated in cells that reenter S phase. Overexpression of CycE from a heat 
inducible promoter lowers Rux levels, suggesting that rux is destroyed in cells that enter 
S phase. 
Goal of this project 
The data described above strongly argue for a role for Rux as a regulator of CycA in 
Drosophila. Rux overexpression prevents CycA-dependent S phases and inhibits 
mitosis. Rux is a nuclear protein and leads to a nuclear accumulation of CycA. 
Furthermore, removing a single copy of cycA suppresses the rux mutant phenotype. 
However, the exact manner in which Rux regulates CycA is not clear. To address this 
issue this project focuses on the following points. 
1. A biochemical characterization of Rux-mediated inhibition of CycA. The effects of 
Rux on Cdk1/CycA kinase activity were monitored in vivo and in vitro. Several 
questions were addressed in this section; Does Rux physically interact with CycA? Is 
Rux a CKI or is it an adapter protein that recruits an unknown CKI to Cdk1/CycA 
complexes? 
2. Identification of key residues in the Rux protein. Site directed mutagenesis and 
truncated versions of the Rux protein were analyzed to identify the residues in Rux 
required for nuclear localization, interaction with CycA and Rux destruction. 
3. Cell cycle stages of Rux function. The data described above suggest that Rux is 
required to prevent a premature G1 to S transition during eye development. 
However, it is possible that Rux may also function during other stages of the cell 
cycle, as CycA is necessary for mitosis. Comparisons were performed between rux 
mutants and WT embryos to determine if other stages of the cell cycle are disturbed 
in rux mutants. 
4. Analysis of Rux turnover. Examination of eye discs expressing a Rux-lacZ fusion 
protein suggests that Rux is stable in G1 and turned over prior to S phase. The 
molecular basis for Rux destruction, the residues required for this turnover and the 
role of CycE in this process were analyzed in vivo and in vitro. 
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RESULTS 
Rux protein structure 
Rux does not have any obvious homologues in the data bases. However, the primary 
amino acid sequence of Rux has several distinct motifs. Rux has three RXL 
sequences in its primary amino acid sequence (Fig. 2.1A and B). The amino acid 
sequence RXL has been implicated in numerous proteins as necessary for 
interactions with cyclins (Chen et al., 1996). There are two sites which conform to the 
minimal (S/TP) consensus for Cdk-mediated phosphorylation and two sites which 
have the extended (S/TPXR/K) consensus sequence (Fig. 2.1A and B). Rux also has 
a putative bipartite Nuclear Localization Sequence (NLS) at the C-terminus (Dingwall 
and Laskey, 1991), and a potential PEST sequence from amino acids 222 to 243. 
PEST sequences have been implied in several proteins as being required for 
proteasome-mediated destruction (Rechsteiner and Rogers, 1996). The importance 
of these sequence elements for Rux function will be discussed below.  
Several rux mutant alleles were used in this study. rux8 has been described 
previously and is considered a null allele (Thomas et al., 1994). It is an 11bp deletion 
in the coding region that leads to a frameshift after amino acid 78, followed by an 
additional 7 out-of-frame amino acids. Mutant flies display a greatly reduced viability, 
have rough and reduced eyes and males are sterile. The rux2 and rux3 alleles were 
sequenced in this study. rux3 carries a frame shift mutation that encodes a protein 
with 21 out of frame amino acids after amino acid 320 (Fig. 2.1A). This mutation 
eliminates the second basic cluster in the NLS. rux3 and rux2 mutant males are fertile, 
meaning that the mutation can be maintained as a homozygous stock. Genomic DNA 
was isolated from single rux2 mutant flies and sequenced. The reading frame in these 
mutants is intact. The 910bp upstream of the genomic DNA have sufficient promoter 
activity to rescue the rux mutant phenotype (Thomas et al., 1997). A series of primers 
were designed to amplify sections of this promoter region by PCR (Fig. 2.1C). DNA 
fragments of the expected length were amplified from WT genomic DNA, but not rux2 
DNA (Fig. 2.1C), indicating that this particular mutation affects the rux promoter. As 
rux2 males are fertile, this is still a certain amount of expression from the promoter, at 
least during spermatogenesis. However, this level is not sufficient to rescue the eye 
phenotype. 
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Fig. 2.1: Schematic representation of the Rux protein. 
(A) The primary amino acid sequence of WT rux and two mutant alleles, rux3 and rux8 used in this study. 
Italicized residues indicate the out of frame amino acids. (B) A schematic representation of the WT Rux 
protein, indicating potential CDK-phosphorylation sites (TP), cyclin-binding motifs (RXL), a putative 
bipartite nuclear localization sequence (NLS) and a PEST motif (PEST). (C) A schematic representation 
of the region 900bp upstream of the start site of the rux ORF. The ORF is represented as a black box 
and the promoter as a gray box. The scale bar represents 100bp. The relative positions of the three 
primers 2.1, 2.2 and 2.3 used to amplify genomic DNA are indicated. Genomic DNA was isolated from 
single WT or homozygous rux2 mutant flies. As a control the rp49 locus was amplified with the primers 
rp491 and rp492 for WT (lane 2) and rux2 (lane 5). PCR amplification with primers 2.1 and 2.3 and 
primers 2.2 and 2.3 successfully amplified fragments of the expected length for WT DNA (lanes 3 and 4 
respectively), but not rux2 DNA (lanes 6 and 7 respectively). 1kb ladders are loaded in lanes 1 and 8. 
                                                                                                                                                     RESULTS 
 
21
Rux protein localization. 
A polyclonal antiserum was prepared against Rux to analyze Rux protein expression 
and localization. For immunization a GST-Rux fusion protein was purified using 
glutathione-agarose beads. This protein was isolated as an SDS polyacrylamide gel 
slice and used to immunize rats. The antiserum recognizes in vitro translated Rux 
and HA-tagged Rux protein (Fig. 2.2A, blot: Rux), whereas the pre-immune serum 
did not (Fig. 2.2A, blot: PIS). The antiserum also recognized a protein in embryos 
upon induction of rux expression through a heat-inducible promoter (Fig. 2.2Bb, hs-
rux) and not in WT embryos of the same stage (Fig. 2.2Bb, WT). Thus, this antiserum 
is specific for the Rux protein, but it does not detect endogenous Rux expression. 
The Rux protein expressed upon induction from the heat-inducible promoter is 
nuclear (Fig. 2.2Bd-e) in agreement with a previous report which looked at the 
 
Fig. 2.2: Production of an anti-Rux antiserum. 
(A) Rats were immunized with a gel slice containing purified GST-Rux. Purified immune serum 
recognizes in vitro translated WT Rux and HA-tagged Rux on a Western blot, whereas the pre-immune 
serum does not. To confirm translation of the proteins they were radiolabeled with 35S-Met and visualized 
by autoradiography. (B) Anti-Rux antiserum recognizes a protein in embryos after induction of rux 
expression from a heat-inducible transgene (b, hs-rux), whereas WT embryos of the same stage do no 
stain as intensely (b, WT). The protein recognized by the antiserum is nuclear (d), and is excluded from 
the nucleolus (c and e). 
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localization of overexpressed Rux or a Rux-lacZ fusion in the eye disc (Thomas et 
al., 1997). 
To determine if the nuclear localization of Rux is mediated by its C-terminal bipartite 
NLS a hemaglutinin (HA)-tagged Rux construct was made where the NLS was 
deleted (Fig. 2.3A, HA-Rux∆NLS). This was transiently expressed in Drosophila 
embryos by injecting RNA encoding the deletion construct into pre-cellular embryos. 
After a 2hr recovery period, injected embryos were stained with a monoclonal anti-
HA antibody to determine the subcellular localization of HA-Rux∆NLS. As a control 
embryos were injected with RNA encoding a HA-tagged full length Rux (HA-Rux). 
Similar to WT Rux, HA-Rux is a nuclear protein (Fig. 2.3Ba). Therefore, an N-
terminally attached tag on the Rux protein does not affect the subcellular localization 
of Rux. HA-Rux∆NLS is exclusively cytoplasmic (Fig. 2.3Be), indicating that the 
putative C-terminal NLS is responsible for nuclear localization. Interestingly, CycA 
colocalizes in the nucleus with Rux during interphase. This observation is in 
agreement with previous reports that overexpression of Rux leads to a nuclear 
translocation of CycA (Sprenger et al., 1997; Thomas et al., 1997).  
(B) HA-Rux is a nuclear protein (a) that induces a nuclear accumulation of CycA (b). 
HA-Rux∆NLS is a cytoplasmic protein, confirming that nuclear accumulation of Rux is 
mediated by a bipartite NLS in the C-terminus (e). Rux∆NLS and CycA colocalize in 
the cytoplasm (h). 
 
Fig. 2.3: The nuclear localization of Rux is determined by a bipartite NLS in the C-terminus. 
(A) Sequence of the C-terminus of Rux from amino-acids 308 to 319 and the consensus sequence for a 
bipartite NLS. The basic clusters in Rux are indicated in bold. The amino acid sequence of a deletion 
construct (Rux∆NLS), where the second basic cluster is removed is also shown. Z indicates a stop codon. 
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Fig. 2.4: The dynamic subcellular distribution of CycA is not disturbed in rux3 mutants. 
(A) Individual cells from WT embryos in the 14th cell cycle are stained for DNA with bisbenzidine, CycA with 
anti-CycA antibodies and the nuclear envelope with wheat germ agglutinin (WGA). WGA binds specifically 
to O-linked glycosylated proteins of the nuclear envelope. DNA morphology is used as a marker for the 
different cell cycle stages. DNA is decondensed during interphase, condenses during prophase and aligns 
on the metaphase plate during metaphase. Sister chromatids are pulled to separate poles during anaphase 
and decondense in telophase. The nuclear envelope is intact during interphase. Nuclear envelope 
breakdown occurs at the prophase/metaphase transition and persists through anaphase and telophase. 
CycA is a cytoplasmic protein during interphase, accumulates transiently in the nucleus during prophase, is 
distributed evenly throughout the cell following nuclear envelope breakdown and is destroyed during 
metaphase. (B) CycA has the same subcellular distribution in rux3 mutants as in WT embryos. 
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CycA displays a dynamic change in subcellular localization during progression 
through the cell cycle. The protein is cytoplasmic during S phase and G2 and 
accumulates in the nucleus during prophase. After nuclear envelope breakdown at 
the prophase/metaphase transition CycA is found throughout the cell. The protein is 
then destroyed during metaphase (Fig. 2.4A). As WT Rux induces a nuclear 
accumulation of CycA, it is conceivable that the nuclear accumulation of CycA 
observed in Wt cells is mediated by Rux. To determine if this is the case CycA 
localization was analyzed in rux mutant embryos. rux3 was used for this analysis, as 
this mutation affects the NLS in Rux. HA-Rux∆NLS has a very similar sequence to 
rux3, strongly arguing that rux3 is an endogenous Rux∆NLS. The subcellular 
localization of CycA during the cell cycle was compared for WT and rux3 embryos 
(Fig. 2.4A and B respectively). In both cases CycA was strictly cytoplasmic during 
interphase, accumulated in the nucleus during prophase, was homogeneously 
distributed in the cell following nuclear envelope breakdown and was destroyed upon 
progression through metaphase. These results suggest that Rux does not govern the 
nuclear accumulation of CycA during prophase. 
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Rux interacts with CycA and CycB in Drosophila embryos 
As CycA segregates into the same subcellular compartments as overexpressed Rux 
it is possible that both proteins form a physical complex. This was examined in co-
precipitation experiments. Rux was overexpressed in 3-5hr embryos from a heat-
inducible promoter. Rux was then precipitated from a hs-rux embryonic extract and 
the precipitate analyzed for CycA by Western Blotting. CycA coprecipitated with Rux 
(Fig. 2.5A, lane 4). CycA did not precipitate with pre-immune serum (lane 3) and Rux 
antiserum did not coprecipitate the even-skipped control proteins (lane 6), indicating 
that the interactions observed between Rux and CycA are specific. The same results 
 
Fig. 2.5: Rux physically associates with CycA and CycB. 
Rux was overexpressed in 3-5hr embryos from a heat-inducible transgene (lanes 3-7, hs-rux). An extract 
prepared from hs-rux embryos was precipitated with normal rat serum (lane 3, NRS) or rat anti-Rux (lane 
4) serum. As controls buffer (lane 1) or a WT extract (lane 2) was precipitated with the Rux antiserum. 
The individual precipitates were probed by Western blotting for the presence of CycA (upper panel) or 
CycB (lower panel) with anti-CycA and anti-CycB antibodies respectively. As controls unprecipitated 
extract was probed for CycA or CycB (lane5). The Rux antiserum specifically precipitates CycA and CycB 
from hs-rux extracts. The arrowhead in the CycB blot indicates the position of the heavy chain from the IP 
reaction. As a control extract was precipitated with the anti-Rux antiserum and assayed for the presence 
of the even-skipped protein (lane 6). Unprecipitated extract was probed with anti-eve antiserum to show 
the expected position of the protein (lane 7). 
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were observed when the precipitate fractions were analyzed by Western blotting with 
an anti-CycB antiserum (Fig. 2.5B). Thus, it appears that Rux physically associates 
with both mitotic cyclins A and B. 
CycA and CycB are required for execution of mitosis. As Rux interacts with both 
cyclins the effect of Rux on progression through mitosis was examined. Rux was 
expressed in segmental stripes of the embryonic epidermis by crossing UAS-rux flies 
to prd-GAL4 flies. prd-GAL4 induces gene expression from UAS promoters during 
cell cycle 15 (data not shown). Expression of Rux using the prd-GAL4 driver line 
inhibited progression through mitosis (Fig. 2.6). Nuclear density was approximately 
twice as high in interstripes as in paired stripes (Fig. 2.6b and c), showing that Rux 
overexpression induces a pre-mitotic cell cycle arrest.  
The kinase activity of Cdk1 in embryos overexpressing Rux was measured to 
determine whether Rux induces a cell cycle arrest by downregulating Cdk1. A 
standard assay of Cdk1 activity is to monitor its ability to incorporate radiolabeled 
phosphate into the in vitro substrate histone H1. Cdk1 was precipitated from a 
number of different 3-5hr extracts and analyzed in a H1 kinase assay (Fig. 2.7). The 
H1 kinase activity precipitated from wild-type embryos was set to 100% (lane 5). 
CycA induction led to an almost eight-fold increase in kinase activity (lane 6). This 
was reduced to WT levels when Rux was co-expressed (lane 7). Kinase activity in 
embryos overexpressing Rux (lane 8) was approx. 40% of wild-type embryos. Thus, 
it appears that Rux inhibits Cdk1 activity in embryos.  
 
 
Fig. 2.6: Rux overexpression prevents mitosis.  
Rux was over expressed in alternating segmental stripes of the embryonic epidermis from a UAS 
transgene (UAS-rux) by crossing UAS-rux flies to paired-GAL4 (prdGAL4) files (a). The nuclear density 
in Rux-expressing cells is half of that in non-expressing cells (b), showing that Rux prevents execution 
of mitosis 15. DNA was visualized by staining with bisbenzidine and Rux with the anti-Rux antiserum. A 
merge of (a) and (b) is shown in (c) with Rux in blue and DNA in red. 
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Cdk is tightly regulated by the independent activity of several intrinsic and inducible 
cellular processes. A highly conserved means of inhibiting Cdk1 is phosphorylation of 
several conserved residues. Phosphorylation of Cdk1 on T14 and Y15 by wee and 
myt kinases inhibits CDK activity (Morgan, 1995). This is reversed by String 
(Cdc25Stg), the Drosophila homologue of the Cdc25 phosphatase (Edgar and 
O'Farrell, 1989). Cdc25Stg mediated activation of Cdk1 is the rate-limiting step for 
initiation of mitosis (Edgar and O'Farrell, 1990). cdc25stg levels are controlled by 
zygotic transcription which precedes mitosis by a couple of minutes and occurs 
asynchronously throughout the embryo. The expression of cdc25stg and subsequent 
mitoses occur in 25 distinct domains in a symmetrical pattern along the 
anterior/posterior axis of the embryo. As CycA is destroyed upon progression through 
 
Fig. 2.7: Rux inhibits embryonic Cdk1 kinase activity. 
Cdk1 was precipitated with a polyclonal anti-Cdk1 antiserum from embryonic extracts prepared from 3-5hr 
WT (lane 5), hs-cycA (lane 6), hs-cycA ; hs-rux embryos (lane 7) and hs-rux (lane 8) embryos. To confirm 
that equal amounts of Cdk1 were precipitated from each extract a sample was analyzed by Western 
blotting with an anti-PSTAIRE antibody (upper panel, PSTAIRE blot). Each precipitated sample was 
assayed for its ability to incorporate radiolabeled phosphate into the in vitro CDK substrate, histone H1 
(central panel). The kinase activity of WT extract was set to 100% (lower panel, lane 5). The 
overexpression of CycA greatly enhances Cdk1 activity (lane 6) and this is reverted by co-expression of 
Rux (lane 7). Furthermore, overexpression of Rux inhibits Cdk1 activity close to background levels (lane 
8). To determine background levels equal volumes of the same extracts were mock-precipitated with 
normal rabbit serum and assayed in H1 kinase assays (lanes 1-4). 
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mitosis the disappearance of CycA is a reliable reporter for completion of mitosis in 
the different domains.  
A wild-type embryo is shown in Fig. 2.8Aa where mitosis has occurred in approx. half 
the embryo, as judged by the absence of CycA. In a hs-rux embryo CycA was 
present throughout the entire embryo (Fig. 2.8Ab). Using the extent of germband 
extension as a marker for age (Fig. 2.8Ab, arrowhead) approximately half of all cells 
in this embryo should have completed mitosis and degraded CycA. Thus, in 
agreement with previous reports and as described in Fig. 2.6 overexpression of Rux 
inhibited mitosis (Thomas et al., 1997). Overexpression of stg induced mitosis 
throughout the embryo (Fig. 2.8Ac) but mitosis did not occur in embryos where stg 
and rux were co-expressed (Fig. 2.8Ad). This experiment does not determine 
whether Rux downregulates Cdk1 by inducing an inhibitory phosphorylation of Cdk1 
on T14 or Y15. To address this question rux was co-expressed with a Cdk1 where 
the inhibitory T14 and Y15 residues were replaced by an alanine and phenylalanine 
respectively (cdc2AF). As this Cdk1 cannot be inhibited by wee and myt like kinases 
its activation does not require the presence of the Stg phosphatase. Therefore, a 
ubiquitous expression of cdc2AF and cycA induces mitosis in all cells of the embryo 
(Fig. 2.8Ae). When rux was co-expressed in this background mitosis was once more 
inhibited (Fig. 2.8Af). Thus, Rux does not inhibit Cdk1 by inducing inhibitory 
phosphorylation of Cdk1, as it inhibits Cdk1 irrespective of the phosphorylation status 
of T14 and Y15. 
Cdk1 was precipitated from hscdc2AF/hscycA and hscdc2AF/hscycA/hsrux embryos 
and Cdk1 activity was monitored in a H1 kinase assay (Fig. 2.8B). The H1 kinase 
activity of Cdk1 was reduced by almost 75% in hscdc2AF/hscycA/hsrux embryos 
compared to hscdc2AF/hscycA embryos. A second fraction of the Cdk1 precipitate 
was analyzed by Western blotting using SDS-PAGE conditions that allowed the 
separation of distinct phosphoisoforms of Cdk1 (Edgar et al., 1994). Under these 
conditions T14 or Y15 phosphorylated Cdk1 have the slowest mobility. 
Unphosphorylated Cdk1 has a slightly higher mobility and T161 phosphorylated Cdk1 
displays the highest mobility (Fig. 2.8B). Cdk1 is activated by phosphorylation on 
T161 in the T-loop by CAK (Cdk Activating Kinase). Interestingly, the T161-
phosphorylated isoform was barely present in hscdc2AF/hscycA/hsrux embryos. Thus, 
the overexpression of Rux in embryos appears to inhibit mitosis by preventing both 
Cdk activation and activity. 
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In summary, Rux is a Drosophila cell cycle regulator with no obvious homologues. It 
is a nuclear protein and the nuclear localization of Rux is mediated by a bipartite NLS 
in the C-terminus of the protein. Rux physically associates with the mitotic cyclins A 
and B and triggers a nuclear accumulation of both when overexpressed. High level 
expression of Rux inhibits mitosis, independent of regulating Stg activity and reduces 
embryonic Cdk1 The reduction of Cdk1 activity is associated with a decrease in the 
extent of T161 phosphorylation on Cdk1.  
 
 
 
Fig. 2.8: Rux does not inhibit Cdk1 by regulating inhibitory phosphorylation of Cdk1. 
(A) Mitosis 14 occurs in asynchronous domains on the embryonic epidermis, as can be distinguished 
by the stereotyped pattern of CycA disappearance (a). Overexpression of Rux in hs-rux embryos 
arrests cells before mitosis, preventing CycA destruction (b). Overexpression of Cdc25Stg induces 
mitosis in most cells simultaneously. Arrowhead indicates the tip of the extending germband (c). This 
effect is inhibited by co-expression of Rux (d). The effect of Cdc25Stg overexpression is mimicked by 
overexpression of CycA and a Cdk1 refractory to wee and myt-mediated inhibition (Cdc2AF) (e). 
Cdc2AF/CycA do not induce mitosis when co-expressed with Rux (f). Thus, Rux inhibits Cdk1 activity 
in a manner that does not rely on phosphorylation of T14 or Y15 on Cdk1. (B) Cdk1 precipitated from 
hs-cdc2AF ; hs-cycA has a high kinase activity (upper panel, lane 1 set to 100%) and is highly 
phosphorylated on T161 (lower panel, lane 1). In contrast, Cdk1 activity is reduced in a hs-cdc2AF ; 
hs-cycA ; hs-rux extract (upper panel, lane 2) and is not phosphorylated on T161 (lower panel, lane 
2). 
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Fig. 2.9: An in vitro assay of CDK kinase activity. 
HA-tagged CDKs, their cyclin partners and Rux were transcribed and translated in vitro using 35S-Met as 
a radiolabel to allow monitoring of the individual proteins. Active Cdk/cyclin complexed were formed by 
mixing the correct proteins with a source of CDK Activating kinase (CAK). CAK phosphorylates Cdk1 on 
T161, thereby inducing a conformational change in the T-loop of the CDK and allowing access of CDK 
substrates to the active site. Either a crude embryonic extract or purified yeast Civ1p were used as CAK. 
After activation, HA-tagged CDK/cyclin complexes were precipitated with anti-HA antibodies and protein-
G beads, washed and tested for their ability to phosphorylate histone H1. H1 phosphorylation was 
visualized by autoradiography and quantified with a phosphorimager. 
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Rux inhibits Cdk1/CycA and Cdk1/CycB complexes 
Overexpression of Rux in embryos shows that Rux can inhibit Cdk1 activity. To 
analyze the biochemical nature of this effect, an in vitro assay was used in which the 
different steps of Cdk1 activation and activity can be monitored (Foley, 1997). cDNA 
coding for different CDKs and their respective cyclin partners were transcribed in 
vitro (Fig. 2.9). The resulting mRNAs were translated in a reticulocyte lysate and 
radiolabeled with 35S-Met to allow visualization of distinct proteins. The CDKs were 
HA-tagged at the C-terminus to allow their purification. CDKs were mixed with their 
cyclin partners and co-incubated with a source of CAK to activate CDKs by 
phosphorylation on T161. The CDK/cyclin complexes were immunoprecipitated with 
an anti-HA antibody, washed several times and monitored for their ability to 
incorporate radiolabeled phosphate in H1. This assay has several advantages. The 
relative amounts of different proteins can be experimentally controlled, the order in 
which different complexes are assembled and the time point at which Rux is added 
can also be decided. As all proteins are radiolabeled it is possible to determine 
covalent modifications such as inhibitory or activating phosphorylations on CDKs. 
In the first experiment the effect of Rux on Cdk1/CycA, Cdk1/CycB and Cdk2/CycE 
was monitored. HA-tagged Cdk1 and Cdk2, CycA∆170, CycB∆46, CycE and Rux 
were translated in the presence of 35S-Met (see Figure 2.10A for translation 
products). The proteins were co-incubated with a 0-1hr embryonic extract which 
served as a source of CAK. CDKs alone were incubated with extract as a negative 
control. CDKs and cyclins were co-incubated as positive controls. The N-terminal 
truncations of CycA (CycA∆170) and CycB (CycB∆46) were used as they are stable 
in an embryonic extract and are capable of activating CDKs in vitro. After incubation 
the complexes were purified by anti-HA immunoprecipitation and tested in H1 kinase 
assays. Cdk1 alone had minimal kinase activity (Fig. 2.10D and E, lane 1). Co-
incubation of Cdk1 with either CycA or CycB led to an increase in H1 kinase activity 
(Fig. 2.10D and E, lanes 2 and 4, respectively). The activity of Cdk1/CycA was set to 
100%. Similarly Cdk2 alone is essentially inactive (Fig. 2.10D and E lane 6) and 
Cdk2/CycE complexes had strong kinase activity (Fig. 2.10D and E lane 7). 
 The kinase activity of Cdk1/CycA or Cdk1/CycB was greatly reduced after co-
incubation with Rux (Fig. 2.10D and E lanes 3 and 5 respectively). Cdk1 kinase 
activity was inhibited to almost background levels in the presence of Rux. On the 
other hand, Rux did not inhibit Cdk2/CycE. Cdk2/CycE was an equally potent kinase 
in the absence or presence of Rux (compare Fig. 2.10D and E, lanes 7 and 8 
respectively). Therefore, Rux specifically inhibits the in vitro kinase activity of Cdk1. 
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This is in agreement with previous reports, where Rux inhibits Cdk1, but not Cdk2 in 
an in vivo context. 
A second fraction of the Cdk1 precipitates was monitored using SDS-PAGE under 
conditions that allow distinction of CDK phosphoisoforms. The incubation of Rux with 
Cdk1 and CycA or Cdk1 and CycB reduced the level of T161 phosphorylation 
onCdk1 when compared to Cdk1/CycA and Cdk1/CycB alone (Fig. 2.10C, lanes 2-5). 
In contrast no reduction in the T163 phosphorylation of Cdk2 is seen after addition of 
Rux (compare Fig. 2.10C, lanes 7 and 8). T163 on Cdk2 is the equivalent residue to 
T161 on Cdk1.  
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Fig. 2.10: Rux specifically inhibits Cdk1 in vitro kinase activity. 
(A) A representative example of 35S-Met labeled in vitro translated cell cycle proteins separated by 
SDS-PAGE. Rux migrates with an electrophoretic mobility of approx. 50kDa (lane 4). (B) Cdk1 was 
incubated alone (lane 1), with CycA (lane 2), CycB (lane 4), CycA and Rux (lane 3) or CycB and Rux 
(lane 5). Similarly, Cdk2 was incubated alone (lane 6), with CycE (lane 7) or CycE and Rux (lane 8). 
Each reaction was filled to an equal volume with reticulocyte lysate. CDKs were activated with 
embryonic extract as a source of CAK. After activation a sample was taken from each reaction and 
analyzed by SDS-PAGE as an input control. (C) CDK/cyclin complexes were precipitated with anti-HA 
antibodies and half the precipitate was analyzed by SDS-PAGE  to separate CDKs into their constituent 
phosphoisoforms. Cdk1 is less T161 phosphorylated after co-incubation with Rux and CycA (lane 3) or 
Rux and CycB (lane 5) than after incubation with CycA (lane 2) or CycB (lane 4) alone. Rux does not 
diminish the extent of T163 phosphorylation of Cdk2. The T163 phosphoisoform is equally represented 
in Cdk2/CycE samples (lane 7) and Cdk2/CycE/Rux samples (lane 8). (D) A second half of the 
CDK/cyclin precipitate was monitored for its ability to phosphorylate H1. Cdk1 (lane 1) and Cdk2 (lane 
6) are relatively inert kinases, which are activated by the addition of the correct cyclin partner; CycA and 
B for Cdk1 and CycE for Cdk2 (lanes 2, 4 and 7 respectively). CycB is more potent at stimulating Cdk1 
(lane 4) than CycA (lane 2). Rux inhibits the H1 kinase activity of Cdk1/CycA (lane 3) and Cdk1/CycB 
(lane 5), whereas it does not inhibit the H1 kinase activity of Cdk2/CycE (compare lanes 7 and 8). (E) A 
graphical representation of the phosphorimaging of the H1 kinase activity in (D). The kinase activity of 
Cdk1/CycA was set as 100%. 
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The effect of Rux on the activity of different Cdk1/Cyc complexes was then analyzed 
in greater detail. The experimental setup employed was the same as described 
above. The effect of different amounts of Rux on fixed amounts of single Cdk/cyclin 
complexes was assayed. In these assays Rux had a relatively predictable effect on 
Cdk1/CycB complexes. Cdk1 alone was an inert kinase (Fig. 2.11D and E, lane 1). 
CycB considerably stimulated Cdk1 kinase activity (Fig. 2.11D and E, lane 2). This 
activity diminished as increasing amounts of Rux were used (Fig. 2.11D and E, lanes 
3-6). Large amounts of Rux reduced kinase activity to background levels (compare 
Fig. 2.11D and E, lanes 1 and 6). A reduction in the extent of T161 phosphorylation 
on Cdk1 also accompanied Rux-mediated inhibition (Fig. 2.11C). The precipitated 
Cdk1 samples were analyzed by SDS-PAGE and Western Blotting for the relative 
levels of co-precipitating CycB (Fig. 2.11B). Equal amounts of CycB precipitated with 
Cdk1 irrespective of the amount of Rux added, indicating that Rux does not function 
by disrupting the Cdk1/CycB complexes. 
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Fig. 2.11: Rux inhibition of Cdk1/CycB kinase activity in vitro. 
(A) Equal amounts of Cdk1 and CycB were co-incubated with extract and increasing amounts of Rux. 
Each reaction was brought to an equal volume by the addition of reticulocyte lysate where necessary. 
An aliquot was taken from each sample after the activation of Cdk1/CycB by CAK to monitor input levels 
of the different proteins. (B) HA-Cdk1 was immunoprecipitated and the amount of co-precipitating CycB 
for the different samples determined by SDS-PAGE. CycB separates into two separate 
phosphoisoforms under these conditions. Regardless of the amount of Rux added approx. equal 
amounts of CycB co-precipitate with Cdk1. (C) Similarly, Cdk1 phosphoisoforms were distinguished by 
SDS-PAGE. A faint T161 phosphoisoform of Cdk1 is distinguishable in the absence of added cyclin 
(lane 1). This probably reflects the partnering of Cdk1 to cyclins provided in the extract. A consistent 
drop in the extent of T161 phosphorylation is discernible upon addition of large amounts of Rux (lane 6). 
(D) The H1 kinase activity of a fraction of the HA-immunoprecipitate was measured by autoradiography. 
Increasing amounts of Rux lead to a drop in the intensity of phosphorylation by Cdk1 (lanes 3-6). This 
experiment was repeated three separate time and identical results observed. (E) A graphical 
representation of the phosphorimaging of the H1 kinase activity in (D) confirms that as Rux levels 
increase H1 kinase activity decreases. The kinase activity of Cdk1/CycB was set to 100%. 
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Fig. 2.12: Rux is a bimodal regulator of Cdk1/CycA in vitro kinase activity. 
(A) Equal amounts of Cdk1 and CycA were co-incubated with extract and increasing amounts of Rux. 
Each reaction was brought to an equal volume by the addition of reticulocyte lysate where necessary. 
A sample was taken after the activation of Cdk1/CycA by CAK to monitor input levels of the different 
proteins and resolved by SDS-PAGE. (B) HA-Cdk1 was immunoprecipitated and the amount of co-
precipitating CycA for the different samples determined by SDS-PAGE. CycA separates into several 
distinct phosphoisoforms under these conditions. The number of different isoforms are regularly 
proportional to the extent of Cdk1 activity (not shown). Irrespective of the amount of Rux added 
approx. equal amounts of CycA co-precipitate with Cdk1. (C) Cdk1 phosphoisoforms were 
distinguished by SDS-PAGE. A consistent drop in the extent of T161 phosphorylation is 
distinguishable upon addition of large amounts of Rux (lane 6). Although small amounts of Rux 
enhance Cdk1/CycA activity there is not a corresponding increase in the extent of T161 
phosphorylation on Cdk1 (compare lanes 2 and 3). (D) The H1 kinase activity of a fraction of the HA-
immunoprecipitate was measured by autoradiography. Large amounts of Rux lead to a drop in the 
intensity of phosphorylation by Cdk1 (lane 6), while low amounts of Rux greatly stimulate Cdk1/CycA 
activity (lane 3). This experiment was repeated five separate time and identical results observed. (E) 
A graphical representation of the phosphorimaging of the H1 kinase activity in (D). The kinase activity 
of Cdk1/CycA was set to 100%. 
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A surprising difference was observed when the experiments were repeated for 
Cdk1/CycA. As already described, Cdk1 alone displayed little kinase activity (Fig. 
2.12D and E, lane 1) and was stimulated by the provision of a cyclin partner, in this 
case CycA (Fig. 2.12D and E, lane 2). Contrary to the results observed for 
Cdk1/CycB small amounts of Rux did not mildly reduce Cdk1/CycA activity. Instead, 
low levels of Rux enhanced Cdk1/CycA kinase activity by a factor greater than three 
(Fig 2.12D and E lanes 3 and 4). Only large amounts of Rux inhibited Cdk1/CycA 
kinase activity to background levels (Fig. 2.12D and E lanes 6).This inhibition was 
accompanied by a decrease in the extent of T161 phosphorylation on Cdk1 (Fig. 
2.12C, compare lanes 2 and 6). However, the enhancement of Cdk1/CycA activity by 
low amounts of Rux did not have a corresponding increase in the extent of T161 
phosphorylation (Fig. 2.12C, compare lanes 2 and 3). Thus, Rux does not appear to 
stimulate Cdk1 by enhancing the T161 phosphorylation of Cdk1. Enhancement of 
Cdk1/CycA activity does also not appear to arise as a result of enhancing Cdk1/CycA 
complex formation. Equal amounts of CycA precipitate with Cdk1 in the absence or 
presence of small amounts of Rux (Fig. 2.12B, compare lanes 2 and 3 respectively). 
Similarly, inhibition does not rely on disturbing Cdk1/CycA complex formation (Fig. 
2.12B compare lanes 2 and 6). 
 
 
Fig. 2.13: Rux does not require additional 
Drosophila factors to inhibit Cdk1. 
(A) The crude extract used in Figs. 9-11 was 
replaced with bacterially expressed and 
purified GST-Civ1p. Civ1 phosphorylates 
monomeric Cdk1 (lane 1) making it 
impossible to distinguish effects of Rux on 
T161 phosphorylation in this assay (lane 
4). (B) Monomeric Cdk1 is inactive (lane 
1), as is CycB (lane 2). Civ1 is a potent 
stimulator of Cdk1/CycB kinase activity 
(lane 3) and this is reduced by almost 
60% upon co-incubation of Rux. (C) A 
graphical representation of the 
phosphorimaging of the H1 kinase activity 
in (B). 
 
 
 
 
 
 
There is no obvious explanation for Rux enhancement of Cdk1/CycA activity. 
However, similar effects have been observed for other cell cycle regulators, such as 
rum1 from S. pombe and mammalian p21 (Correa-Bordes and Nurse, 1995; Zhang 
et al., 1994). Interestingly, both of these proteins are Cyclin-dependent Kinase 
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Inhibitors (CKIs). CKIs have been identified in a large number of eukaryotes. 
Although there are no clearly conserved sequence motifs in all CKIs they have a 
defined set of functional characteristics. CKIs physically associate with CDKs, cyclins 
or both. They inhibit CDKs and prevent CDK activation, without covalently modifying 
CDKs. Based on the results presented above Rux fulfills these criteria. However, the 
inhibition of Cdk1 activity and activation was either observed in embryos or an in vitro 
system that used an embryonic extract as a source of CAK. Therefore, it cannot be 
excluded that Rux is a mediator protein that activates an unidentified CKI in 
Drosophila embryos.  
To rule this possibility out the in vitro assay described above was repeated 
eliminating the embryonic extract and instead using GST-Civ1p as a source of CAK. 
CIV is the S. cerevisiae CAK. It is a monomeric protein of approximately 40kDa and 
has no homology to the Drosophila CAK; Cdk7/CycH. GST-Civ1p was expressed in 
bacteria and purified using glutathione-agarose beads. This was used to activate 
reticulocyte translated Cdk1/CycB. No additional Drosophila factors are required in 
this experiment, meaning that any effects observed are Drosophila-independent. 
Civ1p phosphorylated monomeric Cdk1 on T161 (Fig. 2.13A lane 1), (Kaldis et al., 
1998). This monomeric Cdk had no kinase activity (Fig. 2.13B and C, lane 1). Upon 
addition of CycB, Cdk1 displayed strong H1 kinase activity (Fig. 2.13B and C, lane 
3). When Rux was co-incubated with Cdk1 and CycB the kinase activity dropped to 
almost 40% of that for Cdk1/CycB alone (Fig. 2.13B and C, compare lanes 3 and 4). 
Thus, Rux directly inhibits Cdk1 in the absence of all other Drosophila factors. 
Inhibition of Cdk1 by Rux in the assays described above always had a concomitant 
reduction in the level of T161 phosphorylation on Cdk1, raising the possibility that 
Rux inhibits Cdk1 by preventing the initial CAK-dependent activation. This question 
was addressed in a two-step assay. Cdk1 was activated by incubation with CycA and 
Civ1p (Fig. 2.14A and B, lane 3). In a second step, Rux was incubated with the 
activate Cdk1/CycA complexes. As a control, activate Cdk1/CycA was incubated with 
reticulocyte lysates. A fraction of each sample was removed and directly assayed for 
their ability to phosphorylate H1. The addition of Rux in the second step greatly 
diminished Cdk1 activity (Fig. 2.14A and B, compares lane 3 without Rux and lane 6 
with Rux). Thus, Rux inhibited pre-activated Cdk1/CycA complexes. Precipitation of 
the individual samples with anti-HA antibodies and subsequent analysis of aliquots of 
the precipitate fractions confirmed that the Cdk1 had been successfully 
phosphorylated on T161 in the initial step. The Cdk1 incubated with CycA and Rux is 
as extensively phosphorylated on T161 as the Cdk1 incubated with CycA alone (Fig. 
2.14C, compare lanes 12 and 9 respectively). Thus, inhibition by Rux did not depend 
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on regulating CAK activity and Rux did not recruit a phosphatase to inactivate Cdk1. 
Therefore, Rux does not solely rely on preventing T161 phosphorylation of Cdk1 as a 
means of inhibiting Cdk1 activity, rather Rux also inhibits T161-phosphorylated 
Cdk1/cyclin complexes. 
 
 
Fig. 2.14: Rux inhibits active Cdk1/CycA complexes. 
(A) In a two-step experiment Cdk1 was activated by incubation with CycA and GST-Civ1p (lanes 3 and 6) 
for 20min. After activation Cdk1/CycA complexes were incubated with either reticulocyte lysate (lane 3) or 
an equal volume of Rux (lane 6) for an additional 20min. The H1 kinase activity of these samples was 
then directly assayed. As controls the activity of Cdk1 alone (lanes 1 and 4) or Cdk1 and Civ1p (lanes 2 
and 5) were measured. The addition of Rux to activated Cdk1/CycA greatly diminishes Cdk1 activity 
(compare lanes 3 and 6). (B) The remainder of each sample was immunoprecipitated with anti-HA 
antibodies. A fraction was analyzed by SDS-PAGE to monitor T-161 phosphorylation. Cdk1 is as equally 
T161 phosphorylated in lane 3 as in lane 6, confirming that the Cdk1/CycA complexes had been activated 
before addition of Rux and that Rux did not diminish this phosphorylation. (C) A graphical representation 
of the phosphorimaging of the H1 kinase activity in (A). 
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The simplest interpretation of the result above is that Rux specifically inhibited Cdk1. 
Another potential interpretation is that the inhibition observed was not specific, rather 
that Rux is a substrate for Cdk1 and consequently functioned as a competitor with H1 
for radiolabeled phosphate in the kinase assays. To exclude this possibility the 
endogenous kinase activity of an embryonic extract was assayed in the presence or 
absence of HA-Rux. As expected, an embryonic extract had high H1 kinase activity 
due to the presence of endogenous CDK/cyclin complexes (Fig. 2.15B and C, lane 
1). Similar to the result described for Fig. 13, Rux inhibited embryonic CDK/cyclin 
activity (Fig. 2.15B and C, lane 2). Inhibition was not a result of diminishing T161 
phosphorylation of Cdk1, as the T161 phosphoisoform was equally present either in 
the absence or presence of Rux (Fig. 2.15A, compare lanes 1 and 2 respectively). 
Furthermore, inhibition was not caused by Rux acting as a competitor with H1, as no 
 
Fig. 2.15: Rux does not compete with in vitro substrates for phosphates. 
(A) Extracts from 0-1hr embryos were incubated with reticulocyte lysate (lane 1) or non-radiolabeled 
HA-Rux (lane 2). Cdk1 analysis with anti-PSTAIR Western blotting showed that Rux did not reduce the 
extent of T161 phosphorylation on Cdk1 (compare lanes 1 and 2). (B) Both samples were analyzed 
directly in a H1 kinase assay. In lane 3 a Western blot of reticulocyte-translated HA-Rux is loaded as a 
control to mark the position of the HA-Rux in lane 2. The addition of HA-Rux reduced kinase activity to 
almost 14%, although no phosphorylation of Rux was observed. (C) Quantification of the H1 kinase 
activity in (B) by phosphorimaging. The kinase activity of extract without added Rux was set to 100%. 
                                                                                                                                                     RESULTS 
 
41
phosphorylation of Rux was observed (Fig. 2.15A, compare lanes 2 and 3). 
Therefore, Rux directly inhibits active Cdk1/cyclin complexes. 
In conclusion, Rux specifically inhibits Cdk1 associated with either CycA or CycB. 
Rux directly inhibits Cdk1 activity and inhibits the initial Cdk1 activation step. These 
functions of Rux do not require additional Drosophila factors and are not caused by 
Rux competing with other substrates for Cdk1. Based on these results I propose that 
Rux is a novel Drosophila CKI. Rux is the first CKI to be characterized in a 
multicellular organism with specificity for mitotic cyclins. All other multicellular CKIs 
characterized to date inhibit G1 CDK/cyclin complexes. Both S. cerevisiae and S. 
pombe have CKIs specific for mitotic cyclins; SIC1 and rum1 respectively. Therefore, 
the possibility arises that there is an evolutionarily conserved requirement for CKIs 
that regulate the activity of mitotic cyclins. 
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Rux interacts with CycA via two distinct RXL motifs. 
 
As Rux has no obvious homologues in the databases it is difficult to deduce key 
amino acids from the primary sequence. Nonetheless, there are several short amino 
acid sequences in the Rux protein which have been identified as critical in other 
CKIs. One such sequence is the cyclin-binding, Cy or RXL motif (Adams et al., 1996; 
Chen et al., 1996). This motif has been identified in numerous proteins as mediating 
interactions with cyclins and consists of the amino acids arginine-X-lysine, where X is 
any amino acid. Recent three-dimensional structural analysis of the human CKI p27 
revealed that the RXL motif inserts into the cyclin box of CycA (Russo et al., 1996). 
There are three RXLs in the Rux protein (Fig. 2.1B). Point mutations were introduced 
into the RXLs separately converting each motif to a KXK. The individual RXL mutant 
constructs were tested in three separate assays for their ability to interact with 
Drosophila CycA.  
The first assay is based upon the observations described in Fig. 2.3 that 
overexpression of Rux leads to a nuclear accumulation of Rux and CycA. As Rux 
physically associates with CycA, it is possible that Rux RXL mutants with an impaired 
ability to interact with CycA will be less efficient at triggering a redistribution of CycA 
to the nucleus. RNA encoding a point mutation in the C-terminal RXL (HA-
Rux∆RXL3) motif was injected into pre-blastoderm embryos. A representative 
example is shown in Fig. 2.16. The RNA has been injected into the anterior of the 
embryo. HA-Rux∆RXL3 has the same subcellular localization as wild-type Rux, i.e. it 
is a nuclear protein (Fig. 2.16b and f). Similar to wild-type Rux, HA-Rux∆RXL3 directs 
a nuclear accumulation of CycA. CycA displays a nuclear localization in the anterior 
part of the embryo (Fig. 2.16e) and is exclusively cytoplasmic in interphase cells at 
the posterior of the embryo (Fig. 2.16i). The nuclear accumulation of CycA in the 
anterior of the embryo is not a consequence of cell cycle state of these cells. DNA 
staining reveals that all anterior cells are in interphase (Fig. 2.16d). At this stage of 
the cell cycle CycA is normally cytoplasmic (Fig. 4A, interphase). Thus, both wild-
type Rux and HA-Rux∆RXL3 are equally competent at driving a nuclear 
accumulation of CycA. 
 The embryo depicted is in the process of germband extension (Fig. 2.16a 
arrowhead). This is a process which begins early during mitosis 14. As mentioned 
above mitosis 14 occurs in a stereotyped pattern of domains over the embryo 
surface. In a wild-type embryo at this stage of germband extension mitosis 14 is 
ongoing in the anterior domains 1,2,5,6 and 7, as well as domain 4. Domain 4 is 
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located at the anterior tip of the extending germband. A number of condensed 
metaphase chromosomes can be detected in domain 4 (Fig. 2.16h, arrowheads and 
2.16j). A correlating change in CycA subcellular localization occurs in the same 
mitotic cells (Fig. 2.16i and j), indicating that mitosis 14 occurs normally at the 
posterior of the embryo. No mitotic figures are visible at the anterior of the embryo 
where Rux∆RXL3 is expressed, although at this stage mitosis occurs in domains 1,2 
and 5 in WT embryos (Fig. 2.16d). Thus, identical to what has been described for 
wild-type Rux (Fig. 2.3), Rux∆RXL3 is a nuclear protein, which when overexpressed 
drives a nuclear accumulation of CycA and inhibits mitosis. 
 
 
Fig. 2.16: The C-terminal RXL in Rux is not required for Rux-CycA in vivo interactions. 
mRNA encoding HA-tagged Rux∆RXL3 was injected into the anterior of an embryo and the protein 
visualized with anti-HA antibodies (b). The embryo depicted is at the start of mitosis 14, as determined by 
germband extension (a, arrowhead). An overlay of the CycA and Rux staining is shown in (c) with CycA in 
Red and Rux in green. Higher magnification of HA-Rux∆RXL3 expressing cells (f) shows that DNA is in a 
decondensed interphase state (d), CycA accumulates in the nucleus (e) and HA-Rux∆RXL3 is a nuclear 
protein. An overlay of the CycA and Rux staining is shown in (g) with CycA in Red and Rux in green. 
Mitosis 14 occurs in a WT manner in non HA-Rux∆RXL3 expressing cells. Metaphase cells are detectable 
in domain 4 (h, arrowheads) and CycA is cytoplasmic in interphase cells (i). An overlay of the DNA and 
CycA staining is shown in (j), with CycA in pink and DNA in blue. DNA was visualized by staining with 
bisbenzidine, CycA with anti-CycA antiserum and HA with anti-HA antiserum. 
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Introducing point mutations into the central RXL (HA-Rux∆RXL2) had a different 
effect on the ability of Rux to interact with CycA in blastoderm embryos. HA-
Rux∆RXL2 is a nuclear protein (Fig. 2.17b and e). However, in contrast to wild-type 
Rux, the mutant isoform is unable to direct a nuclear accumulation of CycA. The 
embryo presented here is in interphase of cycle 14 and the RNA has been injected 
into the anterior part. In this part of the embryo CycA is entirely cytoplasmic, despite 
a large accumulation of HA-Rux∆RXL2 (Fig. 2.17a and d). Thus removing RXL2 
severely impairs the ability of Rux to interact with CycA in vivo, suggesting that this is 
a key motif for mediating Rux-CycA interactions. Embryos expressing HA-Rux∆RXL2 
also display a WT pattern of cell divisions (data not shown), demonstrating that HA-
Rux∆RXL2 does not inhibit Cdk1 in vivo. 
 
Fig. 2.17: Mutations in the central RXL motif abrogate Rux-CycA in vivo interactions. 
mRNA encoding HA-tagged Rux∆RXL2 was injected into the anterior of an embryo and the protein 
visualized with anti-HA antibodies (b). This embryo is in interphase 14 and no cell are undergoing mitosis 
(a). An overlap of the HA-Rux∆RXL2 and CycA staining is shown in (c) with CycA in red and HA-
Rux∆RXL2 in green. Higher magnification of HA-Rux∆RXL2 expressing cell confirms that it is a nuclear 
protein (e). HA-Rux∆RXL2 does not trigger a nuclear accumulation of CycA, as cycA is strictly 
cytoplasmic in the same cells (d). An overlay of (d) and (e) is shown in (f) with HA-Rux∆RXL2 in green 
and CycA in red. DNA was visualized by staining with bisbenzidine, CycA with anti-CycA antiserum and 
HA- with anti-HA antiserum. 
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A point mutation converting the N-terminal RXL to KXK (HA-Rux∆RXL1) produces 
results intermediate to HA-Rux∆RXL2 and HA-Rux∆RXL3. The embryo depicted in 
Fig. 2.18 was injected in the posterior half. HA-Rux∆RXL1 is detected in the dorso-
central part of the embryo because posterior cells move forward during germband 
extension. HA-Rux∆RXL1 is a nuclear protein in all cells where it is expressed (Fig. 
2.18b). CycA is present only in the cytoplasm of cells expressing low amounts of HA-
Rux∆RXL1 (Fig. 2.18e, closed arrowheads) (Fig. 2.18d and f, closed arrowheads). 
Cells expressing higher amounts of HA-Rux∆RXL1 (Fig. 2.18d, open arrowheads) 
have an even distribution of CycA throughout the cell. Thus, it appears that HA-
Rux∆RXL1 is only moderately able to interact with CycA and that high levels of HA-
Rux∆RXL1 expression are required to induce a partial nuclear accumulation of CycA. 
In the embryo presented here the nuclear accumulation of CycA in some cells may 
merely arise from the particular cell cycle state of those cells. It is possible that these 
cells are in prophase, which is a cell cycle stage where CycA normally accumulates 
in the nucleus. Some of the cells expressing HA-Rux∆RXL1 are approximately half 
the size of other cells, demonstrating that HA-Rux∆RXL1 does not prevent progress 
through the cell cycle.  
In a second series of assays all three deletion constructs were tested for their ability 
to moderate the in vitro kinase activity of Cdk1/CycA. As observed above, Cdk1 
alone is essentially inert as a H1 kinase (Fig. 2.19A and B, lane 1). Addition of CycA 
as a regulatory subunit greatly enhances Cdk1 kinase activity (Fig. 2.19A and B, lane 
2). Large amounts of WT Rux inhibit Cdk1/CycA activity to almost background levels 
(Fig. 2.19A, lane 3), whereas low amounts of Rux stimulate Cdk1/CycA kinase 
activity (Fig. 2.19B, lane 3). In contrast, Rux∆RXL1 only mildly inhibits Cdk1/CycA 
(Fig. 2.19A, lane 4) and low amounts of Rux∆RXL1 enhance Cdk1/CycA to almost 
wild-type levels (Fig. 2.19B, lane 4). Rux∆RXL2 does not inhibit Cdk1/CycA. Instead, 
large amounts actually enhance Cdk1/CycA activity by more than 50% (Fig. 2.19A, 
lane 5). Furthermore, low levels of Rux∆RXL2 do not stimulate Cdk1 kinase activity 
as well as wild-type (Fig. 2.19B, lane 5). Finally, Rux∆RXL3 influences Cdk1/CycA 
activity in a manner almost identical to wild-type Rux. A large amount of Rux∆RXL3 
potently inhibits Cdk1/CycA (Fig. 2.19A, lane 6) and lower amounts of Rux∆RXL3 
enhance Cdk1/CycA activity by a factor of 2 (Fig. 2.19B, lane 6). 
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Fig. 2.18: Mutations in the N-terminal RXL motif diminish Rux-CycA in vivo interactions. 
mRNA encoding HA-tagged Rux∆RXL1 was injected into the posterior of an embryo and the protein 
visualized with anti-HA antibodies (b). This embryo is in cell cycle 14, as judged by the extent of 
germband extension (a). Mitosis 14 occurs in a normal pattern as determined by the orderly 
disappearance of CycA, demonstrating that HA-Rux∆RXL1 does not inhibit progression through mitosis 
(a). An overlap of the Rux and CycA staining is shown in (c) with CycA in red and Rux in green. Higher 
magnification of HA-Rux∆RXL1 expressing cell confirms that it is a nuclear protein (e). HA-Rux∆RXL1 
only triggers a partial nuclear accumulation of CycA in cells expressing high amounts of HA-Rux∆RXL1 
(d and e, open arrowheads). CycA remains cytoplasmic in cells where low amounts of HA-Rux∆RXL1 
are expressed. HA-Rux∆RXL1 does not inhibit mitosis as cell expressing lower amount have a higher 
nuclear density than cells expressing large amounts (e, compare open and closed arrowheads). A 
merge of (d) and (e) is shown in (f) with Rux in green and CycA in red. DNA was visualized by staining 
with bisbenzidine, CycA with anti-CycA antiserum and HA with anti-HA antiserum. 
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To confirm that RXL2 is essential for Rux-CycA interactions HA- Rux∆RXL2 was 
transiently expressed in WT embryos and precipitated from an extract prepared from 
the embryos. As a control WT HA-Rux was translated in embryos and precipitated. 
Whereas, WT HA-Rux precipitates large amounts of CycA from cellularized embryos 
(Fig. 2.20, lane 1), HA- Rux∆RXL2 does not (Fig. 2.20, lane 2). 
In summary, Rux∆RXL1 is greatly impaired in its ability to regulate CycA localization 
in vivo and inhibit Cdk1/CycA in vitro. Rux∆RXL2 does not direct a nuclear 
accumulation of CycA and does not inhibit Cdk1/CycA in vitro. Furthermore, 
Rux∆RXL2 is incapable of precipitating CycA from embryos, whereas WT Rux does. 
The effects of Rux∆RXL3 on CycA in vivo and Cdk1/CycA in vitro are identical to 
wild-type Rux. These results strongly argue that RXL2 in Rux is essential for 
interaction with CycA and inhibition of Cdk1/CycA, RXL1 is important for both 
functions and RXL3 is dispensable in both regards. 
 
 
Fig. 2.19: RXL1 and RXL2 are important for inhibiting Cdk1/CycA kinase activity. 
(A) The average results for three separate experiments are presented graphically. In each case kinase 
assays were performed as described for Fig. 9 using extract as a source of CAK. The kinase activity of 
Cdk1/CycA was set to 100% (lane 2) and all reactions were performed in an identical volume. As a 
negative control the activity of Cdk1 was determined (lane 1) and as a control for Rux activity 
Cdk1/CycA was incubated with WT Rux (lane 3). Large amounts of Rux∆RXL1 only mildly inhibits Cdk1 
activity (lane 4), while large amounts of Rux∆RXL2 actually enhance Cdk1/cycA activity (lane 5). In 
contrast, Rux∆RXL3 inhibits Cdk1/CycA as effectively as WT Rux (lane 6). (B) Low amount of WT Rux 
enhance Cdk1/CycA kinase activity (lane 3). Rux∆RXL1 enhances Cdk1/CycA to almost the same 
extent as WT Rux (lane 4), whereas Rux∆RXL2 (lane 5) and Rux∆RXL3 (lane 6) display a slightly 
diminished ability to do so. 
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Fig. 2.20: Rux∆RXL2 does not interact with CycA in vivo. 
mRNA encoding either HA-Rux or HA-Rux∆RXL2 was injected into approximately 300 pre-blastoderm 
embryos respectively. After a 2hr recovery period embryos were homogenized and the homogenate 
precipitated with anti-HA antibodies. As a control for the amount of recovered HA-tagged protein a 
sample of both homogenates was analyzed for the presence of the HA tag (upper panel, HA blot). A 
second sample was analyzed by Western blotting with anti-CycA antiserum for the co-precipitation of 
CycA (lower panel, CycA blot). HA-tagged Rux transiently expressed in Drosophila embryos binds and 
precipitates CycA (lane 1), whereas HA-Rux∆RXL2 does not (lane 2), demonstrating that the central 
RXL motif in Rux is essential for Rux-CycA interactions. 
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A role for Rux in exit from mitosis 
 
Endogenous rux is expressed at low level and cannot be detected by in situ 
hybridization. To determine the stages during which the rux gene is transcribed total 
mRNA was isolated from different developmental stages and amplified by RT-PCR 
using oligonucleotides specific for the rux transcript. No transcript was detected in 0-
2hr embryos, indicating the absence of maternally provided mRNA (Fig. 2.21A). 
Zygotic transcription started in 2-hr embryos and persisted in 12-24hr embryos. No 
transcript was detected in L1 larvae. This may be due to inadequate preparation of 
mRNA, as the control transcript for the ribosomal protein rp49 is also 
underrepresented. Transcription occurs in older larvae, pupae and adult flies. 
Interestingly, rux is transcribed in 2-4hr embryos. At this stage embryos are in 
interphase or early mitosis 14. These cycles occur without any G1 stage. However, 
the initial characterization of rux mutants indicated that Rux is required for 
establishing a G1.  
To determine whether Rux functions at this period progression through mitosis 14 
was compared for rux3 mutant and WT embryos. Mitosis 14 occurs in a series of 
domains over the embryonic epidermis (Fig. 2.22A) and (Foe, 1989). An antibody 
raised against phosphorylated histone H3 (PH3) is a reliable reporter for mitosis in 
many species including Drosophila. This antibody binds PH3 during all stages of 
mitosis from DNA condensation in prophase, through chromosome alignment at the 
 
Fig. 2.21: Rux is expressed during most stages of Drosophila life. 
Poly-adenylated mRNA was isolated from different staged embryos, larvae, pupae and adults. Rux 
transcript was amplified from each stage by RT-PCR (upper panel lanes marked ‘+’). The primer RT1 was 
used for the RT reaction and the primers RT1 and RT2 were used for the PCR reaction. As a negative 
control isolated mRNA was amplified by PCR, without a preceding reverse transcription step (upper 
panel, lanes marked ‘-‘). As a control for transcript length 1ng plasmid DNA containing the Rux ORF was 
amplified using the PCR primers RT1 and RT2 (‘rux’). As a control for the quality of mRNA preparation 
the purified mRNA was assayed for the presence of the ribosomal protein transcript, rp49. rp49 mRNA 
was amplified with the primer rp491 and the subsequent PCR reaction performed with the primers rp491 
and rp492. The rux transcript is absent from 0-2hr embryos, indicating the absence of a maternal 
provision of transcript. rux mRNA is present in embryos from 2hr onward, as well as larvae, pupae and 
adults. Transcript is not detected in L1 larvae, although this may be due to a poor preparation of mRNA, 
as the rp49 transcript is underrepresented in the same sample. 
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metaphase plate, chromatid separation at anaphase and chromosome 
decondensation during telophase (Fig. 2.22B). Therefore, this antibody is a reliable 
tool for recognizing all stages of mitosis in the distinct mitotic domains. Fig. 2.22C 
shows a dorsal view of WT embryos stained with the PH3 antibody at different stages 
of mitosis 14. The temporal order of the mitotic domains agrees with those described 
previously (compare Fig. 2.22A and C). This pattern is reproducible between 
individual embryos and between different WT strains. Higher magnification allows the 
identification of distinct stages for the individual domains (Fig. 2.22D shows the 
different stages of mitosis 14 for domain 4). Mitosis 14 generally starts as a thin wisp 
of 1-2 cell widths for a particular domain. This rapidly expands by another 2-3 cell 
widths and then takes on a very defined structure. Mitosis is completed in the central 
cells first giving each domain a hollowed-out appearance, before completion of 
mitosis for the entire domain. 
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Fig. 2.22: Mitosis 14 occurs in a stereotyped pattern of domains. 
(A) Schematic representation of the domains of mitosis 14. Mitosis 14 occurs as a series of domains 
with bilateral symmetry along the anterior-posterior axis. The later domains M and N are not 
synchronous and the anterior domains A (amnioserosa) and B do not divide. Presented is a dorso-
lateral view of an embryo taken from (Foe, 1989). (B) An antibody raised against a phosphorylated 
form of histone H3 (PH3) specifically recognizes H3 during mitosis and reveals DNA conformation 
during prophase, metaphase, anaphase and telophase. (C) The anti-PH3 antibody reliably 
reproduces the domain pattern of mitosis 14. Presented is an dorsal view of an embryo early in 
gastrulation and germband extension. Anterior is to the left. Individual domains are numbered. 
Domain 4 is intimately associated with the tip of the extending germband and is a reliable reporter of 
developmental stage. (D) Higher magnification of individual domains reveals that mitosis 14 can be 
divided into stages for each domain. A dorsal view of domain 4 is presented here with anterior to the 
left. Mitosis starts as a thin wisp of cells, which rapidly expands laterally, hollows out in the center and 
completes for peripheral cells. The central cells exit mitosis first, as they are the first to enter. The 
shape of the domain changes during progression through mitosis as a result of cell movements 
during germband extension. 
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Using this staging technique the rates of progression through mitosis 14 were 
compared for WT and rux mutant embryos. As rux3 mutants are not male sterile it is 
possible to compare a homozygous WT population with a homozygous mutant 
population. A WT embryo and rux3 embryo were aligned, such that domain 1 was at 
the same stage for both embryos (Fig. 2.23A and B). The other domains were then 
compared to determine whether the synchrony was maintained. The order in which 
the domains enter mitosis was identical for both populations (data not shown). 
However, when domain 1 was at the same stage in WT and mutant embryos the later 
 
Fig. 2.23: Mitosis 14 is prolonged in rux3 mutants. 
To compare the duration of mitosis 14 between WT and rux3 mutants, individual embryos were chosen 
where domain 1 had progressed equally far in WT (A) and mutant embryos (B). In the embryos presented 
in A and B domain 1 has a hollow appearance, indicating that mitosis is approx. half completed for this 
domain. A comparison between later domains shows that mitosis is further advanced in mutant than WT 
embryos. For example, whereas all cells of domain 4 are still in metaphase in the WT embryo (A) many 
have completed mitosis in the mutants (B). In a similar comparison a WT embryo was chosen where 
domain 4 is at an identical stage for a rux3 mutant (B) and a WT embryo (C). In this case, domain 1 is 
further advance in the WT than mutant embryo. 
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domains were further advanced in the mutants. For example, whereas domain 4 was 
in a synchronous metaphase in WT embryos, most cells were in anaphase, 
telophase or had exited mitosis in rux3 mutants. Similarly when domain 4 was set at 
an identical stage for WT and mutant embryos (Fig. 2.23B and C), domain 1 was 
more advanced in WT than rux3 mutants. In the WT embryo shown in 2.23C, domain 
1 had almost completely exited mitosis. A single line of cells were in 
anaphase/telophase. The rux3 embryo in 2.23B was half way through mitosis 14 in 
domain 1, as can be seen by the large number of peripheral prophase cells and the 
central anaphase/telophase cells. 
The same comparison described in Fig. 2.23 was performed for homozygous rux2 
mutant embryos and a heteroallelic combination of rux3 and rux8 embryos. In all 
tested mutant combinations mitosis was prolonged in mutants in comparison to WT 
embryos, indicating that the phenotype observed is linked to the rux locus (Fig. 2.24). 
Domain 1 was set at the same stage in all embryos in Fig. 2.24. All later domains are 
further advanced in mutants embryos than in the WT embryo Therefore, The effect 
described in Fig. 2.23 is not specific to the rux3 allele and is not the result of a 
background mutation in the rux3 genotype. 
Mitosis was followed in living embryos to further analyze the mitotic phenotype of rux3 
mutants. A transgene expressing GFP-tagged histone H2 (GFP-His2AvD; (Clarkson 
and Saint, 1999) was crossed into the rux3 mutant background, producing rux3 ; GFP-
His2AvD flies. Using fluorescence microscopy images were taken of developing 
embryos at 10s intervals over a period from shortly before gastrulation until the 
 
Fig. 2.24: mitosis 14 is prolonged in all rux mutants 
To confirm that the prolonging of mitosis observed in Fig. 2.23 is specifically caused by mutations in the rux 
locus mitosis 14 was compared between WT and different rux alleles. Embryos were staged such that 
domain 1 is at the same stage in WT, rux2, rux3 and rux8 mutants. Close examination revealed that mitosis 
is further advanced in all mutants in later domains, such as 4, 5 and 11. Furthermore mitosis 14 is approx. 
equally advanced in the different mutant embryos. 
                                                                                                                                                     RESULTS 
 
54
completion of germband extension. This period covers the bulk of mitosis 14 and is 
therefore suitable for following mitosis in individual domains (Fig. 2.25).  
Higher magnification allows resolution of mitosis for individual cells to an extent that 
prophase, metaphase, anaphase and telophase can be satisfactorily distinguished 
(Fig. 2.26).  
 
Fig. 2.25: Following mitosis 14 in living embryos. 
Presented are individual frames from live observations of a single rux3 ; GFP-His2AvD embryo. Anterior is 
to the left and dorsal is up. The arrowhead marks the position of the tip of the germband. DNA 
condensation during metaphase reveals the individual mitotic domains at lower magnification. Domains 1 
and 5 are presented as boxed regions. Mitosis 14 begins within minutes of the initiation of germband 
extension. Pictures were taken every 10s after the beginning of germband extension to follow mitosis 14. 
 
Fig. 2.26: Higher magnification of mitosis 14 in a single cell. 
Individual pictures of mitosis 14 in an individual cell of domain 5 of a rux3 ; GFP- His2AvD. At this 
magnification the individual stages of mitosis are discernible. At time 0 DNA is in a decondensed 
prophase state. After 80s DNA begins to condense and align on the metaphase plate. Metaphase is 
visible as the time of maximal alignment of sister chromatids on the interphase plate. After 200s sister 
chromatids are pulled to opposite poles. By telophase sister chromatids reach opposite poles and DNA 
starts to decondense. 
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Mitosis was timed for individual cells in specific domains at 10s intervals. As a control 
the experiment was repeated using the parent GFP-His2AvD strain. The cells of 
domains 2 and 5 were concentrated on, as they are most amenable to live 
observations. These observation revealed that metaphase is significantly longer in 
mutants than WT embryos for both domains (Fig. 2.27A and B). Metaphase is 
prolonged by almost 80% in rux3 mutants (Fig. 2.27A and B). Prophase, anaphase 
and telophase, in contrast, are not significantly changed in mutant embryos. A 
representative example is shown in 2.27A, where there is a dramatic lengthening of 
metaphase in rux3 mutants, while all other stages of mitosis proceed at WT pace. In 
summary, analysis of fixed, and living rux mutant embryos demonstrates that mitosis 
is prolonged in comparison to WT embryos. Specifically, metaphase is considerably 
 
Fig. 2.27: Metaphase is significantly longer in rux3 mutants. 
(A) Mitosis was followed for individual cells of GFP- His2AvD and rux3 ; GFP- His2AvD embryos in 
domains 2 and 5. Individual frames for a WT and a rux3 mutant are presented in the upper series of 
panels. Although prophase, anaphase and telophase occur at equal rates in both genotypes metaphase 
is almost twice as long in the mutant cell (metaphase). The total results are represented graphically in 
the lower panel. (B) Prophase anaphase and telophase are approx. equally long in WT and mutant 
embryos. In contrast, metaphase is significantly longer in mutant cells. Metaphase is on average 79% 
longer in mutant embryos than in WT embryos. Numbers in parentheses indicate the number of 
observations made for the individual mitotic stages for both genotypes. Times of the individual stages are 
given in seconds. 
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longer in mutants, indicating that a wild-type function of the Rux protein is to 
contribute to mitotic exit by downregulating Cdk1/CycA activity at metaphase. A 
potential interpretation of these results is that Rux mediated inhibition of Cdk1/CycA 
cooperates with APC/C dependent destruction of CycA during metaphase. The 
combined effects of these activities suppress Cdk1/CycA activities to a level where a 
transition to anaphase is possible. In the absence of Rux protein CycA is only 
downregulated by proteolysis alone, lengthening metaphase. 
To test if Rux can downregulate Cdk1/Cyclin activity during metaphase the effects of 
Rux induction on cells expressing an indestructible CycA (CycA∆170) were followed. 
prd-GAL4 X UAS-CycA∆170 embryos express CycA∆170 in stripes in the epidermis 
of the embryo resulting in a metaphase arrest in these stripes. rux expression was 
induced from a second transgene under the control of a heat-inducible promoter (hs-
rux) to determine whether Rux induces an exit from mitosis in the CycA∆170 
expressing cells. This experiment has several potential drawbacks: Densely packed 
mitotic DNA is only poorly accessible to transcription factors and nascent transcripts 
are aborted during mitosis. As the experiment requires induction of transcription 
during mitosis by administration of a heat pulse the effects of a heat-shock on mitosis 
were first examined.  
Mild heat pulses affect the mitotic program in Drosophila embryos. 
Embryos fixed immediately after administering a 5min heat-shock have normal 
mitotic figures (Fig. 2.28A), where various stages such as metaphase (Fig. 2.28Aa, 
white arrowheads) and anaphase (Fig. 2.28Ab, black arrowhead) are distinguishable. 
5min after heat shock no mitotic figures are visible (Fig. 2.28B). Using germband 
extension as a timer (Fig. 2.28Ba), mitosis 14 should be occurring in domains 1 and 
5 in the anterior section of the embryo depicted in Fig. 2.28Ba. Close examination of 
this region reveals that the DNA has a uniform decondensed morphology, 
reminiscent of interphase/early prophase. The pattern of mitosis 14 returns to the 
embryo 10 min. after heat shock. Mitosis 14 is visible in domains 1,4 and 5 of the 
embryo depicted in Fig. 2.28Ca. A higher magnification of domain 1 (Fig. 2.28Cb) 
reveals that the mitotic pattern for domain 1 is also comparable to a WT embryo. 
Peripheral cells enter mitosis (Fig. 2.28Cb, white arrowheads metaphase), while 
more central cells exit mitosis (Fig. 2.28Cb, black arrowheads anaphase). 
Furthermore, cells from domain 5 are initiating mitosis (Fig. 2.28Cb, circles) 
confirming that domain 1 is more advanced than domain 5. 
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5min after administration of a 5min heat shock all cells appear to be in interphase. To 
determine if this is the case other known markers of mitosis, such as nuclear 
envelope breakdown (NEB), histone H3 phosphorylation and mitotic spindle 
formation were examined. Embryos were stained for β-tubulin and with a 
fluourescently tagged wheat-germ agglutinin (WGA) as a marker for mitotic spindle 
formation. No mitotic spindle was apparent 5 min after heat shock, as the β-tubulin 
staining was entirely cytoplasmic (Fig. 2.29C). Surprisingly, the pattern of PH3 
staining suggested that mitosis 14 continued after a heat shock. In the embryo in Fig. 
2.29B a PH3 staining pattern was detectable which overlaps with the expected 
pattern of mitotic domains. However, higher magnification of either the DNA or PH3 
staining suggested that the DNA in all cells was in a decondensed 
interphase/prophase state. The germband was extending in the embryo shown (Fig. 
 
Fig. 2.28: A mild heat-shock disturbs mitosis. 
WT embryos were submitted to a 5min heat pulse by floating them on a thin apple juice-agar plate on a 
37°C water bath. Embryos were fixed immediately (A), 5min (B) or 10min (C) after the heat pulse. DNA 
morphology was visualized by staining embryos with bisbenzidine. Embryos are oriented with dorsal 
surface up and anterior to the left. Mitosis proceeds as normal during a heat pulse. A higher 
magnification of the embryo in Aa reveals the presence of metaphase (open arrowheads) and 
anaphase chromosomes (closed arrowheads) (Ab) immediately after a heat pulse. No mitotic figures 
are visible 5min after a heat pulse. The embryo shown in Ba is undergoing germband extension 
(arrowhead). At this stage mitosis occurs in domains 1 and 5 (boxed region) in a WT embryo. DNA has 
a uniform morphology in heat shock embryos (Bb). 10 min after a heat pulse the mitotic program 
resumes. Mitotic figures are visible in domains 1, 4 and 5 of a WT embryo (Ca). Higher magnification of 
domain 1 (Cb) confirms that mitosis 14 is asynchronous in domain 1. Peripheral cells are in metaphase 
(open arrowheads) and central cells are in anaphase (closed arrowheads). Meanwhile, cells of domain 
5 are at the prophase/metaphase transition (open circles). 
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2.29Aa, arrowhead). In a WT embryo of this stage domain 1 of mitosis 14 is near 
completion (compare Fig. 2.29A and Fig. 2.23A). However, all cells in the region of 
the embryo in Fig. 2.29 corresponding to domain 1 stained positive for PH3 and had 
a decondensed, non-mitotic DNA morphology. PH3 positive cells are not always in 
mitosis. Therefore, it is not possible to deduce from a persistence of PH3 staining 
after a heat pulse regime that the cells are still in mitosis. 
 
 
Fig. 2.29: No mitotic spindles are visible 5min after a heat pulse. 
Embryos were fixed 5min after a 5min heat shock. The embryo presented is in a dorso-lateral 
orientation.  
(A) DNA is visualized by staining with bisbenzidine, confirming the absence of mitotic figures 5min after a 
heat pulse. (B) Despite the apparent absence of mitotic figures many cells stain positive for PH3 in a 
manner that resembles the WT pattern of mitotic domains. (C) β-tubulin is visualized by staining with an 
anti- β−tubulin antibody. No mitotic spindles are detected 5min after a 5min heat pulse. (D) The three 
images are merged with DNA in red, β-tubulin in green and PH3 in blue. All DNA is in an 
interphase/prophase configuration (Aa), although many cells stain positive for PH3 (Ba). Furthermore, 
mitotic spindles are not discernible, as β-tubulin is associated with the cell cortex (Ca). Thus, 5min after a 
heat pulse all cells appear either in prophase or interphase. 
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The heat shock protocol also had effects on the nuclear envelope. A heat-shock 
embryo is shown in Fig. 2.30 with an extending germband (Fig. 2.30Aa, arrowhead). 
At this point in a WT embryo mitosis 14 occurs throughout the anterior and all stages 
of mitosis are visible. NEB starts at the prophase/metaphase transition and persists 
until telophase (Fig. 2.4). The nuclear envelope is fully intact in heat shock embryos 
(Fig. 2.30Ca and b) 5min after the heat pulse despite the presence of numerous PH3 
positive cells (Fig. 2.30Ba and C) in the anterior of the embryo. Higher magnification 
of DNA or PH3 staining suggests a prophase-like morphology for all mitotic cells. 
 
Fig. 2.30: Nuclear envelope breakdown is not detectable 5min after a heat pulse. 
Embryos were fixed 5min after a 5min heat shock. The embryo presented is in a dorsal orientation with 
anterior to the left. (A) DNA is visualized by staining with Hoechst. (B) A mitotic domain pattern of PH3 
positive cells is detected despite the decondensed structure of the DNA. (C) The nuclear membrane is 
detected by staining cells with a fluourescently labeled WGA. All nuclear envelopes are intact 5min after 
a heat pulse. (D) The three images are merged with DNA in red, WGA in green and PH3 in blue. Based 
on the extent of germband extension (Aa, arrowhead) and the number of PH3 positive cells in the 
anterior of the embryo (Ba) a large portion of cells should be in metaphase, anaphase and telophase. 
Nuclei are not distinguishable during these stages of mitosis. Nonetheless the nuclei are intact in almost 
all cells of a heat shock embryo, as one finds in interphase/prophase cells. 
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In summary, the mitotic program is affected 5min after administration of a mild heat 
shock. DNA has a uniform morphology, mitotic spindles are not detected and all 
nuclear envelopes are intact. The DNA morphology is particularly interesting, as it 
has a decondensed form, reminiscent of interphase/early prophase. It is possible that 
a heat shock induces a stress response which involves DNA decondensation, spindle 
disassembly and reassembly of interphase structures, such as the nuclear envelope. 
In this model all prophase and metaphase cells will appear as prophase after a heat 
shock. Individual embryos were observed where the asynchrony within individual 
domains was clearly disturbed as a result of the heat shock. The central cells of a 
WT domain enter mitosis first, followed by the peripheral cells (Fig. 2.22C). Thus, 
individual WT domains are distinguishable where central cells are in anaphase (Fig. 
2.31c, circle), surrounded by metaphase (Fig. 2.31c, black arrowheads) and 
prophase (Fig. 2.31c, white arrowheads) cells. Heat shock embryos of the same 
stage were observed where all peripheral cells had an apparent early prophase 
structure (Fig. 2.31b, white arrowheads). Only one central cell appeared in 
metaphase (Fig. 2.31b, blue arrowhead). All other central cells did not stain for PH3, 
suggesting that they were not in mitosis. Thus, it appears a mild heat shock interferes 
with mitosis in such a way that DNA decondenses, and cells adopt either a transitory 
prophase or interphase nature. Mitotic cells retain their mitotic nature, despite the 
absence of NEB or spindle formation, as can be deduced from the persistence of 
PH3 staining and the fact that the arrest observed is transitory. 
To confirm that the administration of a 5min heat pulse caused a decondensation of 
metaphase DNA a heat shock was administered to GFP-His2AvD embryos early in 
mitosis 14 and the effects on DNA morphology followed by time lapse microscopy. 
Similar to Fig. 2.28 no mitotic figures were visible in living cells several minutes after 
heat pulsing. In particular, nuclei were observed where the DNA was in metaphase 
after completion of the heat-shock, retained a metaphase morphology for an 
unusually long period (5min compared to the expected 2min) and then decondensed, 
without execution of anaphase or telophase. A time course is shown for a cell of 
domain 1 in Fig. 2.32. The DNA was in metaphase immediately after administration 
of a heat pulse (Fig. 2.32, 0s). Metaphase persisted for an additional 5min (Fig. 2.32, 
300s). The DNA slowly decondensed for the following 5min, without completing 
mitosis. Instead, it assumed an interphase-like morphology, without any intervening 
anaphase or telophase (Fig. 2.32, 600s). Therefore, administration of a mild heat-
pulse induces a rearrangement of DNA morphology for a brief period, where all cells 
adopt an interphase-like structure. This is a transitory effect, as the mitotic program is 
reinitiated after a brief recovery period. 
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Fig. 2.31: Heat pulses transitorily disturb the PH3 pattern of individual domains. 
Mitosis 14 occurs asynchronously within a particular domain. A typical WT domain 1 is shown in (c). 
Central cells are in anaphase (circles), while external cells are in metaphase (black arrowheads) and 
prophase (white arrowheads). In a WT embryo 5min after administration of a 5min heat pulse external 
cells have a prophase-like PH3 staining (b, white arrowheads), while only one metaphase cell is 
distinguishable in the center of the domain (blue arrowhead). The WGA staining is shown for the 
corresponding embryo in (d) and (e). A merge of the two staining is shown in (f) and (g) with PH3 in red 
and WGA in blue. 
 
Fig. 2.32: A 5min heat pulse transitorily leads to a decondensation of metaphase DNA. 
A GFP-His2AvD embryo was exposed to a 5 min heat shock at the beginning of mitosis 14 for domain 1. 
Progression through mitosis for an individual cell from domain 1 was followed by time lapse fluorescence 
microscopy. A single picture was taken every 10s. Stills from every 50s are presented here. A single cell 
is outlined. Immediately after mitosis at t=0s the cell is in metaphase. This state persists for almost 6min, 
in comparison to the normal metaphase, which lasts only 2min. Afterwards, the DNA begins to 
decondense and assume an interphase/prophase like morphology without any apparent anaphase or 
telophase. 
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Rux expression drives cells from metaphase to interphase. 
The same heat-shock protocol was applied to prd-GAL4 X UAS-CycA∆170 ; hs-rux 
embryos. The heat-shock was applied to embryos in late mitosis 15. At this stage 
expression of UAS-CycA∆170 was sufficiently high to arrest cells in metaphase in 
stripes in the embryo (data not shown). The heat-shock did not abrogate UAS-
CycA∆170 function, as the metaphase arrest was re-established after the heat-shock 
in control prd-GAL4 X UAS-CycA∆170 embryos (Fig. 2.33A). The heat-shock 
protocol was sufficient to induce expression of rux from the hs-rux transgene in all 
cells, including those expressing CycA∆170. In situ hybridization with a rux RNA 
probe showed a uniform level of rux expression in both stripes and interstripes (Fig. 
2.33B). Rux protein was detected 15 min after induction (data not shown). 
CycA∆170-expressing cells exited mitosis 20 min after induction of Rux. Stripes of 
telophase cells were visible in prd-GAL4 X UAS-CycA∆170 ; hs-rux embryos (Fig. 
2.33Cb, brackets). An hour after rux induction almost all cells were arrested in 
interphase (Fig. 2.33D), demonstrating that Rux induced a mitotic exit. As nuclear 
density was equally high in the paired expressing stripes and the interstripes (Fig. 
2.33D) this exit from mitosis must have involved completion of mitosis. Thus, 
expression of rux was sufficient to induce an exit from mitosis in cells expressing an 
indestructible CycA. 
Examination of the prdGAL4 X UAS-CycA∆170 embryos at later developmental 
stages showed that the metaphase arrest induced by expression of CycA∆170 was 
transitory. The DNA of most cells in prdGAL4 X UAS-CycA∆170 embryos was in a 
decondensed metaphase state approx. 2hr after initiation of UAS-CycA∆170 
expression (Figure 2.34a-b). The nuclear density of CycA∆170-expressing stripes 
was half of that for interstripes, suggesting that cells expressing CycA∆170 exited 
mitosis with a 4n DNA content. If Rux is involved in mitotic exit it is likely that Rux 
was one of the factors which downregulated CycA∆170 and induced a metaphase 
exit in these embryos. Therefore, rux3 ; prdGAL4 X rux3 ; UAS-CycA∆170 embryos of 
the same developmental stage were examined. Numerous cells expressing stable 
CycA in a rux mutant embryo remained trapped in metaphase (Figure 2.34a-d). 
Whereas almost all cells in the embryo depicted in 2.34a-b were in interphase, 
approximately half the cells in the rux mutant were in metaphase. Thus, rux mutants 
are impaired in their ability to overcome a CycA∆170 induced cell cycle arrest, as 
Rux activity is required to downregulate CycA activity during metaphase. This is very 
similar to an observation made previously in budding yeast. Low level overexpression 
                                                                                                                                                     RESULTS 
 
63
of a stable cyclin in S. cerevisiae leads to a transitory metaphase arrest (Amon et al., 
1994). Cells eventually exit metaphase as the yeast CKI, Sic1p downregulates cyclin 
activity. 
 
Fig. 2.33: Rux overexpression is sufficient to drive cells from metaphase into interphase. 
(A) A control prdGAL4 X UAS-CycA∆170 was exposed to a 5min heat pulse and fixed 20 min later. The 
heat-pulse does not reverse a metaphase arrest induced by overexpression of CycA∆170, as cells arrest 
in metaphase in stripes of the embryo after the heat pulse (A, arrows). A magnification of the boxed 
region in A confirms that the cells have arrested in metaphase (brackets). (B) rux expression is induced 
throughout the embryo by a 5min heat pulse in a prd-GAL4 X UAS-CycA∆170 ; hs-rux embryo. The 
embryo presented in B is at the same developmental stage as the embryo in A and was fixed 10min after 
a heat pulse. rux expression is visualized by in situ hybridization with a rux RNA probe. The gene is 
expressed to equal extents in CycA∆170-expressing and non-expressing cells. (C) 20min after 
administration of a heat pulse to prdGAL4 X UAS-CycA∆170 ; hs-rux embryos cells in paired stripes start 
to exit metaphase. As well as a reduction in the number of metaphase cells (arrowheads) a number of 
cells are discernible that are in anaphase/telophase (brackets). (D) 1hr after rux induction all cells are in 
interphase. 
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In summary, Rux is a CKI specific for mitotic cyclins. Rux overexpression inhibits 
mitosis and mitosis is prolonged in rux mutants. In particular, metaphase is 
significantly longer in rux mutants and expression of rux is sufficient to force cells 
trapped in metaphase into interphase. CycA is required for execution of metaphase 
and CycA must be downregulated to exit metaphase, as expression of an 
indestructible CycA leads to a metaphase arrest (Sigrist et al., 1995). The data 
presented above strongly argue for a role for Rux in contributing to exit from mitosis 
by downregulating Cdk1/CycA activity. In rux mutants CycA proteolysis alone is 
responsible for downregulation of Cdk1/CycA, leading to a prolonging of metaphase.  
 
 
 
Fig. 2.34 rux mutants display an impaired ability to overcome a transient metaphase arrest 
induced by CycA∆170. 
(A) The metaphase arrest induced by CycA∆170 in Fig. 2.23 is not permanent. Approximately 2hr after 
metaphase arrest cells exit mitosis with separating sister chromatids (a), resulting in stripes of cells with 
half the nuclear density of interstripes. Most cells in the CycA∆170 expressing stripes are in interphase 
after 2 hr (b). (B) In a rux mutant embryo expressing CycA∆170 a greater number of cells are arrested 
in metaphase at the same developmental stage (c). A higher magnification shows that almost half of 
the rux mutant cells are still in metaphase (d). Therefore, Rux activity is required to downregulate 
CycA∆170 during metaphase. 
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SIC1 functions as a CKI in Drosophila embryos 
SIC1 from S. cerevisiae is the only CKI known with a role in exit from mitosis. The 
data presented above and in previous reports reveal a number of similarities between 
Rux and SIC1. Both are CKIs specific for mitotic cyclins, with a role in G1 
establishment. Both interact directly with target cyclins via RXL motifs and are 
downregulated toward the end of G1. There are no obvious similarities between the 
two proteins at the level of the amino acid sequence. However, it is possible that both 
proteins function in a similar manner. To test this SIC1 was assayed for its ability to 
inhibit Drosophila cell cycle proteins in vivo and in vitro. SIC1 mRNA was transiently 
expressed by injecting mRNA into pre-blastoderm embryos. The embryos were aged 
for a further 2 hours and analyzed for cell cycle progression. A typical embryo is 
presented in Fig. 2.35. SIC1 mRNA was injected into the anterior half of the embryos 
(Fig. 2.35Ab). Based on the extent of germband extension (Fig. 2.35a, arrowhead) 
most cells in a WT embryo of this stage have undergone mitosis 14. However, cells 
expressing SIC1 mRNA arrest in G2 of cycle 14. The nuclear density in the SIC1 
expressing part of the embryo is approx. half of that in the remainder of the embryos 
(Fig. 2.35c). Higher magnification of SIC1 expressing cells confirms that they are in 
interphase as the DNA is decondensed (Fig. 2.35Af). CycA is also present in all SIC1 
expressing cells (Fig. 2.35Aa) and is exclusively cytoplasmic (Fig. 2.35Ae), 
confirming that these cells have arrested in G2 of cell cycle 14. The identical DNA 
morphology and CycA staining pattern was observed for all embryos examined. In 
each case SIC1 arrested cells in G2 of cycle 14. 
In a second series of experiments Sic1p was tested for its ability to modify the in vitro 
kinase activity of Drosophila CDK/cyclin complexes. The experimental setup was 
identical to that described in Fig. 10. CDKs, cyclins, and Sic1p were translated in 
vitro and co-incubated using an embryonic extract as a source of CAK. CDK/cyclin 
complexes were then precipitated and tested for their ability to phosphorylate the in 
vitro substrate histone H1. Sic1p is a potent inhibitor of Cdk1/CycA (Fig. 2.36a) and 
Cdk1/CycB (Fig. 2.36b), but not of Cdk2/CycE. Cdk2/CycE activity was enhanced by 
a factor of 2.6 by the addition of Sic1p. Thus, identical to Rux Sic1p specifically 
inhibited the kinase activity of Drosophila mitotic CDK/cyclin complexes and induced 
a cell cycle arrest in G2 upon overexpression in Drosophila embryos. 
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Fig. 2.35: SIC1 overexpression in Drosophila embryos arrests cells in G2. 
mRNA for HA-tagged SIC1 (HA-SIC1) was injected into the anterior of pre-blastoderm Drosophila 
embryos. HA-Sic1p was visualized by indirect immunofluorescence with anti HA antibodies (b). The 
protein is ubiquitously expressed in the anterior of the embryos. Sic1p is nuclear in cells of the 
amnioserosa (b, arrowheads). CycA was visualized by staining embryos with anti-CycA antiserum (a) 
and DNA was visualized by staining with bisbenzidine (c). The three images are merged in (d) with 
DNA in red, CycA in green and Sic1p in blue. The germband (a, arrow) is fully extended in the embryo 
depicted here, indicating that the embryo is undergoing mitosis 15. The boxed region in (a) and (c) is 
shown under higher magnification in (e-g). CycA is clearly cytoplasmic in all Sic1p expressing cells (e) 
and the DNA is in a decondensed interphase state (f). A merged image of (e) and (f) is shown in (g) 
with CycA in blue and DNA in red. 
 
2.36: Sic1p specifically inhibits Cdk1 kinase activity. 
The H1 kinase activity of Cdk1/CycA, Cdk1/CycB and Cdk2/cycE in the presence and absence of Sic1p 
was assayed. The results presented here are the averages of three individual experiment. As a negative 
control for kinase activity Cdk1 or Cdk2 was assayed in the absence of any cyclin partner. The activities 
of CDK/cyclin complexes was set to 100% for each individual experiment. Cdk1 and Cdk2 are relatively 
inactive kinases (columns 1,4 and 7 respectively) that are enhanced by the addition of CycA or CycB for 
Cdk1 and CycE for Cdk2 (columns 2, 5 and 8 respectively). Cdk1/CycA activity is reduced by approx. 
65% upon co-incubation with Sic1p (column 3). Similarly the activity of Cdk1/cycB is reduced by almost 
80% (column 6). The activity of Cdk2/cycE is enhances by a factor of greater than 2. 
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Rux was transiently expressed in U2OS carcinoma cells to test whether Rux also 
inhibits cell cycle progression in other species. As a positive control p27, a 
mammalian CKI known to elicit a G1 arrest, was expressed in cells of the same line. 
Rux induced a G1 arrest in cells to almost the same extent as the control CKI, p27, 
demonstrating that Rux also functions as a CKI in other organisms (Figure 2.37). The 
arrest induced in this case was in G1, not G2 as is observed in Drosophila. This 
probably reflects the fact that CycA is principally an S phase cyclin in mammals, 
whereas it is primarily a mitotic cyclins in Drosophila.  
 
 
 
Fig. 2.37: Rux prevents cell cycle progression in U2OS cells. 
Rux was transfected into U2OS cells and the cell cycle profile monitored after transfection. 62% of all 
cells transfected with Rux are in G1, whereas 27% of control cells transfected with vector alone are in 
G1, indicating that Rux induces a G1 arrest in human cells. In agreement with this 74% of all cells 
transfected with p27 are in G1. p27 is a CKI if the CIP/KIP family, known to induce a G1 arrest. These 
experiments were performed by Rene Medena at the University of Utrecht. 
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Downregulation of Rux activity during cell cycle progression 
As Rux is a negative regulator of cell cycle progression it is likely that Rux is also 
negatively regulated at some point during the cell cycle to allow progression into the 
next phase. This phenomenon has been observed for numerous CKIs. Generally, 
CKIs are downregulated at discrete times, mainly before S phase by proteasome 
mediated degradation. The signal that triggers CKI destruction is often 
phosphorylation by specific CDK/cyclin complexes. It has been proposed that Rux is 
downregulated in such a manner (Thomas et al., 1997). A Rux-lacZ fusion protein is 
destroyed prior to S phase and this destruction is enhanced by overexpression of the 
S phase cyclin, CycE. Furthermore, Cdk2/CycE phosphorylates Rux in vitro. Thus, it 
was proposed that Cdk2/CycE targets Rux for destruction at S phase by 
phosphorylation. 
High level overexpression of Rux in embryos arrested cells in G2 (Fig. 2.6), 
preventing analysis of Rux destruction during specific stages of the cell cycle. 
However, lower level overexpression of Rux did not completely inhibit cell cycle 
progression. Instead, the cell cycle was considerably slower. Virgin females that 
maternally provided GAL4 (matGAL4) induced low levels of Rux expression during 
interphase of cell cycle 14 when crossed to UAS-rux males (data not shown). These 
expression levels were not sufficient to elicit a cell cycle arrest. Nonetheless, cell 
cycle 14 was considerably slower in these embryos than in control WT embryos. A 
WT and matGAL4 X UAS-rux embryo are compared in Fig. 2.38. Both embryos were 
approximately at the same developmental stage, as determined by the extent of 
germband extension (Fig. 2.38a and b, arrowhead). In matGAL4 X UAS-rux embryos 
mitosis 14 had only begun in domains 1 and 5, whereas mitosis 14 was underway in 
approximately half the domains (1-11) in the WT embryo. Although mitosis 14 was 
delayed the overall pattern of mitosis was maintained in matGAL4 X UAS-rux 
embryos (Fig. 2.38b and data not shown). Cdc25Stg activity is the limiting factor for 
entry into mitosis 14. cdc25Stg is transcribed in most mitotic domains about 10 
minutes in advance of entry into mitosis. In the matGAL4 X UAS-rux embryos mitosis 
was not delayed as a result of delaying cdc25Stg transcription. In situ hybridization 
analysis with cdc25Stg RNA probes revealed that cdc25Stg was transcribed in the 
same domains in WT (Fig. 2.38e) and matGAL4 X UAS-rux embryos (Fig. 2.38f) at 
the same developmental stage (arrowheads in Fig. 2.38e and f indicate extent of 
germband extension). 
                                                                                                                                                     RESULTS 
 
69
 
 
Fig. 2.38: Mild overexpression of Rux delays execution of mitosis. 
Rux was expressed early during embryogenesis by crossing matGAL4 virgins to UAS-rux males. Rux 
protein is first visible in interphase 14 of matGAL4 X UAS-rux embryos. The level of Rux expression is 
such that it does not completely inhibit mitosis, rather mitosis is delayed. A WT (a) and matGAL4 X 
UAS-rux (b) from similar developmental stages is shown (observe relative position of germband, 
marked with an arrowhead). Mitosis is visualized by staining embryos with anti-PH3. Whereas mitosis 
14 is proceeding in domains 1-11 of the WT embryo (a) it is only detectable in domains 1, 2, 3 and 5 of 
the matGAL4 X UAS-rux embryo. The temporal order of mitosis 14 is preserved in the matGAL4 X 
UAS-rux embryo (b). The expression levels of Rux are shown in (c) and a merge of (b) and (c) is shown 
in (d) with Rux in blue and PH3 in red. Rux does not delay mitosis at the level of regulating cdc25stg 
transcription. In situ hybridization with a cdc25stg RNA probe are shown for a WT (e) and a matGAL4 X 
UAS-rux (f) embryo. Both embryos are at the same stage of mitosis 14 (arrowhead indicates position of 
germband) and transcription patterns for cdc25stg are the same in both. 
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As Rux overexpression does not prevent cdc25Stg transcription the observed delay in 
mitosis must be downstream of cdc25Stg transcription. There are several possible 
explanations for this observation. One possibility is that Rux prevents Cdk1 from 
phosphorylating its substrate molecules, thereby delaying entry into mitosis (Fig. 
2.39B). It has also been proposed that a positive feed-back loop exists between 
Cdk1 and Cdc25Stg. Low levels of Cdk1 activity are proposed to activate Cdc25Stg by 
phosphorylation. Cdc25Stg increases Cdk1 activity further through removal of 
inhibitory phosphates on Cdk1, thereby precipitating an entry into mitosis (Fig. 
2.39B). In this case Rux overexpression would inhibit both the feedback loop and the 
phosphorylation of downstream targets of Cdk1. The result in this case is a reduction 
in both Cdk1 activation and activity, whereas the first model simply predicts a 
reduction in Cdk1 activity.  
Rux directly inhibits Cdk1 activity (Fig. 2.13) and does not inhibit Cdc25Stg activity 
(Fig. 2.8). Therefore, overexpression of Cdc25Stg should not alter the ability of Rux to 
delay execution of mitosis in the case of the former model, as cdc25Stg in situ 
 
Fig. 2.39: Two potential explanations for the delay of mitosis in matGAL4 X UAS-rux embryos. 
(A) Stg activates Cdk1 by dephosphorylating it on T14 and Y15. Cdk1 activity rises to a critical threshold 
level and triggers entry into mitosis by phosphorylating downstream targets. Moderate levels of Rux brake 
this process, thereby slowing the rate of entry into mitosis for individual domains. (B) Cdc25Stg activates 
Cdk1 by dephosphorylating it on T14 and Y15. A positive feedback is established as Cdk1 hyperactivates 
Cdc25Stg by phosphorylation. Rux delays entry into mitosis by braking the feedback loop as well as the 
phosphorylation of downstream targets of Cdk1. Entry into mitosis is delayed as a result of the 
hypoactivation of Cdc25Stg. 
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analysis confirms that Cdc25Stg levels are high enough to induce mitosis in matGAL4 
X UAS-rux embryos (Fig. 2.38f). In the case of the latter model overexpression of 
Cdc25Stg would enhance the feedback stimulation of Cdk1, thereby at least partially 
overcoming the mitotic delay observed in matGAL4 X UAS-rux embryos. This 
hypothesis was tested by crossing UAS-rux ; UAS-cdc25Stg males to matGAL4 virgin 
females. Overexpression of Cdc25Stg in control matGAL4 X UAS-cdc25Stg embryos 
resulted in replacement of the standard pattern of mitotic domains with simultaneous 
mitoses throughout the embryo (Fig. 2.40a). Co-expression of Rux and Stg using a 
matGAL4 driver also abolished the standard pattern of mitotic domains and led to 
mitoses throughout the embryo (Fig. 2.40c-e). Whereas there are less mitoses in 
matGAL4 X UAS-cdc25Stg ; UAS-rux embryos than in matGAL4 X UAS-rux embryos 
the number is high enough to conclude that overexpression of Cdc25Stg overcomes 
the mitotic delay elicited by matGAL4 X UAS-rux. These data support a model where 
matGAL4 X UAS-rux delay mitosis by inhibiting Cdk1 activity and indirectly 
preventing Cdk1 activation by Cdc25Stg. 
 
Fig. 2.40: Co-expression of Cdc25Stg and Rux reverses the mitotic delay observed in matGAL4 X 
UAS-rux embryos. 
Ubiquitous expression of Cdc25Stg (a) induces mitosis 14 throughout the embryo. Mitosis is visualized 
with anti PH3 antibodies. Mitosis 14 occurs throughout matGAL4 X UAS-rux ; UAS-Cdc25Stg embryos in 
a manner that deviates from the classical domain pattern (c). The Rux staining for the matGAL4 X UAS-
rux ; UAS-Cdc25Stg embryo is shown in (b) and a merge of (b) and (c) is shown in (d) with Rux in blue 
and PH3 in red. The boxed region in b-d is shown at a higher magnification in e-f. Rux expressed in all 
cells by the matGAL4 driver (e). In contrast to control matGAL4 X UAS-rux embryos (Fig. 38) mitosis is 
not delayed in matGAL4 X UAS-rux ; UAS-Cdc25Stg embryos, rather it occurs throughout the embryo to a 
slightly lesser extent than in matGAL4 X UAS-stg embryos. 
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Disappearance of CycA mirrors progression through mitosis as a result of CycA 
destruction during metaphase (Fig. 2.41a,d,g and j). Interestingly, it was observed 
that Rux disappears in a very similar manner in matGAL4 X UAS-rux embryos. Rux 
destruction occurred in a manner that directly reflects the mitotic domains of mitosis 
14 (Fig. 2.41b and e). Rux destruction also mirrored that of CycA in cell cycle 15 (Fig. 
2.41g and h) with the exception of the amnioserosa (Fig. 2.41h, bracketed area). The 
amnioserosa is a specialized group of cells that arrests division in G2 of mitosis 14 
with a DNA content of 4n. Rux was destroyed in mitosis 15 and did not accumulate in 
G2 of cell cycle 16 (Fig. 2.41k), presumably due to a diminishment of matGAL4 
activity. The Rux protein that accumulated in the amnioserosa during cell cycle 14 
was stable for a long time, as the signal can still be detected in embryos of cell cycle 
16 (Fig. 2.41k arrowhead). Thus, it appears that Rux is stable in G2 cells and is 
turned over in dividing cells. 
 
Fig. 2.41: Rux is degraded in dividing cells in the embryo.  
CycA (a, d, g and j) and Rux (b, e, h and k) are shown in matGAL4 X UAS-rux embryos during mitosis 
14 (a-f), mitosis 15 (g-i) and mitosis 16 (j-l). A merge of the corresponding Rux and CycA staining are 
shown in c, f, i and l with Rux in red and CycA in green. CycA is degraded during metaphase (Fig. 4). 
Therefore, the pattern of CycA degradation reflects the course of progression through the different 
mitoses. CycA disappears in a manner that reflects the pattern of mitotic domains in mitosis 14 (a, d). 
The pattern of Rux disappearance is almost identical in the same embryos (b, e). Similarly, the pattern 
of Rux destruction (h) almost mirrors that of CycA (g) during mitosis 15, with the exception of the 
amnioserosa (h, brackets), a specialized group of cells that arrest in G2 of mitosis 14. No new Rux 
protein is translated during the 16th cell division, due to a lack of activity of the matGAL4 driver (k). 
Nevertheless, the Rux protein in the amnioserosa since the 14th cycle is still present (k, arrowhead). 
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Higher magnification revealed that Rux and CycA are destroyed in a distinct temporal 
order. Whereas CycA was destroyed at the metaphase to anaphase transition (Fig. 
2.4 and Fig. 2.42e-h), Rux was stable in metaphase (Fig. 2.42j) and anaphase cells 
(Fig. 2.42k). Rux protein first disappeared as cells exited mitosis at the telophase to 
interphase boundary (Fig. 2.42l). It is important to emphasize that these observations 
were made with cells in mitosis 14.  
 
Fig 2.42: Rux is degraded after anaphase in dividing cells. 
CycA (e-h) and Rux (i-l) were visualized in single cells from matGAL4 X UAS-rux embryo at different 
stages of the cell cycle. Cell cycle stage was determined by staining for DNA with bisbenzidine (a-d) and 
cells were scored as prophase (a), metaphase (b), anaphase (c) or telophase/interphase (d). CycA is 
destroyed during metaphase (e-h) in agreement with previous observations. Rux is a nuclear protein 
during interphase and prophase (i). The protein is spread throughout the entire cell after nuclear 
envelope breakdown in metaphase (j) and Rux persists during anaphase (k). Rux protein is destroyed 
during or after telophase (l). A merge of the three images is shown in m-p with Rux in red, DNA in blue 
and CycA in green. A merge of the Rux and DNA channels alone is shown in q-t with Rux in red and 
DNA to blue to confirm that Rux persists throughout metaphase and anaphase. 
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The first 16 divisions occur without any G1 phase. S phase 15 follows within 5 
minutes of mitosis 14 (Edgar and O'Farrell, 1990). It is therefore not possible to 
deduce from the above data whether Rux was destroyed as cells exited mitosis or as 
cells entered S phase. To test this possibility directly it is necessary to express Rux 
prior to mitosis 16. Mitosis 16 is followed by a prolonged G1. If Rux persists in G1 
one can deduce that Rux destruction occurs prior to S phase. If, however, Rux is 
destroyed after mitosis 16 then the destruction described above is a mitotic event. To 
perform this experiment it is necessary to express levels of Rux prior to mitosis 16 
that are not high enough to prevent mitosis. A heat shock of 10 minutes produced 
sufficient amounts of Rux to induce a brief mitotic delay during mitosis 14, similar to 
that seen with matGAL4 X UAS-rux embryos. Mitosis 14 proceeded within 1 hour 
after the heat-shock and Rux was degraded in a pattern similar to CycA (Fig. 2.43a-
c). Furthermore, Rux was stable in the amnioserosa (Fig. 2.43b) and higher 
magnification confirmed that Rux was degraded after CycA (data not shown). Thus, a 
10min heat pulse of hs-rux embryos sufficiently recapitulated the Rux expression 
levels and cell cycle effects observed in matGAL4 X UAS-rux embryos. The same 
heat shock protocol was applied to embryos prior to mitosis 16 and the presence of 
Rux was determined after completion of mitosis 16 and entry into G1 of cycle 17. Rux 
was not destroyed in G1 as all cells showed high levels of Rux protein (Fig. 2.43d 
and e). Thus, Rux is stable throughout mitosis and G1 and is degraded as cells enter 
S phase. These data are in agreement with a function for Rux as a CKI with a role in 
triggering an exit from mitosis and maintaining subsequent G1 phases. 
The results described above suggest that Rux and CycA are degraded in distinct 
manners. Rux is stable in the amnioserosa, whereas CycA is not and Rux is 
destroyed before S phase, whereas CycA is destroyed during metaphase. To confirm 
that two separate mechanisms exist for Rux and CycA degradation the levels of both 
proteins were compared in prdGAL4 X UAS-rux embryos. As described above cells 
expressing Rux in these embryos arrest division before mitosis 15 (Fig. 2.6). Rux 
protein levels persisted for several hours afterwards (Fig. 2.44a and d), whereas 
CycA disappeared. (Fig. 2.44b and e). Interestingly, CycA is destroyed in non-
metaphase cells, as Rux induces a G2 arrest. Thus, a cell-cycle independent 
developmental program appears to ensure CycA destruction in embryos of this 
stage. The most likely explanation is that CycA destruction is a result of a rise in the 
levels of fizzy-related (fzr) transcription. Fzr is a component of the APC E3 ligase and 
triggers the destruction of target proteins such as CycA in G1 (Sigrist and Lehner, 
1997). As Rux is not degraded in these cells it appears that Rux is destroyed in a 
different manner to CycA. 
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Fig. 2.43: Rux is stable in G1. 
A 10min heat pulse followed by a 1hr recovery period, reproduces the rux expression levels observed in 
mat-GAL4 X UAS-rux embryos. A hs-rux embryo was subjected to a 10min heat pulse and fixed after 1hr. 
The embryo was stained for CycA (a) and Rux (b). The levels of Rux produced are not sufficient to 
completely prevent mitosis, however they do delay execution of mitosis. CycA and Rux disappear in a 
classical mitotic domain pattern, as observed in matGAL4 X UAS-rux embryos. Furthermore, Rux is not 
degraded in the amnioserosa of hs-rux embryos (b). A merge of the embryos in (a) and (b) is shown in (c) 
with Rux in red and CycA in green. Rux protein is shown in hs-rux embryos 1hr after a 10min heat pulse 
(d). The epidermal cells of this embryo are in a prolonged G1 state. A magnification of a region of the 
embryo in (d) is shown in (e). rux protein is not turned over in G1 cells 1hr after expression (d-e), whereas 
it is turned over in dividing cells (b-c). Thus, Rux destruction occurs prior to DNA replication at S phase 
and not after mitosis. 
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These data are in agreement with previous reports that Rux is degraded at the G1-S 
transition in the eye imaginal disc (Thomas et al., 1997). It was suggested that this 
destruction is mediated by Cdk2/CycE, presumably through phosphorylation of Rux. 
This hypothesis was tested in two separate experiments. prdGAL4 females were 
crossed to UAS-CycE ; hs-rux males. The prd-GAL4 driver line induces high levels of 
CycE in alternating stripes of the epidermis. Rux was expressed at high levels 
throughout 3-4hr old embryos by subjecting them to a 15min heat pulse. The levels 
of Rux protein were then monitored as a function of time. Rux protein was 
ubiquitously present an hour after the heat shock (data not shown) and started to 
subside slightly by 2hr (Fig. 2.45a and d). 3hr after heat shock Rux levels had 
dropped further in all cells and was gone entirely in some (Fig. 2.45b and e). By 4hr 
Rux was absent throughout almost the entire embryo (Fig. 2.45c and f) with the 
exception of cells of the nervous system (Fig.45c, arrowheads). Interestingly Rux 
disappeared at equal rates from CycE overexpressing cells and WT cells (compare 
prd-expressing and non-expressing stripe in Fig. 2.45e), indicating that 
overexpression of CycE in the embryonic epidermis is not sufficient to induce Rux 
destruction. 
 
Fig. 2.44: Rux and CycA are destroyed in distinct manners. 
Expression of Rux from a UAS-transgene by the prdGAL4 driver arrests cells in G2 of the 15th cell cycle 
(Fig. 6). The Rux protein is stable for several hours after expression in these cells (a, an embryo is 
shown with fully retracted germband). CycA, on the other hand is almost completely gone from these 
cells (b), although CycA destruction normally occurs at mitosis and these cells do not divide. A merge 
of (a) and (b) is shown in (c) with Rux in red and CycA in green. The boxed region in a-c is magnified in 
d-f. CycA is almost completely absent in Rux expressing cells, although these cells fail to divide. The 
cell expressing CycA in (e) and (f) is in a different focal plane to the Rux-expressing cells and probably 
belongs to the nervous system. These cells are still mitotically active, whereas most WT epidermal cells 
of this stage are in G1. 
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To directly test whether CycE activity is required for Rux destruction time course 
experiments were done in cycE mutant embryos overexpressing Rux. cycE null 
mutants are homozygous lethal. To construct homozygous mutant embryos 
heterozygous flies were crossed inter se. The parental wild-type chromosome was 
marked with a transgene that expresses β-galactosidase in 14 stripes of the 
epidermis. WT embryos expressing the transgene (Fig. 2.46a, arrowheads) are 
distinguishable from homozygous mutant embryos, which lack β-gal staining (Fig. 
2.46d). Rux is still present 1hr after induction in WT embryos overexpressing Rux, 
and CycA accumulates in the nucleus (Fig. 2.46b). In contrast, Rux is almost 
completely degraded in cycE mutant embryos (Fig. 2.46e), except for the G2 
population of amnioserosa cells (Fig. 2.46e, brackets). Therefore, CycE activity is not 
required for Rux destruction.  
 
Fig. 2.45: CycE overexpression does not accelerate the rate of Rux destruction.  
Rux was overexpressed in prdGAL4 X UAS-cycE ; hs-rux embryos through administration of a heat pulse. 
The disappearance of Rux was monitored over a fixed period. 2hr after overexpression the protein is 
present to relatively high levels throughout the embryo (a, d). 3hr after induction Rux levels decline in all 
cells and disappear in some (b, boxed region magnified in (e)). There is no apparent difference in the total 
amounts of Rux in CycE overexpressing cells (e, bracket) to cells from interstripes. 4hr after induction 
Rux has disappeared from almost the entire embryo in both prd stripes and interstripes (c). The protein 
persists in a subset of cells of the nervous system (c, arrowheads), which are probably in G1. A 
magnification of the boxed region in (c) is shown in (f). 
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Interestingly, CycA is also completely destroyed in cycE ; hs-rux embryos. One 
possible explanation for this observation is that Rux activity indirectly stimulates Fzr-
mediated destruction of target proteins. Fzr is active in its unphosphorylated state 
and is inactivated by CDK/cyclin mediated phosphorylation. It is possible that CycE 
mediated phosphorylation prevents destruction of Rux and CycA in WT embryos 
(Fig. 2.47A). In a CycE mutant overexpressing Rux there is no CDK activity available 
to phosphorylate Fzr, as CycE is absent and Cdk1 is inhibited by overexpression of 
Rux. In this case, Fzr is dephosphorylated after completion of mitosis and CycA is 
rapidly degraded (Fig. 2.47B). It is not clear if the destruction of Rux observed here is 
Fzr-dependent, as Rux is stable in G1 cells and Fzr is active during G1 (Sigrist and 
Lehner, 1997). Furthermore, Rux and CycA destruction are distinct events and CycA 
destruction is mediated by Fzr. 
 
Fig. 2.46: Rux destruction does not depend on CycE activity. 
Rux was overexpressed from a heat-inducible promoter in WT or cycE-/- mutant embryos. For this 
experiment heterozygous cycE mutants were crossed inter se. The WT chromosome bore a transgene, 
expressing β-galactosidase in 14 stripes in the embryos. The embryos were homozygous for a heat-
inducible rux transgene (hs-rux) on a different chromosome. One quarter of the embryos arising from 
this cross are mutant for cycE, while three quarters of all embryos will have either one or two wild-type 
copies of the cycE gene. WT embryos express β-galactosidase in stripes in the embryo (a, arrowheads) 
whereas mutant embryos do not (d). the levels of CycA (a and d) and Rux (b and e) were monitored for 
WT (a and b) and cycE embryos (d and e). No Rux is detectable in cycE embryos 1hr after induction (e) 
with the exception of the amnioserosa (brackets), whereas it persists in WT embryos (b). Furthermore, 
CycA is absent in cycE ; hs-rux embryos (d), while it is present in control hs-rux embryos (a). A merge 
of (a) and (b) is shown in (c) with Rux in red and CycA in green. A merge of (d) and (e) is shown in (f) 
with Rux in red and CycA in green. 
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An in vitro assay was developed to further analyze Rux protein turnover. 
Radiolabeled, in vitro translated Rux was incubated in a 0-1hr embryonic extract and 
aliquots were removed at fixed time points and analyzed by SDS-PAGE. Wild-type 
Rux protein was rapidly degraded in this system, so that almost the entire protein 
was gone by 30mins (Fig. 2.48A). Addition of proteasome inhibitors, such as clasta-
 
Fig. 2.47: A model to explain the disappearance of CycA in cycE ; hs-rux embryos. 
In a WT embryo the overlapping activities of CycE and CycA phosphorylate Fzr, keeping it in an 
inactive state. Overexpression of Rux inhibits CycA, however not CycE. Therefore, Fzr is maintained in 
an inactive state. In cycE ; hs-rux embryos overexpressed Rux prevents Cdk1/CycA from 
phosphorylating Fzr and CycE is no longer present to inactivate Fzr. Thus, Fzr shifts to the active 
unphosphorylated form, triggering a rapid turnover of both Rux and CycA. 
 
Fig. 2.48: Rux is degraded by the proteasome. 
(A) An in vitro assay was developed to monitor Rux protein turnover. Rux was translated in vitro in 
reticulocyte lysate in the presence of 35S-Met. The radiolabeled protein was then incubated in a crude 
0-1hr embryonic extract and samples removed at the indicated times. The sample were resolved by 
SDS-PAGE to monitor total protein levels as a function of time. The Rux protein is rapidly degraded in 
extract. (B) Addition of 100µM of the proteasome inhibitor clasto-lactocystin stabilized the Rux protein. 
The amount used was determined by the ability of clasta-lactocystin to inhibit the destruction of a 
fluourogenic peptide substrate of the proteasome in an embryonic extract. 
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lactocystin significantly stabilizes Rux in this degradation system (Fig. 2.48B). 
Approximately a half of the protein is still detectable after 30min and residual protein 
can still be determined after 90min. The same results were observed using a second 
proteasome inhibitor, NLVS. Thus, it appears that Rux is degraded in a proteasome-
dependent manner in this system. 
Several CKIs are destroyed at specific cell cycle stages by the proteasome. 
Traditionally, this destruction is triggered by CDK-dependent phosphorylation of the 
substrate CKI. Rux has four potential CDK phosphorylation sites with the consensus 
sequence TP (Fig. 2.1B). To determine whether phosphorylation on any of these 
sites was a prerequisite for Rux destruction in the assay described above a series of 
point mutations were introduced into the Rux protein. In each case potential 
phosphor-acceptor threonines were converted to alanines (Fig. 2.49). A total of 
seven different mutant constructs were made. All were degraded with kinetics 
identical to WT Rux. The results are summarized for six different construct 
graphically (Fig. 2.49A). A seventh mutant construct where all four threonines are 
mutated to alanines is shown in Fig. 2.49Bb. Removing all four threonines had no 
effect on the rate of Rux destruction (compare Fig. 2.49Ba and 49Bb), indicating that 
Cdk-mediated phosphorylation is not essential for Rux destruction. This is in 
agreement with the observation in live embryos where Rux is rapidly turned over in 
an in vivo context with low Cdk activity (Fig. 2.46). 
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A commonly used signal for proteasome-mediated destruction is the PEST-motif, 
which is defined as a region of a protein with a high density of prolines, aspartates, 
serines and threonines (Rechsteiner and Rogers, 1996). A very strong PEST motif 
was found in the C-terminus of the Rux protein using the PESTfind algorithm 
(http://emb1.bcc.univie.ac.at/embnet/tools/bio/PESTfind). A C-terminal truncation 
protein where the candidate PEST sequence was completely removed (Rux∆PEST) 
 
Fig. 2.49: Rux in vitro destruction is mediated by a C-terminal PEST sequence. 
(A) A schematic representation of the WT Rux protein showing the relative positions of all potential CDK 
phosphorylation sites (TP) and the PEST motif (PEST). (B) A series of mutant constructs were made 
where different TPs had been replaced by APs. Protein destruction was monitored by incubating 
radiolabeled constructs in an extract, removing samples at specific times and assaying protein amounts 
as a function of time by SDS-PAGE and autoradiography. All constructs were destroyed with the same 
kinetics as WT Rux. A mutant construct where all four potential phosphorylation sites were removed (Bb, 
autoradiograph) was destroyed at the same rate as WT Rux (Ba, autoradiograph). A C-terminal deletion 
removing the PEST (Rux∆PEST) sequence stabilizes the Rux protein (Bc). Rux∆PEST inhibits 
Cdk1/CycA to the same extent as WT Rux. In a standard kinase assay, Cdk1/CycA was incubated with 
reticulocyte lysate (d, lane 2) WT Rux (d, lane 3) or Rux∆PEST (d, lane 4). The kinase activity of 
Cdk1/CycA was set to 100%. Rux and Rux∆PEST reduced kinase levels by almost 75%. 
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was no longer degraded in the in vitro assay (Fig. 2.49Bc). This stability was not the 
result of a gross conformational rearrangement of the Rux protein, as Rux∆PEST still 
inhibited Cdk1/CycA kinase activity as efficiently as WT Rux (Fig. 2.49Bd). HA-
tagged Rux∆PEST construct was also stable in late anaphase (Fig. 2.50a-c) and 
telophase (Fig. 2.50d-f) when injected into WT embryos. Thus, it does not appear 
that Rux destruction is mediated by CDK/cyclin dependent phosphorylation, rather it 
is mediated by PEST-dependent destruction. There is some degree of control to the 
temporal order of destruction, as Rux is stable in G1, G2 and until anaphase during 
mitosis. 
 
Fig. 2.50: Rux∆PEST is stable in embryos. 
mRNA encoding HA-Rux∆PEST was injected into pre-blastoderm embryos. Rux∆PEST was visualized 
by staining blastoderm embryos with anti-HA antibodies (c, f). DNA was visualized by staining with 
Hoechst (a, d) and CycA was visualized with anti-CycA antibodies (b, e). Two individual cells are shown 
in anaphase (a-c) and telophase/interphase. As opposed to WT Rux, Rux∆PEST is present in 
telophase cells, indicating that it is not degraded in the same manner. 
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DISCUSSION. 
Orderly progression through the cell cycle is a prerequisite for the correct 
development and survival of all metazoans. Numerous experimental manipulations 
have demonstrated that disorganized cell cycles are deleterious to organism 
patterning (Follette and O'Farrell, 1997). Furthermore, aberrant cell cycles are 
hallmarks of lethal conditions such as cancer (Sherr, 1996). Several mechanisms 
arose for regulating CDK activity at the correct cell cycle stage early in eukaryotic 
evolution (Morgan, 1995). These include reversible covalent modification of CDKs, 
proteolytic destruction of cyclins and the activity of CKIs. CKIs associate with CDKs, 
cyclins or both (Peter and Herskowitz, 1994). CKIs inhibit CDK activity and prevent 
CDK activation. This report presents evidence that the Drosophila gene product Rux 
is a novel CKI. rux mutants have rough eyes and null mutants are male sterile 
(Gonczy et al., 1994; Thomas et al., 1994). Both phenotypes result from disturbances 
in the WT cell cycle and both are suppressed by removing a copy of cycA or cdc25stg, 
as Rux is required to inhibit CycA activity during eye development and 
spermatogenesis. Here it is shown that Rux interacts physically with CycA and that 
this interaction has several consequences for CycA activity, most importantly 
inhibition of Cdk1/CycA complexes. Interestingly, Rux is the first CKI to be 
characterized in a multicellular organism which is specific for mitotic cyclins. This 
report also presents evidence that, in addition to its established role as a regulator of 
the G1 to S transition, Rux contributes to regulating the metaphase to anaphase 
transition. This is the first time such a function has been ascribed to a metazoan CKI. 
Rux is a novel Drosophila CKI. 
CKIs are defined as proteins that interact with CDKs, cyclins or both, inhibit CDK 
activity and prevent CDK activation without covalently modifying either CDKs or 
cyclins. This report presents evidence that Rux is a Drosophila CKI specific for 
mitotic cyclins. 
1. Rux physically associates with CycA and CycB. Rux is a nuclear protein from 
Drosophila and its overexpression forces a nuclear accumulation of CycA and a pre-
mitotic cell cycle arrest. Rux specifically precipitated CycA and CycB from extracts 
prepared from embryos expressing high amounts of Rux (hs-rux). RXL motifs were 
initially identified in CKIs of the KIP/CIP family of inhibitors as essential for interaction 
with cyclin proteins. The interactions between Rux and CycA are most likely 
mediated by two RXL motifs in the Rux protein. Mutating either the N-terminal or 
central RXL in Rux diminishes the ability of Rux to trigger a nuclear accumulation of 
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CycA and abolishes the ability of Rux to inhibit Cdk1/CycA. These RXL mutant forms 
are also impaired in their ability to prevent cell cycle progression. Furthermore, a 
mutant Rux construct where the central RGL has been mutated to KGK does not 
precipitate CycA from blastoderm embryos, while WT Rux does. The crystal structure 
of a human p27/CycA/Cdk2 complex has been resolved recently (Russo et al., 1996). 
p27 inserts into the cyclin box of CycA via an N-terminal RXL. p27 then inserts into 
the active sites of CDK and excludes ATP, thereby inactivating CDK. It is not clear 
whether Rux interacts with Cdk1. A minor amount of Cdk1 does co-precipitate with 
Rux from hs-rux extracts (data not shown), although it cannot be excluded whether 
this Cdk1 is associated with CycA or Rux. Nonetheless, Rux does inhibit Cdk1 kinase 
activity. Presumably the association of Rux and CycA is such that a part of the Rux 
protein prevents Cdk1 access to substrate molecules. 
The three dimensional structure of a p27/CycA/Cdk2 complex showed that the RXL 
motif of p27 inserted into the cyclin box of CycA. Multiple hydrophobic and van der 
Waals interactions are made between p27 and the conserved MRAIL motif in the 
cyclin box of human CycA. The MRAIL motif is also found in all known Rux 
interacting proteins in Drosophila; CycA, CycB and CycE. It is therefore likely that the 
RXL motifs in Rux inserts into the cyclin box of its interacting partners. Attempts were 
made to confirm this by making a Rux-resistant CycA with point mutations in the 
cyclin box. Conversion of a conserved tryptophan (W242) in human CycA to an 
alanine does not reduce the ability of CycA to activate CDK but this CycA mutant is 
impervious to inhibition by p27 (Schulman et al., 1998). A W242A mutant was made 
with Drosophila CycA. However, this mutant form does not activate Drosophila Cdk1 
(data not shown), making it impossible to determine whether Rux inhibits Cdk1/CycA 
via interactions with the MRAIL motif in CycA. In summary, Rux specifically interacts 
with the Drosophila mitotic cyclins A and B and this interaction is mediated by the N-
terminal and central RXL motifs in the Rux protein. 
2. Rux inhibits Cdk1 activity. Rux inhibited the kinase activity of Cdk1 in several 
experimental setups. The kinase activity of Cdk1 precipitated from hs-rux embryonic 
extracts was considerably lower than the kinase activity of Cdk1 precipitated from 
WT extracts of the same stage. Consistent with an inhibition of Cdk1 activity 
overexpression of Rux inhibits mitosis in embryos and various imaginal discs. An in 
vitro assay was developed to monitor Rux-mediated inhibition of Cdk1. Rux also 
inhibited the in vitro kinase activity of Cdk1/CycA and Cdk1/CycB. These effects were 
specific for Cdk1, as Rux did not inhibit Cdk2/CycE. This is consistent with previous 
reports that Rux does not prevent ectopic S phases induced by overexpression of 
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CycE whereas Rux does inhibit ectopic S phases induced by overexpression of CycA 
(Sprenger et al., 1997). 
The H1 kinase activity of Cdk1/CycB decreased progressively upon addition of larger 
amounts of Rux. Inhibition was not achieved by disrupting Cdk1/CycB complexes, as 
equal amounts of CycB coprecipitated with Cdk1 regardless of the amount of Rux 
added. Large amounts of Rux reduced the extent of T161 phosphorylation on Cdk1. 
In contrast, Rux was a bimodal regulator of Cdk1/CycA activity. Large amounts of 
Rux inhibited Cdk1/CycA to almost background levels. Small amounts of Rux 
enhanced the activity of Cdk1/CycA by a factor of three. Activation was not achieved 
by increasing the total amount of Cdk1/CycA complexes formed. Irrespective of the 
amounts of Rux added in the assay Cdk1 precipitated an approximately equal 
amount of CycA, demonstrating that Rux does not modulate Cdk1/CycA activity by 
affecting the extent of Cdk1-CycA association. Enhancement of Cdk1/CycA activity 
was also not the result of increasing the extent of T161 phosphorylation on Cdk1. 
Cdk1 was phosphorylated to an equal extent on T161 in the presence of small 
amounts of Rux or of control reticulocyte lysate.  
The ability of CKIs to enhance CDK/cyclin in vitro kinase activity has been described 
previously (Correa-Bordes and Nurse, 1995; Zhang et al., 1994). rum1 enhances the 
activity of S. pombe cdc2 and active Cdk2/CycA complexes contain the CKI p21 
under some circumstances. In the case of p21 it was proposed that the stoichiometry 
of the different subunits determine Cdk2 activity. In this model one p21 molecule 
serves as a scaffold to assemble active Cdk2/CycA complexes and two p21 
molecules are required for inhibition. However, more recent studies have 
demonstrated that a single p21 molecule completely inhibits Cdk2/cycA activity 
(Hengst et al., 1998).  
The two cyclin-interacting, RXL motifs in Rux involved in Rux-CycA interactions are 
essential for inhibition of Cdk1/CycA. Removing either RXL abolishes the ability of 
rux to inhibit Cdk1/CycA. Deletion of either RXL motif does not abrogate the ability of 
Rux to enhance Cdk1/CycA activity. Thus, it seems unlikely that Rux enhances the 
kinase activity of CycA via a single RXL motif. It is conceivable that an additional 
region on the Rux molecule determines a mild CycA interaction and in some manner 
brings CycA into a more active confirmation. Alternatively, removing a single RXL 
may not completely eliminate Rux-CycA interactions. It is possible that transitory 
associations still occur via the second RXL which results in an increase in CycA 
activity. As the increase in activity is not associated with an increase in T161 
phosphorylation or Cdk1/CycA complex formation it is difficult to provide a 
mechanistic explanation for the effect. Furthermore, it is not clear whether activation 
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has an in vivo relevance, or whether it is an in vitro artifact. It is conceivable that the 
activation observed may have a minor role during the G1 to S phase transition or 
during S phase. At this stage Rux levels decline due to destruction and CycA levels 
rise due to increased transcription and a decrease in the rate of CycA proteolysis. At 
this point the relatively low levels of Rux may enhance CycA activity, thereby 
accelerating the G1-S transition. 
It was previously reported that a purified GST-Rux fusion product did not inhibit 
Cdk1/CycA (Thomas et al., 1997). However, the GST tag is almost as large as the 
Rux protein itself and was attached to the N-terminus, i.e. proximal to the essential 
N-terminal RXL motif. This experiment was repeated in the in vitro kinase assays 
described in this report using in vitro translated GST-Rux. This fusion protein also 
failed to inhibit Cdk1/CycA (data not shown), confirming that this was an 
inappropriate choice of tag. In the in vitro assays performed above a relatively large 
amount of Rux is necessary to strongly inhibit Cdk1 kinase activity. In most 
experiments inhibition to background levels was only seen after using approximately 
twice as much Rux as CycA. However it is not possible to interpret these ratios in 
terms of efficiently folded and translated protein. Furthermore, analysis of the rux 
mutant phenotypes indicate that Rux functions in cooperation with other cellular 
activities at times when cyclin levels are low. Thus, in a cellular context the extent of 
inhibition is sufficient to downregulate CycA activity and establish a G1 state. 
In several experiments a reduction of T161 phosphorylation on Cdk1 was observed 
after incubation of large amounts of Rux with Cdk1. However, Rux does not rely 
solely on preventing T161 phosphorylation as a means of inhibiting Cdk1. Rux 
inhibited T161-phosphorylated Cdk1 in two separate experiments. Cdk1/CycA 
complexes were pre-activated with a purified source of CAK, incubated with Rux and 
directly assayed for H1 kinase activity. In this experiment Rux greatly reduced the 
kinase activity of Cdk1, although the extent of T161 phosphorylation did not diminish. 
Removal of Rux from the reaction restored kinase activity to Cdk1/CycA entirely, 
confirming that the inhibition was mediated by Rux. In a second experiment, in vitro 
translated Rux was added to an embryonic extract and H1 kinase activity directly 
measured. Kinase levels fell to 14% of control levels although Cdk1 remained 
phosphorylated on T161. 
In summary, Rux specifically inhibits the kinase activity of Cdk1 associated with CycA 
or CycB. Inhibition of CycB occurs in a relatively predictable manner; greater 
amounts of Rux inhibit Cdk1/CycB to greater extents. In the case of CycA the 
regulation is more complex; small amounts of Rux enhance Cdk1/CycA activity and 
large amounts of Rux inhibit Cdk1/CycA. There is no apparent explanation for the 
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observed enhancement either mechanistically or in terms of a potential in vivo 
significance. The inhibition does not rely on accessory Drosophila factors and does 
not depend on disruption Cdk1/cyclin complexes. Although a reduction in T161 
phosphorylation of Cdk1 often accompanies inhibition this is not the only means by 
which Rux inhibits Cdk1, as Rux also inhibits T161 phosphorylated Cdk1 in complex 
with CycA. 
3. Rux prevents Cdk1 activation. Cdk1 is activated by phosphorylation on T161 by 
CAK. T161 phosphorylation of Cdk1 was greatly reduced in the presence of Rux in 
several different experiments. This was seen by Western blot analysis of embryos 
expressing high levels of rux (hs-rux) and also in the in vitro kinase assays when 
Drosophila extract was used as a source of CAK. There are three possible 
explanations for the diminished phosphorylation of Cdk1 in the presence of Rux. Rux 
may be an inhibitor of CAK activity, Rux may promote a dephosphorylation of Cdk1 
or Rux might block access of CAK to the T loop, thereby preventing Cdk1 activation. 
Rux inhibited Cdk1 when activated by GST-Civ1p or a 0-1 hr embryonic extract. An 
extract prepared from cdk7ts embryos raised at the restrictive temperature did not 
phosphorylate Cdk1 on T161 or Cdk2 on T163 (data not shown), suggesting that 
Cdk7/CycH is the Drosophila CAK. Civ1p is a monomeric CAK with no structural 
similarity to the heterotrimeric Cdk7/CycH/Mat1 CAK. In addition, Civ1p and 
Cdk7/CycH/Mat1 differ in their substrate specificity (Kaldis et al., 1998). Thus, as Rux 
inhibited Cdk1 activated by two entirely different sources of CAK, it is unlikely that 
Rux is a CAK inhibitor. As mentioned above, it was shown that Rux inhibited pre-
activated Cdk1/CycA complexes without any observable decrease in T161 
phosphorylation of Cdk1in an in vitro experiment and a kinase assay with an 
embryonic extract, ruling out that Rux recruits a phosphatase to T161. This suggests 
that through its association with CycA, Rux diminishes T161 phosphorylation of Cdk1 
by preventing CAK access to the T-loop of CycA associated Cdk1. 
In conclusion, Rux fulfills all the criteria required to define it as a CKI; it physically 
associates with CycA and CycB, it inhibits Cdk1 activity and prevents Cdk1 activation 
without covalently modifying Cdk1. Thus, Rux is a CKI specific for mitotic cyclins. 
Interestingly, Rux is the first CKI which specifically inhibits mitotic cyclins to be 
described in a multicellular organism. 
Rux does not target CycA for degradation. 
It has been proposed that Rux functions by targeting CycA for destruction, thereby 
downregulating Cdk1/CycA activity (Thomas et al., 1997). However, several lines of 
evidence presented here and elsewhere demonstrate that this is not the case. 
                                                                                                                                               DISCUSSION 
89 
Expression of an indestructible CycA, CycA∆170 induces ectopic S phases in the 
embryo (Sprenger et al., 1997). Co-expression of Rux suppresses these S phases. 
Suppression is not accompanied by a decline in CycA∆170 levels, demonstrating that 
Rux does not solely rely on destruction as a mechanism of inhibiting CycA in vivo. 
Furthermore, in the in vitro kinase assays presented here Rux inhibits Cdk1 
partnered to CycA∆170 or CycB∆46. These N-terminally truncated cyclin molecules 
are stable in embryonic extracts. Thus, Rux inhibits Cdk1 activity, irrespective of 
whether Cdk1 is partnered to a destructible or indestructible cyclin. Finally, 
expression of Rux at three different levels in the embryo did not accelerate CycA 
protein turnover in vivo. Low level expression of Rux early in embryogenesis by 
crossing UAS-rux males to mat-GAL4 females did not accelerate CycA turnover. The 
level of Rux expression slightly delayed cell cycle progression and a corresponding 
delay in CycA turnover was observed. CycA was destroyed at the metaphase to 
anaphase transition in dividing cells of matGAL4 X UAS-rux embryos, as is observed 
in WT cell cycles. Therefore, CycA was destroyed at the expected time upon low 
level overexpression of Rux. A higher expression of Rux was observed in prdGAL4 X 
UAS-rux embryos. This level was sufficient to arrest cells in G2 of mitosis 15. 
However, despite the fact that the cell cycle was disturbed in these embryos, CycA 
turnover was no different in prd-expressing stripes to interstripes. Finally, high level 
expression of Rux from a heat-inducible promoter during embryogenesis arrested cell 
cycle progression for up to three hours (data not shown). This arrest was 
accompanied by a persistence of both CycA and Rux. Thus, no case was observed 
where Rux accelerated CycA destruction in vivo and Rux inhibited an indestructible 
CycA both in vitro and in vivo. 
Rux functions during mitosis 
RT-PCR revealed that rux is transcribed in 2-4hr embryos; a developmental stage 
where no G1 occurs, raising the possibility that Rux has functions extraneous to G1 
maintenance. 2-4hr embryos are in the 14th and 15th cycles where cell cycle length is 
controlled primarily at the level of the G2 to M phase transition. To determine whether 
Rux functions during this stage of development entry into, passage through and exit 
from mitosis was compared for WT and rux mutant embryos. This was monitored by 
following the relative rates of appearance and disappearance of the various mitotic 
domains for mitosis 14. Mitosis 14 is the first zygotically controlled division and its 
spatiotemporal nature has been well described (Foe, 1989). rux mutants enter 
mitosis 14 at the same stage as WT embryos suggesting that G2 of mitosis 14 is 
equally long in both embryos. However, individual mitotic domains persist longer in 
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mutant embryos than in WT embryos, indicating that mutants progress through 
mitosis at a slower rate. This effect is not peculiar to an individual rux allele, as 
similar defects were observed in rux2, rux3 and rux8 mutant embryos. 
Progression through mitosis was followed in live embryos to analyze the mutant 
phenotype more closely. Mitosis was followed in individual cells from rux mutants 
where DNA was labeled with a GFP-histone transgene. At high magnification the 
individual stages of mitosis could be reliably distinguished and their relative lengths 
determined. Mitosis was considerably longer in rux mutants than in WT embryos. In 
particular, metaphase was almost doubled in rux mutants. The other stages of 
mitosis were not considerably longer in mutant embryos, indicating that Rux functions 
during the metaphase to anaphase transition. 
The metaphase to anaphase transition is a tightly regulated event. A prerequisite for 
progression through mitosis in all eukaryotes studies is the correct alignment of DNA 
on the metaphase plate. Incorrectly oriented spindles induces a metaphase arrest 
(Waters et al., 1999). DNA damage induces a metaphase arrest in S. cerevisiae and 
a G2 arrest in other organisms (Su et al., 2000). A prolonged G2, misaligned 
chromosomes, abnormal spindles or lagging chromosomes were not detected in rux 
mutants (data not shown), suggesting that the metaphase delay is not related to 
activation of a DNA or spindle damage checkpoint. An additional requirement for the 
metaphase to anaphase transition is inactivation of Cdk1/CycA. In Drosophila, CycA 
function is required for metaphase execution (Lehner and O'Farrell, 1989). Mitotic 
cyclin activity must be downregulated to allow exit from mitosis in all eukaryotes. 
Downregulation of CycA activity is necessary for the metaphase to anaphase 
transition in Drosophila (Sigrist et al., 1995). It has been demonstrated previously that 
Rux interacts genetically with CycA (Sprenger et al., 1997; Thomas et al., 1994; 
Thomas et al., 1997). Here it was also shown that Rux interacts physically with CycA, 
inhibits the in vitro kinase activity of Cdk1/CycA and inhibits Cdk1 activity when 
overexpressed in embryos (Su et al., 2000). Therefore, the most likely explanation of 
the mitotic phenotype described is that Rux contributes to the inactivation of 
CycA/Cdk1 during metaphase. In the absence of Rux, CycA is only downregulated 
by proteolytic destruction. Accordingly, CycA is down-regulated at a slower rate in rux 
mutants, leading to an extension of metaphase.  
The heat shock response in Drosophila embryos affects mitosis. 
To confirm that Rux can function during the metaphase to anaphase transition, cells 
were arrested in metaphase in stripes of the embryonic epidermis by crossing UAS-
CycA∆170; hs-rux flies to prd-GAL4 flies. Rux expression was induced from a heat-
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inducible promoter after cells had arrested in metaphase and progression through the 
cell cycle was then monitored as a function of time. Induction of rux expression 
during metaphase is not a trivial issue for two reasons. Firstly, the highly compact 
nature of DNA in metaphase is a large physical barrier for access of transcription 
factors to promoter regions. For this reason metaphase DNA is considered 
transcriptionally inert, although recent gene expression studies have demonstrated 
that approximately 300 genes are specifically transcribed during mitosis in S. 
cerevisiae (Krebs et al., 2000; Spellman et al., 1998). Secondly, nascent transcripts 
are aborted during mitosis (Shermoen and O'Farrell, 1991).  
Nonetheless, it was shown here that a mild heat pulse is sufficient to induce rux 
expression in metaphase-arrested cells. rux mRNA was detected by in situ 
hybridization in metaphase arrested cells 10min after a 5min heat pulse. Rux protein 
was detected several minutes later, demonstrating that a mild heat pulse is sufficient 
to induce gene expression from mitotic cells and that the transcripts are stable 
enough to allow translation. This is possible because of several effects heat pulses 
have on mitotic cells. Analysis of live embryos showed that a heat pulse induces 
decondensation of metaphase DNA, allowing access of transcription factors to the 
correct promoters. Furthermore, tubulin staining and nuclear envelope structure 
reveal that all cells adopt an interphase or early prophase structure in which 
transcription and translation is possible. These effects do not completely disturb the 
cell cycle program of an organism and are transitory. PH3 staining persists 
throughout the recovery period of a heat pulse regime and the mitotic program is 
completely restored within 10min. 
A heat pulse is not sufficient to abrogate a CycA∆170-mediated metaphase arrest in 
control prdGAL4; UAS-CycA∆170 embryos. However, induction of Rux does 
overcome this arrest. The number of metaphase cells drops 5min after appearance 
of Rux protein and is greatly reduced 40min later. Rux induction forces completion of 
mitosis, as anaphase and telophase figures are distinguishable 20min after induction. 
Therefore expression of Rux is sufficient to induce a metaphase to anaphase 
transition in CycA∆170 expressing cells. 
The prd-GAL4 driver line used in the experiment described above induces a 
sufficiently high expression of CycA∆170 to induce a metaphase arrest during mitosis 
15 in late stage 10 embryos. Examination of DNA morphology of expressing cells in 
stage 12 prdGAL4 X UAS-CycA∆170 embryos approximately two hours later 
revealed that most cells had exited metaphase and had decondensed interphase 
DNA. Therefore, other mechanisms of CycA downregulation exist, which are 
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independent of proteolysis. As Rux appears to have a role in the metaphase to 
anaphase transition it was reasoned that Rux may be one of the activities 
contributing to CycA inhibition in prdGAL4; UAS-CycA∆170 embryos. Stage 12 rux3; 
prdGAL4; UAS-CycA∆170 embryos were examined to address this issue. DNA 
morphology revealed that almost half of all CycA∆170 expressing cell were still in 
metaphase. Therefore, rux3 mutants were greatly impaired in their ability to overcome 
a metaphase arrest induced by CycA∆170, confirming that Rux contributes to down-
regulating CycA during mitosis. These results are very similar to what has been 
described previously for the budding yeast. In S. cerevisiae the metaphase arrest 
induced by low level expression of a stable CLB in yeast is only transitory (Amon et 
al., 1994). Eventually, CDC28 is down-regulated by rising Sic1p activity. 
Understanding of exit from mitosis in budding yeast has advanced rapidly in the last 
decade and a picture of multiple intrinsic cellular activities overseeing the process 
has emerged (Bachant and Elledge, 1999). APC/C mediated destruction of mitotic 
cyclins and Sic1p dependent inhibition of Cdc28p downregulate Cdc28p in mitosis. In 
contrast, the only function known to be conserved in multicellular organisms is 
APC/C dependent destruction of cyclins. It is likely that the more complex nature of 
metazoans necessitates an equal if not more rigorous regulation of exit from mitosis 
than in budding yeast. The data described above indicate that Rux performs 
functions very similar to SIC1 and that Rux cooperates with other mechanisms to 
trigger exit from mitosis. Removal of Rux function does not abrogate the ability of a 
cell to leave mitosis, however the process is delayed. This delay is specific to 
metaphase as Rux is a negative regulator of CycA and CycA must be downregulated 
to exit metaphase. It was demonstrated in this report that Rux interacts with CycB 
and that Rux inhibits the in vitro kinase activity of Cdk1/CycB. However, Rux does 
not appear to downregulate CycB during mitosis, as rux mutants progress through 
anaphase and telophase almost as quickly as WT embryos. It is possible that Rux 
function is only required during the metaphase to anaphase, transition as this is a key 
step in mitosis. Prolonged metaphases are potentially deleterious to a cell, as they 
increase the possibility of incorrect segregation of sister chromatids. In a cell where 
no spindle or DNA damage has occurred a prompt metaphase to anaphase transition 
is expedient, as it lowers the likelihood of an incorrect segregation. 
Rux is downregulated prior to S phase. 
Many CKIs are downregulated at distinct stages to permit cell cycle progression. 
Sic1p is destroyed at the G1/S transition and the mammalian CKI p27 is degraded 
prior to S phase (Montagnoli et al., 1999; Swanson et al., 2000; Vlach et al., 1997). 
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Down-regulation is often initiated by CDK dependent phosphorylation of the target 
CKIs. Phosphorylated CKIs are recognized by specific E3s such as the APC or SCF 
complexes, ubiquitinated and degraded by the proteasome. SIC1 was originally 
purified as a substrate of CDC28 (Mendenhall, 1993). Sic1p is phosphorylated by 
rising CLN levels in late G1 and targeted for destruction by the SCFCdc4 complex 
(Feldman et al., 1997).  
It has been demonstrated previously that Rux protein levels are also regulated at 
specific cell cycle stages (Thomas et al., 1997). Rux is stable in G1 cells and 
destroyed in S phase cells of the developing eye imaginal disc. In agreement with 
this result Rux was also shown here to be stable in G1 cells of cycle 17. In this report 
the course of Rux protein turnover was also monitored in embryonic cell cycles that 
lack a G1. Rux expression was induced from a UAS transgene early in 
embryogenesis with a maternal-GAL4 driver line and the Rux protein was followed in 
the 14th and 15th division cycles. Rux protein was stable in G2 cells and in early 
mitotic cells. The protein disappeared in telophase or early interphase. This pattern of 
Rux destruction matches the proposed cell cycle stages of Rux function. Rux is 
stable during metaphase, where it contributes to downregulation of Cdk1/CycA 
kinase activity. Rux is rapidly turned over prior to S phase, allowing CycA to 
contribute to S phase. Rux is stable during G1, thus allowing G1 maintenance in 
cooperation with cyclin destruction and inhibitory phosphorylation of Cdk1 (Sprenger 
et al., 1997). 
It was proposed that Rux is targeted for destruction by Cdk2-dependent 
phosphorylation (Thomas et al., 1997). Rux is phosphorylated by Cdk2/CycE 
precipitated from embryos and overexpression of CycE in the eye imaginal disc 
accelerates the rate of Rux disappearance. However, several results presented here 
show that Rux destruction does not require CycE activity. Overexpressing CycE in 
segmental stripes does not accelerate the rate of Rux turnover in the embryo. 
Furthermore, a Rux mutant construct lacking all potential CDK phosphorylation sites 
is turned over in an in vitro degradation assay as rapidly as WT Rux. More 
importantly, Rux is rapidly degraded in cycE mutant embryos. It is unlikely that Rux is 
phosphorylated by Cdk1 in this experiment, as Cdk1 is efficiently inhibited by Rux in 
the embryo. Therefore, CycE activity is not essential for Rux destruction. It is more 
likely that the increased rate of Rux turnover in imaginal discs overexpressing CycE 
is a secondary cause of an increased rate of S phase entry caused by CycE 
overexpression. 
An in vitro assay was established to monitor the turnover of radiolabeled Rux in a cell 
free system. Rux was rapidly turned over in this assay, and the protein was stabilized 
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by the addition of proteasome inhibitors. Therefore, it is likely that Rux is degraded in 
a proteasome dependent manner. Interestingly, no Rux-Ubiquitin conjugates were 
detected (data not shown) and ubiquitination inhibitors such as methylated-Ubiquitin 
or Ubiquitin-Aldehyde did not prevent destruction (data not shown). There are at least 
two other cases known where proteins are turned over by the proteasome in a 
ubiquitin-independent manner. One of these proteins is the mammalian CKI, p21 
(Sheaff et al., 2000).  
A sequence element known to target several proteins to the proteasome for 
destruction is the PEST motif (Rechsteiner and Rogers, 1996). PEST sequences are 
defined as hydrophilic stretches of amino acids greater than or equal to 12 residues 
in length. Such regions contain at least one proline, one aspartate or glutamate and 
one serine or threonine. They are flanked by lysine, arginine or histidine residues. 
Positively charged residues are disallowed within the PEST sequence. A potential 
PEST sequence of 21 amino acids was identified in Rux, starting at residue 222. An 
algorithm designed to predict secondary structure predicts that the potential PEST 
sequence forms a loop which is flanked N-terminally by an alpha helix and C-
terminally by a β-pleated sheet (Rost and Sander, 1993). Rux∆PEST also migrates 
as a protein of its predicted molecular weight under SDS-PAGE, whereas WT Rux 
displays decreased electrophoretic mobility (data not shown). Thus, removing the 
PEST from Rux removes a secondary structure which is not resolved under 
denaturing conditions. A C-terminal truncation removing the PEST motif confers 
stability on the protein in vitro. The C-terminally deleted protein still functions as a 
Cdk1/CycA inhibitor in in vitro kinase assays. Rux∆PEST is also stable in vivo, as it is 
not degraded in telophase/interphase cells. 
Similarities between Rux and other CKIs 
The data presented above highlight similarities between Rux and other CKIs. The 
similarities between Rux and SIC1 are particularly strong. Both have roles in 
maintenance of G1 by inhibiting the kinase activity of mitotic CDK/cyclins. Both 
interact with target cyclins via RXL motifs. Neither gene product is essential, as they 
functionally overlap with other mechanisms, such as APC/C mediated proteolysis. 
Overexpression of either inhibits mitosis and induces endocycles. Both proteins are 
downregulated at the G1/S transition by the proteasome. This report also 
demonstrates that Rux functions in mitosis, as has been described for SIC1. Despite 
the numerous similarities there is no homology between both sequences. Thus, it is 
likely that both genes evolved separately, or diverged at an extremely rapid pace. In 
this case it appears there is an evolutionary advantage to having such a gene 
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function, raising the possibility that functional homologues may exist in other 
organisms. In support of this idea it has been demonstrated that SIC1 from S. 
cerevisiae and rum1 from S. pombe can complement each other although the 
sequence homology between both proteins is extremely tenuous (Sanchez-Diaz et 
al., 1998). Thus, it appears that there are very few sequence constraints on CKIs with 
specificity for mitotic cyclins. 
Despite the lack of a sequence homology between SIC1 and Rux it was 
demonstrated here that Sic1p has similar effects to Rux on the Drosophila cell cycle. 
Overexpressing either protein in embryos during the cellular blastoderm cell cycle 
induced a G2 cell cycle arrest. Sic1p also efficiently inhibited the in vitro kinase 
activity of Drosophila Cdk1/CycA and Drosophila Cdk1/CycB, whereas it did not 
inhibit Cdk2/CycE complexes. Thus, Sic1p recognized the same target proteins as 
Rux and Sic1p elicits the same cell cycle arrest as Rux. 
There are several differences between the behavior of Sic1p and Rux under these 
experimental conditions. Whereas Rux is an exclusively nuclear protein Sic1p is 
present throughout the cell. Furthermore, nuclear Rux leads to a nuclear 
accumulation of CycA, whereas nuclear Sic1p does not. Sic1p does not have any 
obvious NLS. The nuclear fraction of Sic1p observed is likely the result of free 
diffusion of the protein through the cell as it has a relatively small molecular weight 
(40kDa). It is possible that Drosophila CycA is retained in the cytoplasm by an active 
cytoplasmic retention signal (CRS) and that the CRS is overcome by an NLS on 
CycA-interacting proteins, such as Rux. In this model, Sic1p is unable to direct a 
nuclear accumulation of CycA, as it lacks the sequence determinant necessary to 
overcome the CRS on CycA. Another difference between Rux and Sic1p is that 
Sic1p enhances the in vitro kinase activity of Cdk2/CycE, whereas Cdk2/CycE is 
refractory to Rux activity. However, It is noteworthy that low levels of Rux enhance 
Cdk1/CycA activity and that both CycE and CycA have S phase functions in 
Drosophila. Thus, in the in vitro kinase assays described here both Rux and Sic1p 
specifically enhance the activity of S phase cyclins, whereas Rux and Sic1p 
specifically inhibit the activity of M phase cyclins. Despite the minor differences 
between both proteins the data presented above further emphasize the functional 
similarity between both proteins. Identical to what has been described for Rux, Sic1p 
inhibits the kinase activity of Drosophila mitotic CDK/cyclin complexes and arrests 
cells in G2 of the cell cycle when overexpressed. 
                                                                                                                                               DISCUSSION 
96 
A model for Rux function 
Based on the results described above and published elsewhere the following model 
of Rux function is presented (Fig. 3.1). Rux is a nuclear protein that interacts 
physically with the mitotic cyclins A and B via two cyclin-binding RXL motifs in the 
protein. Overexpression of Rux induces a nuclear import of the two mitotic cyclins in 
a manner that relies on two critical RXL motifs, indicating that the nuclear 
accumulation observed for CycA and CycB is a direct result of their interaction with 
Rux. Rux specifically inhibits the kinase activity of Cdk1/CycA and Cdk1/CycB 
complexes in vitro and overexpressing Rux prevents execution of mitosis in embryos 
and imaginal disc cells. Rux also prevents CAK dependent activation of Cdk1, 
demonstrating that Rux is a CKI specific for mitotic cyclins. This is the first such CKI 
to be described in a multicellular organism and Rux does not have any obvious 
homologues in the sequence databases. However, genes with similar activities have 
been described in budding and fission yeast and it was shown here that the budding 
yeast gene product, SIC1 mimics Rux in Drosophila. Thus, it is probable that the 
requirement for a CKI activity which specifically inhibits mitotic cyclins has been 
conserved during evolution. 
Rux is an integral element of the Drosophila cell cycle which establishes and 
maintains a G1 by inhibiting the kinase activity of Cdk1/CycA complexes from 
metaphase until S phase. This is necessary for correct patterning of the developing 
eye epithelium and spermatogenesis. Cdk1/CycA activity is elevated in rux mutants 
resulting in precocious S phase in the morphogenetic furrow of the eye disc, as well 
as an extra meiotic division during spermatogenesis. As rux mutants display a 
reduced viability the protein must also function during other stages of development. 
Rux protein and mRNA levels are low at all stages of development. However, the 
expression levels are sufficient to make a significant contribution to cell cycle control 
as Rux cooperates with other CDK inhibiting activities such as cyclin proteolysis and 
inhibitory phosphorylation of Cdk1. rux transcript is not detected in 0-2hr old embryos 
which corresponds to the first 13 cell cycles. These cycles are extremely rapid in 
Drosophila embryos and occur in a common syncitium without any G1. Any aberrant 
mitoses at this stage are dealt with by internalizing resulting nuclei and subsequently 
destroying them. Therefore, Rux function is not required during these cycles, 
explaining the lack of a maternally provided transcript.  
After completion of mitosis 13 cell cycle control shifts from maternally provided 
products to zygotically transcribed genes. Cycles 14 to 16 are much longer and occur 
in a cellular blastoderm. Incorrect cell cycles at this stage of development are 
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potentially deleterious to the entire organism. The embryo responds to this challenge 
by introducing numerous controls to cell cycle progression, such as inhibitory 
phosphorylation of Cdk1, responsiveness to checkpoints and Rux. The Cdc25Stg 
phosphatase controls entry into mitosis by removing inhibitory phosphates from 
Cdk1. Cdk1 activity must be downregulated to allow a subsequent exit from mitosis. 
this is achieved mainly by APC/C mediated proteolysis of mitotic cyclins. In addition 
to irreversible destruction of mitotic cyclins, Rux also contributes to exit from mitosis 
in these cycles by inhibiting the kinase activity of Cdk1/CycA. This activity is not 
absolutely necessary for exit from mitosis, however in its absence metaphase is 
almost twice as long. The 14th, 15th and 16th cell cycles occur without any G1 and 
Rux is destroyed almost immediately after completion of mitosis, allowing CycA to 
contribute to S phase. Rux is stable during G1, which is introduced during later cell 
cycles.  In G1 rux cooperates with other cellular activities such as APC/C dependent 
proteolysis of CycA and inhibitory phosphorylation of Cdk1 to maintain Cdk1/CycA 
activity in a low state. Prior to entry into S phase Rux is turned over in embryonic and 
imaginal disc cells. Rux destruction does not depend on Cdk2/CycE activity or on 
CDK mediated phosphorylation of Rux, rather it depends on a PEST motif towards 
the C-terminus of the protein. The decline in Rux protein levels, as well as a 
concomitant increase in CycA levels allows CycA to contribute to execution of, or 
passage through S phase. 
 
Fig. 3.1: A model of Rux function during the Drosophila cell cycle. 
Cdk1/CycA is activated during G2 by the phosphatase Cdc25Stg, which removes inhibitory phosphates 
from T14 and Y15 on cdk1. Rising levels of Cdk1 activity induce entry into mitosis. It is then necessary 
to downregulate Cdk1, as high levels of Cdk1 activity prevent transition through mitosis. CycA is 
destroyed by APC/C dependent proteolysis during metaphase and Cdk1/CycA is also inhibited by Rux. 
The resulting drop in Cdk1/CycA activity allows a transition from metaphase to anaphase. APC/C 
dependent proteolysis of the B-type cyclins completes mitosis. Cdk1/CycA activity is maintained in a low 
state through proteolysis and inhibition by Rux during G1. Rux is degraded by the proteasome before S 
phase in a manner that depends on a C-terminal PEST sequence in the Rux protein. The continuous 
black line represents Cdk1/CycA activity levels during the various cell cycle stages. Arrows indicate 
activation and bars indicate inhibition. 
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MATERIALS AND METHODS 
 
MATERIALS 
 
Computers and software 
This thesis was prepared on an Apple Macintosh using Adobe PhotoShop (Adobe 
Systems), Canvas (Deneba Systems), IPLab Spectrum (Signal Analytics) Microsoft 
Word and Excel (Microsoft Corp.).  
 
Drosophila melanogaster 
Oregon R flies were used for the preparation of embryo extracts and as WT embryos 
for immunohistological staining. The prd-GAL4 4 flies have been described in 
(Leismann et al., 2000). mat-GAL4 flies were a gift of Maythrei Narashima. hs-rux, 
hs-cycA, hs-Cdc2AF and hs-stg flies have been described in (Foley et al., 1999) 
respectively. The rux8 and rux3 strains have been described previously (Thomas et 
al., 1994; Thomas et al., 1997). rux2 was a gift from the Bloomington stock collection. 
The GFP-His2AvD flies have been described in (Clarkson and Saint, 1999). UAS-rux 
flies were a gift of Dr. Barbara Thomas. hs-rux ; cycE/CyO were a gift of Nikita 
Yakubovitch. UAS-CycE flies were provided by Ruth Grosskortenhaus. UAS-stg flies 
were provided by Dr. Bruce Edgar. 
 
Antibodies 
The Rux antibody was made by immunizing rats with a purified GST-Rux gel slice 
(Eurogentec). Antibodies against CycA, CycB and Cdk1 have been previously 
described (Knoblich and Lehner, 1993). The antibodies against β-tubulin, HA, PH3 
and PSTAIR were obtained from Amersham, Boehringer Mannheim, Upstate 
Biotechnology and Sigma respectively. Secondary antibodies were purchased from 
Dianova. 
 
Escherichia coli 
Transformations were performed in E. coli strain DH10B (gift of Robert Wilson, 
genotype; F’, mcrAD- (mrr hsdRMS-mcrBX), j80dlacZDM15, DlacX74, deoR, recA1, 
araD139, D(ara, leu)7694, galU, galK, λ−, rspL, endA1, nupG). GST fusion proteins 
were produced in E. coli strain C43 (Miroux and Walker 1996). GST-CIV was 
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produced using E. coli strain B834 (Genotype; F- ompT hsdSB (rB-mB-) gal dcm met 
(DE3)pLysS (camR). The E. coli strains ES1301 and JM109 were used for site 
directed mutagenesis. 
 
DNA Molecular weight markers. 
A 1kb molecular weight marker from GibcoBRL was used to mark molecular lengths 
of DNA fragments. 
 
Oligonucleotides 
The following oligonucleotides were used for making the various point mutations 
CycA W242A  CACAATGCGCGCTCCATCGCTATTGATGCGCTGGTT 
Rux T10A  CTCCAAAGGGGCCTCCTTATG 
Rux T128A  ACGGGGCGGGGCGATCAGGGT 
Rux T238A  TGTTGGCGGGGCTGAATCCTC 
Rux T309A  TTTCCTCGGGGCACAGCTGCT 
Rux R29KL31K GCAGTCCTCCCCTTTGTCTTTGCGTATGGTCCCC 
Rux R196KL198K TTTGAGGCTTGTTTTACCTTTATCGTAGACAGC 
Rux R248KL250K CTCCTCTGTAAATTTAGTTTTACGCACGCAGCG 
SIC1 DNA was amplified with the following two oligonucleotides 
SIC1.1   ATATCCATGGCTCCTTCCACCCCACCAA 
SIC1.2   TATATCTAGAGCTCTTGATCCCTAGATT 
The following oligonucleotides were used for the RT-PCR reactions 
rp49.1   CGACCAGGTTACAAGAAC 
rp49.2   CCGCCCAGCATACAGGCC 
rux.1   GAAACGCATCCGCCT 
rux.2   AACGCATCCGCCTTGGTC 
The rux promoter was amplified in the rux2 mutant using the primers 
rux2.1   GCTGCTGAATGCTGGAAA 
rux2.2   GGAGATAAAAGTGTATAA 
rux2.3   CCACTTCTATGTTCTTC 
The Rux∆PEST construct was made with the following oligo 
Rux∆PEST  TATATCTAGATATTACATCGGGCGCTGGC 
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Restriction endonucleases. 
Restriction enzymes and the corresponding reaction buffers from Boehringer 
Mannheim and New England Biolabs were used for DNA digestion. 
DNA constructs 
GST-Rux was produced by cloning the 1700bp fragment of an Nco I/Sac I digest of 
pSF821 (Frank Sprenger) into the 3000bp vector arising from digesting pSF470 with 
Nco I/Sac I (Frank Sprenger). HA-Rux (EF018) was produced by cloning the 1360bp 
fragment arising from a Bam HI/Sac I digest of pSF821 into the 3000bp vector arising 
from a Bam HI/Sac I digest pSF398 (gift of F. Sprenger). Other DNA constructs. e.g. 
pSF 191 (HA-Cdk1), pSF63 (Cdk1), pSF281 (CycA∆170), pSF421 (CycA) and 
pSF821 (Rux) were provided by F. Sprenger. SIC1 genomic DNA was a kind gift of 
Sue Jaspersen. SIC1 was amplified as a PCR fragment using the oligos SIC1.1 and 
SIC1.2 and cloned into EF018 as a Nco I/Xba I fragment to make SP6-SIC1 or into 
TS002 as a Nco I/Xba I to make HA-SIC1 under the control of an SP6 promoter. 
 
Protein molecular weight markers. 
Medium range molecular weight markers from Amersham and BioRad were used to 
determine apparent molecular weights after SDS-PAGE of proteins. 
 
GST-fusion proteins 
Proteins were produced as described in Methods section, except GST-CycB which 
was provided by F. Sprenger. Cells stably transformed with a GST-CIV expression 
vector were a gift of Carl Mann. All GST-fusion proteins were prepared by Hayati 
Özden.  
 
Films 
Amersham hyperfilm ECL films were used for Western blotting and Kodak Biomax 
MR films for autoradiography. 
 
Media, solutions and buffers 
 
Agarose gel loading buffer 
0.25% BPB 
0.25% Xylene cyanol 
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30% Glycerol 
 
Coomassie staining solution 
0.25% Coomassie brilliant blue, R250 
50% Methanol 
10% Glacial acetic acid 
 
Destaining solution 
10% Glacial acetic acid 
30% Ethanol 
 
First strand buffer (FSB) 
250mM Tris/Cl (pH 7.6) 
300mM KCl 
50mM MgCl2 
 
GST-wash buffer 
100mM NaCl 
10mM Tris pH 8 
1mM EDTA 
500µl 0.5M PMSF 
2µg/ml Leupeptin 
2µg/ml Pepstatin A 
2µg/ml Chymostatin 
2µg/ml Aprotinin 
 
GST-Suspension buffer 
500µl 0.5M PMSF 
2µg/ml Leupeptin 
2µg/ml Pepstatin A 
2µg/ml Chymostatin 
2µg/ml Aprotinin 
1X PBS 
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GST-binding buffer 
500µl of 50% Glutathione Sepharose 4B (Pharmacia) slurry per 25ml 
15mM DTT 
0.1% Tween-20 
 
GST-elution buffer 
50mM Tris pH 8.0 
250mM KCl 
2mM DTT 
 
Homogenization buffer 
10mM Tris pH 7.5 
80mM K-β-Glycerophosphate pH 7.3 
20mM EGTA 
15mM MgCl2 
10% Glycerol 
 
Shortly before use add: 
1mM benzamidine 
2mM Na3VO4 
1mM DTT 
 
Directly before use add 
25µg/ml aprotinin 
25µg/ml leupeptin 
0.5mM PMSF 
 
Immunoprecipitation buffer 
10mM Tris pH 7.5 
80mM K-β-Glycerophosphate pH 7.3 
20mM EGTA pH 8.0 
15mM MgCl2 
10% Glycerol 
0.02% NP40 
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Before use add 
0.5mM DTT 
2mM Na3VO4 
 
Pre-kinase wash buffer 
25mM HEPES pH 7.4 
10mM MgCl2 
1mM DTT 
5µM ATP 
 
Kinase assay buffer 
25mM HEPES pH 7.4 
10mM MgCl2 
1mM DTT 
125µM ATP 
250µg/ml Histone H1 
0.3mCi/ml γ-ATP 
 
Laemmli sample buffer (4X) 
8% SDS 
400mM DTT 
240mM Tris pH 6.8 
0.004% BPB 
40% Glycerol 
 
DNA Mini-prep buffers and solutions 
Resuspension buffer P1 
100µg RNase A 
50mM Tris/HCl 
10mM EDTA pH 8.0 
 
Lysis buffer P2 
200mM NaOH 
1% SDS 
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Neutralization buffer P3 
3.0M Kac pH 5.5 
 
Na-acetate buffer 
50mM Na-acetate pH5.1 
10mM EDTA 
 
2l 10XPBS 
160g NaCl (1.37M) 
4g KCl (26.8mM) 
28.8g Na2HPO4 (80mM) 
4.8g KH2PO4 (17.6mM) 
Adjust pH to 7.4 with HCl 
 
2l 10XPBT 
0.1% TWEEN 20 IN PBS 
 
10XPonceau S 
2g Ponceau S 
30g Trichloracteic acid 
30g Sulfosalicylic acid 
 
SDS-Polyacrylamide minigels 
     8.5% 10% 12.5% 15% 17.5% 
H2O (ml)    3.5 3.1 2.5 1.8 1.2 
30% Acrylamide (ml)   2.0 2.4 3.0 3.7 4.3 
4X Resolving gel buffer (ml)  1.9 1.9 1.9 1.9 1.9 
10% APS (µl)    112 112 112 112 112 
TEMED (µl)    5 5 5 5 5 
 
10l 10X running buffer for SDS-PAGE 
300g Tris-base (0.25M) 
1440g Glycine (1.9M) 
1l 10% SDS 
                                                                                                                     MATERIALS AND METHODS 
 
106
 
1l 4X Resolving gel buffer 
181.7g Tris base (1.5M) 
4ml 10% SDS 
Adjust pH to 8.8 with HCl 
 
500ml 4X Stacking gel buffer 
30.3g Tris base (0.5M) 
20ml 10% SDS 
Adjust pH to 6.8 with HCl 
 
Stripping buffer 
100mM β-mercaptoethanol 
2% SDS 
62.5mM Tris pH6.7 
 
Squashing buffer 
10mM Tris/Cl pH8.2 
1mM EDTA pH8.0 
25mM NaCl 
200µg/ml Proteinase K 
 
1l Transfer buffer for western blots 
5.82g Tris (48mM) 
2.93g Glycine (39mM) 
3.75ml 10% SDS 
200ml Methanol 
 
TE 
10mM Tris/Cl pH 8.0 
1mM EDTA pH 8.0 
 
1l 50X TAE 
242g Tris base (2M) 
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57.1ml glacial acetic acid 
500mM EDTA pH 8.0 
 
 
Terrific broth 
A 12g Bactotrypton 
24g Bacto-yeast-extract 
4ml Glycerol 
Adjust to 900ml with ddH2O 
 
B 2.31g KH2PO4 
 12.54g K2HPO4 
 Adjust to 90ml with ddH2O 
Mix A and B when less than 60°C 
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METHODS 
 
DNA Methods 
 
Restriction digests of DNA. 
Restriction digests were performed in buffers and at temperatures recommended by 
enzyme manufacturers for a minimum of 1.5hrs and maximum of 16hrs. 
 
Dephosphorylation of DNA ends. 
Vectors to be dephosphorylated were brought to a total end volume of 50µl by the 
addition of H2O, 5µl dephosphorylation buffer and 0.3µl CIP (Calf Intestinal 
Phosphatase, 56U/µl). This was then incubated at 37°C for 15 min. The reaction was 
stopped by incubating at 75°C for 10 min in 5mM EDTA. 
 
Klenow fill in of DNA ends. 
The substrate DNA was incubated with 40µM of each dNTP and 1U Klenow/µg DNA 
for 15 min at 25°C. Reaction was stopped by adding EDTA to 10mM and heating at 
75°C for 10 min. 
 
Eluting DNA. 
DNA fragments to be isolated from agarose gels were first separated by 
electrophoresis. The required fragment was then visualized on a UV lamp and 
excised using a sterile scalpel. DNA was then purified from these fragments using 
the Qiaex II kit from Qiagen or the DNA Purification Kit from Biozym. 
 
Agarose gel electrophoresis. 
Agarose gel electrophoresis was performed as described (Sambrook et al., 1989). 
DNA fragments were separated on a 1 % agarose gel, with 10µl 10mg/ml EtBr in 
100ml TAE buffer. 
 
DNA ligation. 
Ligation reactions were carried out with an approximate molar ratio of insert : vector 
of 3:1. Finally 0.5µl T4 DNA Ligase was added and the ligation reactions were either 
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incubated overnight at 16°C or for 3 hours at RT. DNA was then used to transform 
competent cells. 
 
Preparation of electrocompetent cells. 
The method used to prepare electrocompetent cells is based on the protocols from 
Dower et al. (Dower et al., 1992). DH10B cells were plated out from a DH10B 
glycerol stock onto LB plates and grown overnight at 37°C. A colony was picked from 
this plate and grown overnight in 50ml LB. The following day these cells were diluted 
1 in 100 with TB and grown until the OD600 was 0.5. The cells were cooled on ice for 
30 min. and then centrifuged at 4000rpm in a Sorvall GS3 rotor for 10min at 4°C. The 
cells were resuspended on ice over about 30 min in 500ml filtered Millipore water 
and then spun at 8000rpm in a Sorvall GS3 rotor for 20 min at 4°C. Cell were 
resuspended in ice cold 10% (w/v) glycerol and spun out in a Heraeus bench top 
centrifuge at 4000rpm for 7min at 4°C. The cells were resuspended in 1ml ice cold 
10% glycerol. They were then divided into 40µl aliquots, frozen in liquid nitrogen and 
stored at -70°C. 
 
Transformation. 
coli cells were transformed by electrotransformation. 0.5-1µl of the plasmid DNA to 
be transformed was mixed with a 40µl aliquot of electrocompetent cells. Immediately 
after transformation cells were resuspended in 1ml LB. 100µl were then plated on 
LB-Agar plates containing the appropriate antibiotic for selection. Plates were 
incubated overnight at 37°C and individual colonies were then picked.  
 
Isolation of Plasmid DNA 
The following protocol was used to isolate plasmid DNA for sequencing. 1.5ml of an 
overnight culture was centrifuged for 10min at 4000 rpm. The pellet was 
resuspended in TE with100µg/ml RNase. 200µl lysis buffer was added to the 
resuspended bacteria, shaken and incubated for 5min at RT. Afterwards 150µl 
neutralization buffer was added, shaken and incubated for a further 5min at RT. The 
mix was spun for 30min at 14000rpm in a bench top centrifuge. 1ml of 100% ethanol 
was added to the supernatant and centrifuged for 20min at 14000rpm. 1ml of 70% 
ethanol was added to the pellet and centrifuged for 5min at 14000rpm. The pellet 
was dried and resuspended in 20µl TE. 
The following protocol was used to isolate plasmid DNA for all other applications. 
1.5ml of an overnight culture was centrifuged briefly at 14000rpm in a bench top 
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centrifuge. The pellet was resuspended in 100µl TE and mixed with 100µl lysis 
buffer. Lysis was stopped after 5min by addition of 100µl neutralization buffer and 
mixing. The mixture was centrifuged for 1min at 14000rpm. 250µl TE-saturated 
phenol was added to the supernatant, vortexed and centrifuged for 1min at full 
speed. The upper aqueous phase was removed, mixed with 500µl 100% ethanol and 
centrifuged for 5min at full speed. The pellet was washed with 100µl 80% ethanol 
and centrifuged for 1min at full speed. The pellet was dried and resuspended in 20µl 
TE with 25µg/ml RNase. 
 
Precipitation of DNA. 
1/10 Vol. NH4Oac, 3 Vol. 96% Ethanol and 0.5µl glycogen were added To the DNA to 
be precipitated. This mixture was incubated at -70°C for 20 min and centrifuged at 
14,000 rpm for 15 min in a bench top centrifuge at 4°C. The supernatant was 
removed and the pellet washed in 1 ml 80% ethanol. This was centrifuged for a 
further 15 min at 14,000 rpm an 4°C in a bench top centrifuge, the supernatant was 
removed and the pellet dried at 37°C for 10 min. Finally the DNA was resuspended in 
TE. 
 
Site directed mutagenesis 
Site directed mutagenesis was performed according to the Altered Sites II manual 
from Promega. 
 
DNA sequencing 
DNA sequencing was done using an ABI-Sequencer (Models 373 and 377) with the 
Dye-Terminator Kit (Perkin-Elmer). 
 
Single fly PCR 
One fly was placed in a 0.5ml tube and mashed for 10 seconds with a pipette tip 
containing 50µl squashing buffer. After mashing the remaining buffer was expelled. 
The mixture was incubated for 30min at 37°C and then 95°C for 2min. The 
preparation was stored at 4°C and typically 2.5µl used in a 25µl PCR reaction. 
 
Isolation of mRNA from flies. 
Total RNA was isolated from 100 adult flies or the equivalent number of embryos, 
larvae or pupae using phenol as a grinding material. Phenol was saturated with Na 
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acetate buffer, frozen in a mortar filled with liquid nitrogen and ground to a fine 
powder using a heavy pestle. The samples were then submerged in liquid nitrogen 
and ground with the phenol for 6min. The samples were thawed by addition of 
1%SDS and heated to 60°C for 10min. Samples were then cooled on ice and 
centrifuged to separate the phases. The aqueous phase was removed, extracted 
once with phenol/chloroform/iso-amylalcohol (25:24:1) and once with chloroform/iso-
amylalcohol (24:1). RNA was precipitated with 0.1vol 3M Na-acetate (pH 58) and 
2.5vols ethanol, centrifuged at 12000Xg for 10min and washed with 70% ethanol. 
The pellet was resuspended in 20µl TE and stored at –70°C. Poly-adenylated mRNA 
was isolated with the QuickPrep micro mRNA Purification Kit (Pharmacia). 
 
RT-PCR 
The following reaction was incubated for 2hr at 42°C. for the synthesis of cDNA 
H2O    25µl 
dNTPs (10mM)  2.5µl 
5XFSB    10µl 
DTT (100mM)   5µl 
Primer (10pmol/µl)  0.5µl 
RNasin (40U/µl)  1µl 
SuperscriptII (200U/µl) 0.5µl 
PolyA+-RNA (100µg/µl) 5µl 
 
 
Database searches. 
Homology searches were performed using the Basic Local Alignment Search Tool 
(BLAST); http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST/nph-blast (Altschul et al., 1997).  
PEST motifs were identified using a PESTfind algorithm (Rechsteiner and Rogers, 
1996). 
 
BIOCHEMICAL METHODS 
 
Production of GST fusion proteins. 
GST-fusion proteins (GST-Rux and GST-CIV) were produced according to the 
following protocol. A 50ml overnight culture was prepared in LB/Amp (50µg/ml Amp). 
The following morning 10ml of the overnight culture was inoculated in 500ml 
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LB/Amp, grown at RT and induced with 0.1mM IPTG upon reaching an OD of 0.4 at 
600nm. Culture was then allowed grow overnight. The following day the culture was 
centrifuged for 10min at 5,000 rpm and 4°C. The supernatant was decanted and the 
pellet resuspended in 25ml GST-wash buffer. Cells were centrifuged for 10min at 
10,000 rpm and the supernatant removed. The pellet was suspended in 25ml ice-
cold GST-suspension buffer.  
Pellet was sonicated at a duty cycle of 40 and Output Control of 4 for 3 periods of 
2min on ice. KCl (final conc. 250mM), DTT (final conc. 15mM) and Triton X-100 (final 
conc. 1%) were added to the pellet. This was then incubated under gentle shaking 
for 30min. at 4°C and centrifuged at 10,000 rpm for 10min. at 4°C. The supernatant 
was decanted into new containers. GST-binding buffer was added to the supernatant 
and incubated for 30min under gentle agitation at 4°C. Suspension was centrifuged 
at 2500 rpm and 4°C for 5min. The supernatant was decanted and the beads were 
washed 3 times in 25ml PBS and 15mM DTT. Finally, GST-fusion proteins were 
eluted by incubating the beads in GST-elution buffer three times at 4°C under gentle 
agitation followed by centrifugation for 2min at 2500 rpm and 4°C 
 
Determining protein concentration 
Protein concentration was determined using the Bio-Rad Protein Micro Assay Kit. 
 
Gel electrophoresis of proteins. 
Proteins were analyzed on a 0.75mm thick polyacrylamide gel using the SDS-
discontinuous buffer system (Laemmli 1970). Analysis was done using a Mini 
Protean 2 System (Biolabs). Samples were suspended in loading buffer and heated 
for 5 min at 95°C before loading. Gels were run at a constant current that gave a 
starting voltage of approx. 100V. For large gels analyzing phosphoisoforms of Cdk1 
the default voltage was set to 600V and the gel was run at 55mA and 4°C to prevent 
overheating. Kinase assay products were primarily run on large gels with a default 
voltage of 300V. 
 
Coomassie blue staining. 
Gels were incubate in approx. 5 vol. staining solution for 4hr to overnight at RT with 
shaking. They were then fixed in destaining solution and dried on Whatman 3MM 
paper. 
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Ponceau S staining. 
Filter was incubated for 5-10 min in 1X Ponceau S with gentle agitation. It was then 
washed in several changes of deionized H2O with agitation at RT, until individual 
protein bands became apparent. 
 
Western blotting. 
Gels to be analyzed by Western blotting were blotted onto Amersham Hybond 
Nitrocellulose filters for ECL analysis using a dry blotting system (Biorad). The 
current limit was set to 5.5mA/cm2 for minigels and blotting was performed for 30 
min. The filter was then blocked by washing it in 5% low fat milk in PBT with gentle 
agitation for 1hr at 4°C. The filter was washed 3 times in PBT and incubated with the 
corresponding primary antibody (preabsorbed for 1hr at 4°C in 5% low fat milk in 
PBT) and shaken overnight at 4°C. After washing 3 times in PBT the secondary 
antibody (also preabsorbed for 2hr in 5% low fat milk in PBT at 4°C) was added to 
the filter and this was shaken for 2 hr at RT. The filter was washed three times in 
PBT and proteins were visualized using the Amersham ECL protocol. 
 
SP6 in vitro transcription. 
The following reaction protocol is for the transcription of 2µl RNA 
 
10X Transcription buffer (Boehringer) 2µl 
10X NTPs (10X=5mM)   2µl 
Template DNA (approx. 1µg/ml)  2µl 
RNasin (40U/µl)    1µl 
SP6 RNA Polymerase (Boehringer)  2µl 
ddH2O      11µl 
 
Transcription was performed for 2hr at 40°C and RNA was stored at -70°C. Capped 
mRNA was produced using the MEGAscript transcription kit from Ambion. 
 
Rabbit reticulocyte in vitro translation. 
The following reaction protocol is for a translation volume of 50µl 
 
Rabbit reticulocyte lysate  35µl 
1mM  Amino acids minus Met 1µl 
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35S-Met (11mCi/ml)   4µl 
RNasin (40U/µl)   0.5µl 
Template RNA(100-200µg/ml) 2µl 
ddH2O     7.5µl 
 
The relative proportions of each of the individual components was maintained for 
every in vitro translation reaction. Reactions were performed for 1.5 hr at 30°C.  
 
Kinase assays. 
Aliquots of Cyclin A and Cdk1 were in vitro translated using the protocol outlined 
above. These aliquots were then mixed together with either a 0-1hr embryonic 
extract or an aliquot of GST-CIV with 10mM MgCl2 and 2mM ATP. Mixtures were 
incubated for 30 min at 30°C to allow sufficient T161 phosphorylation of Cdk1. 
Fractions were immunoprecipitated through the addition of 1.5µl monoclonal mouse 
anti-HA antibody (1mg/ml, Boehringer clone 12CA5) and 10µl Protein G-agarose 
beads (Pharmacia). This was then gently shaken in 300µl immunoprecipitation buffer 
for 2hr at 4°C. Beads were pelleted by centrifuging for 2min at 2000rpm in a bench-
top centrifuge at 4°C, washed twice in immunoprecipitation buffer and either directly 
analyzed on a polyacrylamide gel or processed further for a kinase assay. 
Immunoprecipitation fractions were washed a further two times in 300µl pre-kinase 
wash buffer. Beads were then pelleted by centrifuging at 4°C for 2min with 2000rpm 
in a bench-top centrifuge and the buffer was completely removed. Each fraction was 
completely resuspended in 15µl kinase buffer and incubated for 20min at 30°C. 
Reactions were stopped by the addition of 15µl sample loading buffer. For the 
analysis of kinase assay reaction products on small gels 7.5µl aliquots of each 
sample was loaded on a 5%-12% gel. For the analysis of reaction products on larger 
gels 15µl samples were loaded. Electrophoretic conditions were as described above. 
32P-H1 was visualized by autoradiography and phosphorimaging. 
 
Phosphorimaging. 
phosphorimaging was performed using a Fuji phosphorimager screen and 
phosphorimager. Large gels were exposed for 3hr and minigels were exposed for a 
maximum of 2hr. To determine the intensity of each signal an area corresponding to 
what could be clearly identified as the 32P-H1 signal was marked and analyzed. An 
equal area was then marked in the lane in which the molecular weight markers ran, 
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and used to determine the background value. This value was subtracted from the 
32P-H1 signal to determine the actual level of H1 phosphorylation. 
 
DROSOPHILA METHODS 
 
Maintenance of flies. 
Flies were maintained under standard conditions (Ashburner, 1989, Wieschaus and 
Nüsslein Volhard, 1986) in large (4.5cm diameter, 9.5cm length) or small (2.1cm 
diameter, 6.3cm length) cylindrical plastic containers filled to one third food and 
plugged with a foam top. They were kept at 18°C. Food was prepared by boiling 
240g Agar in 10l water for 2.5hr. 2.4kg corn flour, 430g yeast, 300g Soya flour, 2.4kg 
malt extract and 640g molasses in 15l water were added and this mixture was boiled 
for a further 2.5 hours. Once the mixture cooled to below 60°C 190ml Propionic Acid 
was added and the food was poured into the plastic containers. 
 
Collecting embryos. 
Embryos were collected under standard conditions (Ashburner, 1989, Wieschaus 
and Nüsslein Volhard, 1986), using laying cages. Apple juice agar plates were made 
by dissolving 90g Select Agar (GibcoBRL) in 3l water by bringing to the boil. 
Meanwhile 1l apple juice, 6g p-hydroxy-benzoic acid methyl ester (Nipagen, Sigma) 
and 100g sugar were heated until the nipagen was dissolved. The two solutions were 
mixed after cooling to below 60°C. The mixture was then poured onto 100mm 
diameter plates. Embryos were collected from apple-juice agar plates and snap 
frozen in liquid nitrogen (see Embryo Homogenization) for preparation of extracts. 
Embryos were fixed in formaldehyde/heptane, dehydrated in methanol and stored in 
methanol at –20°C for immunohistology. 
 
Production of embryo extracts. 
Wild type eggs were collected on apple juice agar plates, as described above. The 
eggs were gathered hourly and snap frozen immediately in liquid nitrogen. 0.75ml 
samples were homogenized on ice in 1ml homogenization buffer with six strokes a 
glass homogenizer. These samples were then centrifuged for 20min at 4°C and 
14,000rpm in a bench-top centrifuge. The interphase was then removed, divided into 
40µl aliquots, snap frozen immediately and stored at -70°C. 
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Precipitation of proteins from Drosophila embryos. 
Embryos of the correct stage and genotype were collected from apple juice agar 
plates, snap frozen in liquid nitrogen and stored at -70°C. 0.75ml embryos were 
homogenized in 1ml homogenization buffer on ice with six strokes of a glass 
homogenizer. 10µl Protein G beads and the correct amount of antibody were added 
to the extract. The extract was shaken overnight at 4°C. Beads were collected at the 
bottom of the tube by centrifuging for 2min at 2000rpm and 4°C in a bench top 
centrifuge. The supernatant was discarded and the beads washed three times in IP 
buffer. Precipitated proteins were either retained for a kinase assay or analyzed by 
SDS-PAGE and Western Blotting. 
 
Fixation of embryos 
Embryos were dechorionated in a 1:1 mixture of water and bleach for 2min on an 
apple juice agar plate. Embryos were poured through a sieve and washed with water. 
The embryos were then transferred to a 1.5ml sample tube containing 700µl heptane 
and 700µl 4% formaldehyde in PBS and shaken for 20min at 37°C. Afterwards the 
aqueous (lower) phase was removed and the embryos devitellinized by shaking 
vigorously for 30s after addition of 700µl methanol. Embryos were washed three 
times with methanol and either stored at –20°C or rehydrated by washing five times 
in PBT. 
 
In situ hybridization 
mRNA was visualized in Drosophila embryos by in situ hybridization (Tautz and 
Pfeifle, 1989). mRNA probes were prepared using the DIG-DNA labeling kit 
(Boehringer Mannheim). 
 
Immunohistology 
Rehydrated embryos were blocked by rotating for 1hr at RT in blocking mix (1%NGS 
and 5%BSA in PBT). Embryos were incubated by rotation in the primary antibody in 
blocking mix overnight at 4°C. The primary antibody was removed and the embryos 
washed five times quickly in PBT. Embryos were then washed for 3 X 15min in 
300mM NaCl in PBT and then washed five times quickly in PBT. The secondary 
antibody was incubated with the embryos in blocking mix for 2hr at RT. Secondary 
antibodies were coupled with a fluorescent dye (FITC, Texas Red, Alexa 488). 
Nuclear envelopes were visualized by incubating the embryos with Texas Red 
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labeled Wheat Germ Agglutinin for 2hr at RT. Embryos were washed five times 
quickly and 3 X 10min in PBT. Stained embryos were imbedded in Vectashield and 
stored at 4°C. 
 
RNA injection into Drosophila embryos 
RNA was injected into Drosophila embryos according to the technique in (Sprenger 
and Nüsslein Vollhard, 1992). 0-1hr embryos were dechorionated on apple juice agar 
plates, collected in a sieve and washed in water. Approx. 300 embryos were lined up 
on a cold slice of apple juice agar and stuck to a coverslip with heptane. The 
embryos were dried for 9-12 minutes in a dessicator and covered with 10S Voltalef 
oil. RNA was injected into one pole of the embryos prior to cellularization and 
embryos were aged for a further 2hr to allow translation of the injected mRNA. 
 
 
Microscopy 
Immunofluorescent pictures were taken using a Leica Confocal microscope and a 
Zeiss Axiovert 10. For high magnification pictures, z-stacks were obtained using a 
piezoelectric mover and deconvolved using the AutoDeBlur program (Autoquant). 
For time-lapse video microscopy, images were taken every 20 sec on the Zeiss 
Axiovert 10 microscope using a Quantix CCD-camera (Photometrics).
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ZUSAMMENFASSUNG 
Ein normaler Ablauf des Zellzyklus ist essentiell für die korrekte Musterbildung und 
das Überleben eines Eukaryontens. Zwei Schlüsselereignisse im Zellzyklus, die DNA 
Replikation während S phase und die Chromatidsegregation während der Mitose, 
werden von einer konservierten Kinasefamilie, den Cyclin Dependent Kinases 
(CDKs), katalysiert. Während der Evolution sind mehrere Mechansimen entstanded, 
die die CDK Aktivität kontrollieren; kovalente Modifikation von CDKs, 
Cyclinproteolyse und CDK/Cyclin Inhibition durch die sogennanten CDK Inhibitors 
(CKIs). 
Das Produkt des Drosophilagens Rux inhibiert CycA abhängige Aktivität aktivität und 
verhindert dadurch einen frühzeitigen Eintritt in die S Phase während der 
Augenentwicklung. In dieser Arbeit wird gezeigt, dass Rux ein Drosophila CKI ist. 
Rux assoziert mit den mitotischen Cyclinen A und B und seine Überexpression im 
Embryo verhindert die Mitose. Die in dieser Arbeit beschriebenen in vitro 
Experimente zeigen, dass Rux die Aktivität von Cdk1/CycA und Cdk1/CycB 
Komplexen inhibieren, aber auch die eigentliche Aktivierung von Cdk1 verhindern 
kann. Die Aktivität des Cdk2/CycE Komplexes wird in diesen Experimenten nicht 
inhibiert und die Überexpression von Rux in Embryonen stört die CycE abhängigen 
S-Phasen nicht. Interesanterweise ist Rux die erste CKI spezifisch für mitotische 
Cycline, die in einem multizellülarem Organismus characterisiert worden ists. 
In dieser Arbeit wird auch gezeigt, dass das Rux Genprodukt eine Rolle in der Mitose 
spielt. Die Metaphase in rux Mutantendauert länger . Rux Überexpression kann einen 
Metaphase-Arrest aufheben, der durch Expression von stabilem CycA hervorgerufen 
wird und rux Mutanten zeigen eine veringerte Fähigkeit die Metaphase nach 
Überexpression von stabilem CycA zu verlassen. Rux trägt also zur Metaphase zu 
Anaphase Transition durch die Inhibition von Cdk1/CycA Aktivität bei, dass heisst in 
einer Weise, die nicht von der CycA Proteolyse abhängt. Eine ähnliche Funktion ist 
schon für den S. cerevisiae CKI, SIC1 gezeigt worden. Diese Arbeit zeigt, dass SIC1 
überexpression in Drosophila Mitose und die Cdk1/CycA und Cdk1/CycB Komplexe 
inhibieren kann. Dies deutet auf eine funktionele Ähnlichkeit zwischen Sic1p und Rux 
deutet. 
In dieser Arbeit wird zusätzlich gezeigt, dass Rux in G1 Zellen stabil ist und vom 
Proteasom vor der S Phase abgebaut wird. Rux abbau is durch ein PEST Sequenz 
im C-terminus des Proteins bestimmt. Aufgrund der vorliegenden Ergebnisse wird 
folgendes Model für die Funktion von Rux vorgeschlagen; Rux ist ein Drosophila 
CDK Inhibitor mit einem spezifität für mitotischen Cycline, der die Cdk1/CycA 
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Aktivität während der Metaphase inhibiert und diese Aktivität auch in der G1 phase 
auf einem niedrigen Niveau hält. Rux wird vom Proteasom vor der S phase 
abgebaut, und dies ist eine Voraussetzung für die Accumulation von CycA 
abhängiger Kinaseaktivität. 
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ABBREVIATIONS 
APS      Ammoniumperoxidisulfate 
ATP      Adenosine Triphosphate 
bp      base pairs 
BSA      Bovine Serum Albumin 
cDNA      complementary DNA 
DMSO      Dimethylsulfoxide 
DNA      Desoxyribonucleic acid 
DTT      Dithiothreitol 
EDTA      Ethelyne Diamine Tetracetic Acid 
Fig.      Figure 
g      gram 
GST      Glutathione-S-transferase 
h      Hour 
IPTG      Isopropyl-thio-galactose 
k      kilo 
kD      kilodalton 
l      liter 
M      mol per litre 
m      milli 
µ      micro 
mRNA      messenger RNA 
n      nano 
NGS      Normal goat serum 
ORF      Open Reading Frame 
PAGE      Polyacrylamide gel electrophoresis 
PBS      Phosphate Buffered Saline 
PCR      Polymerase chain reaction 
RNA      Ribonucleic acid 
RT      Room Temperature 
SDS      Sodium dodecyl sulfate 
TEMED     N,N,N’,N’-Tetramethylendiamin 
U      Unit 
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Single and three letter code for amino acids 
A   Ala   Alanine 
C   Cys   Cysteine 
D   Asp   Aspartate 
E   Glu   Glutamate 
F   Phe   Phenylalanine 
G   Gly   Glycine 
H   His   Histidine 
I   Ile   Isoleucine 
K   Lys   Lysine 
L   Leu   Leucine 
M   Met   Methionine 
N   Asn   Asparagine 
P   Pro   Proline 
Q   Gln   Glutamine 
R   Arg   Arginine 
S   Ser   Serine 
T   Thr   Threonine 
V   Val   Valine 
W   Trp   Tryptophan 
Y   Tyr   Tyrosine 
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